guidelines on the prevention and control of tuberculosis
TRANSCRIPT
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-156-
List of Appendices Appendix 1: List of Groups who were Consulted
Appendix 2: Notification Pathway for a Case of TB
Appendix 3: Tuberculosis Notification Form
Appendix 4: Ways to Assess and Promote Adherence to LTBI Treatment
Appendix 5: TB Therapy Audit Form
Appendix 6: Questions and Answers about TB
Appendix 7: Contact Details for Clinical and Laboratory TB Advice
Appendix 8: International Standards for TB Care
Appendix 9: DOT Referral form-HSE South (Cork and Kerry)
Appendix 10: Standard and Airborne Precautions
Appendix 11: Discharge Instructions for Patients with Potentially Infectious TB
Appendix 12: List of TB-related Websites and Resources
Appendix 13: Respiratory Hygiene and Cough Etiquette
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-157-
Appendix 1: List of groups who were consultedThe following is a list of those to whom a draft of the document was sent for consultation as well as those who made submissions. The document was also posted on the HPSC website. We would like to thank those who made submissions for their invaluable contribution to this document.
Academy of Medical Laboratory Science
Claire Keane, Senior Pharmacist, St. Vincent’s University Hospital, Elm Park, Dublin 4
Consultants in Public Health Medicine
Directors of Public Health
Directors of Public Health Nursing in HSE areas
Dr Eibhlin Connolly, Deputy Chief Medical Officer, Department of Health and Children
Dr Karoline de La Hoz, European Centre for Disease Prevention and Control
Dr Enda Dooley, Medical Director, Department of Justice, Equality and Law Reform
Dr Pat Doorley, National Director of Population Health
Dr Kevin Kelleher, Assistant National Director of Health Protection
Dr Jim Kiely, Chief Medical Officer, Department of Health and Children
Dr Tom O Connell, Chief Medical Officer, Occupational Health Department, Civil Service
Emergency Medicine Association
Faculty of Occupational Medicine, Royal College of Physicians of Ireland
Faculty of Paediatrics, Royal College of Physicians of Ireland
Faculty of Pathology, Royal College of Physicians of Ireland
Faculty of Public Health Medicine, Royal College of Physicians of Ireland
Faculty of Radiology, Royal College of Surgeons of Ireland
Geraldine O Connell Public Health Nurse, South Lee Public Health Nursing Department
Imelda O Connor, Public Health Nurse, HSE-Midwest
Irish College of General Practitioners
Irish Infection Society
Infection Prevention Society
Irish Medicines Board
Irish Society of Clinical Microbiologists
Irish Society of Gastroenterology
Irish Society of Physicians in Geriatric Medicine
Irish Society of Rheumatology
Irish Thoracic Society
Maeve Moran, Senior Pharmacist, St. Vincent’s University Hospital, Elm Park, Dublin 4
Mairead Lane, Occupational Health Department, Mid-Western Regional Hospital, Limerick,
Marie Philbin, Chair of Irish Antimicrobial Pharmacists Group
National Immunisation Advisory Committee, Royal College of Physicians of Ireland
National Immunisation Office
Principal Medical Officers, HSE
Public Health Medicine Communicable Disease Group
Royal College of Physicians of Ireland
School of Pharmacy, Royal College of Surgeons, Ireland
Stella Sheehan, Senior Medical Laboratory Technician, Cork University Hospital
Surveillance Scientists Association
The Federation of Irish Nursing Homes
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-158-
Appendix 2: Notification pathway for a case of TB
TB is a notifiable disease. A case of TB should be notified to the department of public health in the relevant HSE area. Currently, the department of public health in turn notifies HPSC through the enhanced TB surveillance system each quarter. Once TB is incorporated onto CIDR, TB cases will be notified to HPSC in “real-time”/weekly basis. HPSC produces quarterly and annual national TB reports.
Case of TB (GP, respiratory/infectious disease
clinician, nursing home, laboratory, etc)
Notify the department of public health (DPH/MOH) in relevant
HSE area
Weekly notifications once TB is incorporated onto CIDR
Currently NTBSS 2000 quarterly returns
Health Protection Surveillance Centre
Quarterly and annual national TB reports
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-159-
Appendix 3: Tuberculosis Notification Form
National Tuberculosis Notification Form
TB Case Registration: Year Sequence NumberCCACountyHealth Area
Address
First Name / Initial Surname / Initial
Phone
2 0
A. SOCIODEMOGRAPHIC DETAILS B. DIAGNOSTIC & CLINICAL DETAILS
1. Sex:
4. Most recent occupation
3. Age (years)
2. Date of Birth
10. Date of onset of symptoms
12. Date of notification
11. Date diagnosed
If Extrapulmonary or P+E,please specify site(s)
15. Histology:
Negative
Not done
Positive
Unknown
18. Isolate
M. TB
Other
M. Bovis
Unknown
If OTHER, please specify:
22. BCG Given
23. BCG Scar
25. Immune Code (see explanatory notes)
26. (a) At 2 mths:
If ZN pos at 2 mths then go to (b), otherwise go to (d)
(b) At 3 mths:
(c) At 5 mths:
(d) Rx end:
If ZN pos at 3 mths then go to (c), otherwise go to (d)
Please now go to (d)
Direct Sputum microscopy Not done
Direct Sputum microscopy Not done
Direct Sputum microscopy Not done
Direct Sputum microscopy Not done
If YES, please specify new diagnosis
27. Treatment Outcome
If dead, date of death
Interrupted (>2months)
DiedLost to follow up
Completed
C. OUTCOME DETAILS (**Please note that 26 (a), (b), (c) and (d) apply to SMEAR POSITIVE cases ONLY**)
NoYes Unknown
NoYes Unknown
ZN pos
ZN pos
ZN pos
ZN pos
ZN neg
ZN neg
ZN neg
ZN neg
ZN not done
ZN not done
ZN not done
ZN not done
If dead, was TB the direct cause? NoYes
28. Case Denotified? (i.e. was diagnosis changed?)
NoYes
Pos
Pos
Pos
Pos
Neg
Neg
Neg
Neg
Culture
Culture
Culture
Culture
16. Chest x-ray:
Inactive / Old TB
OtherNormal
Active TB
13. Diagnosis (tick one only)
Pulmonary Extrapulmonary
Pulmonary + extrapulmonary (P+E)
8. Race or ethnic group
Caucasian
Black
Indian subcontinent
Traveller
Chinese
Other
If OTHER, please specify:
6. Current living status
Home (private / rented)
B&B / Hotel
Homeless
Other
Prison
Institution
Hostel
5. Current employment status
Paid employment
Retired
Housewife / husband
Unemployed
Student
Other
If OTHER, please specify:
21. Previous history of TB
If YES, please specify:
(b) treated >1month?
(a) year of diagnosis
(c) cured?
NoYes Unknown
NoYes Unknown
NoYes Unknown
24. Risk Factors
If YES, please specify:(e.g. immunosupression, C2H5xs, IVDU)
NoYes Unknown
19. Drug sensitivities (S = sens, R= res, N = not done) (Please fill for each drug used)
20. This case was found by
Presenting as case Contact tracing
Other screeningImmigrant screening
Other (specify)
Isoniazid
Other (specify)
Rifampicin
EthambutolPyrazinamide
If OTHER, please specify:
9. Refugee / asylum seeker
If YES, date/year of entry into Ireland:
NoYes
If OTHER, please specify country:
7. Country of Birth
OtherIreland
FemaleMale
If done, please specify culture site:
17. Culture Results
Culture neg
Culture not done
Culture pos
Unknown
14. Direct sputum microscopy:
Specimen date
Specimen date
(a) 1st specimen
ZN not done
ZN neg
ZN pos
(b) 2nd specimen
ZN not done
ZN neg
ZN pos
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-160-
Thank you for completing this form. Please forward completed forms to your local Department of Public Health
National Tuberculosis Notification Form
(D) CASE LOCATION DETAILS
DED name / code:Hospital name:
Chart Number:
School Address:
Work Address:
(E) CONTACT TRACING DETAILS
Is this case:
Index case or Contact of another case (please tick 1)
If contact of another case, please complete
Address ofindex case:
Name of index case:
REG ID of index case:
Date of notification of index case:
COMPLETING DOCTOR SIGNATURE
Date 1
Date 6
Date 5
Date 4
Date 3
Date 2
Signature 1
Signature 6
Signature 5
Signature 4
Signature 3
Signature 2
Section completed: EDCBA
Section completed: EDCBA
Section completed: EDCBA
Section completed: EDCBA
Section completed: EDCBA
Section completed: EDCBA
Tick section(s) completed:
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-161-
Appendix 4: Ways to assess and promote adherence to LTBI treatmentWays to assess and promote adherence to LTBI treatment
1. Use directly observed therapy (DOT) for LTBI when available especially for foreign-born persons from countries with an annual TB notification rate ≥ 40 cases per 100,000, homeless persons and intravenous drug users
2. Provide written information about the potential adverse effects of the medications at the start of treatment
3. Send reminder letters or call patients before appointments
4. Follow up promptly on missed appointments to prevent interruption or cessation of treatment
5. Minimise wait time at clinics
6. Ask patients at monthly visits about the number of missed pills in the past week
7. Remind patients to bring in their medication bottle (s) and monitor pill counts (but not in their presence)
8. During each monthly visit, stress the importance of adherence and educate patients about the potential adverse effects of medication.
Adapted with kind permission from Tuberculosis, Clinical Policies and Protocols. New York City Department of Health and Mental Hygiene (2008). Available from www.nyc.gov/html/doh/downloads/pdf/tb/tb-protocol.pdf.
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-162-
Appendix 5: Tuberculosis Therapy Audit Form
Tuberculosis Therapy Audit FormPreventive and Curative Therapy Monitor
Month 1 - 6
Bilirubin (total)
Alk Phos (result)
GGTAST / SGOTALT / SGPT
LFTs done? (Y/N)INVESTIGATIONSOther (please specify)ParaesthesiaFatigue (> 3 days)Fever (> 3 days)Dark urineJaundiceRashAbdominal discomfortVomitingNauseaAnorexiaSYMPTOM CHECKAdministration (S or D)*COMPLIANCEOther (please specify)EthambutolStreptomycinPyrazinamideRifampicinIsoniazidTREATMENT
Date
If Resistant, specifyResistance (Y/N)Culture (Pos/Neg)Direct micro (Y/N)Sputum sample (Y/N)Bilirubin (direct)
5321 4 76
Record result once available. Not available =
GOOD = +++, UNCERTAIN = ++, UNSATISFACTORY = +
YES= NO=
* S = Self administered, D = Directly Observed (Preventive) Therapy i.e. DOT
Contact numberIndex case numberIs the patient a: TB case TB contact Date therapy started
Site:NegativePositiveSputum smear:ExtrapulmonaryPulmonaryLaboratory confirmedClinically suspectedTB diagnosis:Index case details -
Surname
Age (years)DOBPhoneAddress
Forename
Hospital/clinicLHOHSE area
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-163-
Appendix 6: Questions and Answers about Tuberculosis
What is Tuberculosis? Tuberculosis or “TB” is a disease caused by a bacterium (germ) called Mycobacterium tuberculosis. TB usually affects the lungs but it can also affect other parts of the body, including the glands, the bones and rarely the brain.
Tuberculosis used to be more common in Ireland. There were nearly 7,000 cases a year in the early 1950s. The incidence of TB has declined steadily since then. In 2006, there were 465 cases notified in Ireland. Doctors are obliged to notify each case of TB to the local departments of public health in the Health Service Executive.
TB disease is preventable and curable.
What are the symptoms of TB? Symptoms of TB can include any of the following:
• Fever and night sweats • Cough (generally lasting more than 3 weeks) • Weight loss • Blood in the sputum (phlegm) at any time.
A person with any of these symptoms should visit their family doctor for advice.
How is TB spread? TB is usually spread in the air from another person who has TB of the lungs. It is spread by that person coughing, sneezing or spitting. People with TB in the lungs or throat can be infectious. This means that the bacteria can be spread to other people. Even then close and prolonged contact with such a person (i.e. family, friends, childminder, co-worker) is needed to become infected. Most cases of infectious TB stop being infectious after a few weeks of treatment. TB in other parts of the body such as the kidney or spine is usually not infectious.
Another type of TB called Mycobacterium bovis can arise from drinking contaminated milk. This form of TB is now rare as pasteurisation of milk removes the risk.
The following people have a greater chance of becoming ill with TB, if exposed to it: • Those in very close contact with infectious people • Children • Elderly people • Diabetics • People on steroids • People on other drugs affecting the body’s defence system • People who are HIV positive • People in overcrowded, poor housing • People dependent on drugs or alcohol • People with chronic poor health.
What happens when a person is found to have infectious TB?• Treatment for TB is started • Public health doctors talk to the infected patient to see if other people need to be checked for TB.
What is the difference between latent tuberculosis infection and active tuberculosis disease? Infection with the TB bacterium may not develop into TB disease. Most people who are exposed to TB are
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2009 HSE/HPSC
-164-
able to overcome the bacteria. The bacteria become inactive but they remain dormant in the body and can become active later. This is called latent TB infection (LTBI).
People with LTBI: • Have no symptoms • Don’t feel sick • Can’t spread TB to others • Usually have a positive skin test reaction • Can develop TB disease later in life.
Most people who have LTBI never develop active TB disease. In these people, the TB bacteria remain inactive for a lifetime without causing disease. But in other people, who have weak immune systems, the bacteria can become active and cause TB disease.
The difference between latent TB infection and active TB disease
A person with Latent TB Infection A person with Active TB Disease
• Has no symptoms
• Does not feel sick
• Usually has a positive skin test or blood test
• Has a normal chest X-ray and sputum test
• Has symptoms which may include:
A bad cough which lasts three weeks or longer
Pain in the chest
Coughing up sputum (phlegm) or blood
Weakness or fatigue
Weight loss
No appetite
Chills
Fever
Night sweats
• May spread TB to others
• Usually has a positive skin test or positive blood test
• May have an abnormal chest X-ray or positive sputum-smear or culture
How is TB diagnosed? There are a number of tests that can be done to check for TB:
• A skin test • A chest X-ray • A test of the sputum (phlegm) • A blood or urine test.
How is TB treated? Yes, today TB is potentially completely curable, if the responsible organism is fully sensitive to the antibiotics being used and the patient takes his or her medication as prescribed.
TB is treated with tablets which must be taken for at least six months. Without treatment, many people used to die from TB. It is essential to take the treatment regularly and to complete the course as prescribed.
The most common medicines used to treat TB are: isoniazid, rifampicin, ethambutol and pyrazinamide. A vitamin B6 tablet called pyridoxine is also prescribed to help prevent some of the side effects that may be caused by isoniazid. Your doctor will decide which TB drugs are best for you.
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2009 HSE/HPSC
-165-
If you have infectious TB (TB disease of the lungs or throat), you will need to stay at home from work or school so that you don’t spread the TB bacteria to other people. After taking your medicines for a few weeks, you will feel better and will no longer be infectious to others. Your doctor will tell you when you can return to work or school or visit friends.
What are the side effects of TB medicines?If you are taking medicines for TB, you should take them as directed by your doctor or nurse. The medicines may cause side effects but everyone can react differently and not everyone will have side effects. It is important to report any side effects to your doctor even if they are not listed below. Side effects include:
• No appetite• Nausea (feeling sick in the stomach) and/or vomiting• Abdominal pain (tummy pain)• Yellowish skin or eyes• Dark-coloured urine• Fever for 3 or more days• Skin rash• Itching• Tingling of fingers or toes or around the mouth• Easy bleeding and/or bruising• Blurred or changed vision• Ringing in the ears• Hearing loss• Dizziness• Aching joints.
The following side effects are caused by rifampicin. If you have any of these side effects you can continue your medications (your doctor will advise you of these before starting treatment for TB):
Rifampicin can: • Turn your urine, saliva (spit) or tears orange. The doctor or nurse will advise you not to wear
contact lenses as they may get stained.• Make your skin more sensitive to the sun. This means you should use a good sunscreen and cover
exposed areas so that they don’t burn.• Make birth control pills and implants less effective. Women who take rifampicin should use another
form of birth control.
How important is treatment? Treatment is very important. If you have TB disease or if you have been infected with the TB bacterium but have not yet become unwell i.e. have LTBI, you must take the treatment as directed. It is very important to complete the full course of treatment as it will stop you being infectious (spreading the disease to others) and it will remove the risk of you developing drug-resistant TB. It is important to remember that TB used to kill people before we had modern treatments. Can I drink alcohol with my medication? It is always best to avoid alcohol while you are taking TB medicines. This is because drinking any alcohol can increase the chances of having problems with your liver when taking the medications.
What precautions need to be taken to prevent TB spreading in the home?Some patients who are infectious (with TB) can remain at home in the household that has already been exposed. However, the following precautions should be taken:
• Use tissues when sneezing or coughing and place into a household bin immediately after use• Wash hands after disposing of the tissues• Stay at home and do not go to places where there will be previously unexposed people (e.g. pubs,
clubs, cinemas)• Attend all outpatient visits • No visits by previously unexposed people
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-166-
• Children who do not live at home should not visit until your doctor allows• Relatives or friends who have weakened immune systems should not visit until your doctor allows• You can go for a walk outside but you should avoid close contact with previously unexposed
people.
Most people are no longer infectious when they have completed a few weeks of TB tablets and are feeling better and their cough is gone or improving. However your doctor will advise you when the above precautions are no longer necessary. It is also very important that you continue your medications until the doctor tells you to stop.
What should I do if I have been in contact with someone with TB? Discuss this with your family doctor. Only close contacts are at risk of catching TB. You may be asked to attend a chest clinic and to have a skin test and/or a chest X-ray. Sometimes a doctor or nurse will contact you first (they will have a list of close contacts of the person who has TB). This does not necessarily mean that you have TB but is a chance to check for it, so it is very important to attend if you are asked to.
Can TB be prevented? Yes it can, in several ways:
• Treating all people with active TB disease promptly. After two weeks of treatment, most patients are no longer infectious to other people.
• Ensuring that all close contacts of people with TB are seen promptly in the chest clinic. Those found to have LTBI or those at high risk of developing TB after close contact may be offered a course of preventive therapy (chemoprophylaxis) once active TB has been ruled out.
• Vaccination: In Ireland the BCG vaccination (vaccine against TB) is recommended for newborn babies. BCG is also given to adults who are considered to be at risk of developing TB where potential contact with the disease could occur or has occurred. BCG vaccine is very effective, particularly in preventing childhood TB and the more severe forms of TB.
What are multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB)
Multidrug-resistant TB (MDR-TB)MDR-TB is a specific form of TB which is resistant to at least isoniazid and rifampicin, two of the main first line drugs used in the treatment of TB. MDR-TB therefore is much more difficult to treat. It takes longer to treat with second line drugs which are more expensive and have more side-effects.
Extensively drug-resistant TB (XDR-TB)XDR-TB is a rare type of MDR-TB which is also resistant to any of a group of drugs called fluoroquinolones and at least one of three injectable second line anti-TB drugs (capreomycin, kanamycin or amikacin). Because XDR-TB is resistant to first line and second line drugs, treatment options are more limited. Further information on XDR-TB can be found on the WHO website at www.who.int/tb/challenges/xdr/en/index.html
Information on TB in Ireland can be found on the Health Protection Surveillance Centre website at www.hpsc.ie/hpsc/A-Z/VaccinePreventable/TuberculosisTB/.
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
Appendix 7: Contact details for clinical and laboratory TB adviceRespiratory PhysiciansDr Tim McDonnell, St Vincent’s University Hospital, DublinDr Brendan Keogh, Mater Misericordiae Hospital, DublinDr Terry O Connor, Mercy University Hospital, CorkDr JJ Gilmartin, University College Hospital, Galway
Infectious disease PhysiciansDr C. Fleming, University College Hospital, GalwayDr Karina Butler, Our Lady’s Hospital, Crumlin, Dublin
Consultant Microbiologists Dr Margaret Hannan, Mater Misericordiae Hospital, DublinDr Bartley Cryan, Cork University Hospital
Irish Mycobacteria Reference Laboratory Mr Noel Gibbons, Chief Medical Scientist, (01) 416 2963, [email protected] Prof T Rogers, Clinical Director, (01) 896 2131, [email protected] Dr J Keane, Consultant Respiratory Physician, (01) 410 3920, [email protected]
Webpage: www.stjames.ie/Departments/DepartmentsA-Z/I/IMRL/DepartmentOverview/ or go to www.stjames.ie choose Lab services and then Irish Mycobacteria Reference Laboratory
Antimicrobial Reference Laboratory,
Department of Medical Microbiology, North Bristol NHS Trust, Southmead Hospital, Bristol BS10 5NB, United Kingdom
The Antimicrobial Reference Laboratory user manual may be found at www.bris.ac.uk/bcare/AssayBooklet.doc
Results and general inquiries: Tel. No: 00-44-117-959-5653
Service Enquiries Prof A. P. MacGowan, Consultant Medical Microbiologist. Contact telephone no: 0044- 117-959-5652Email address: [email protected]
Dr. A. M. Lovering, Consultant Clinical Scientist. Contact telephone no: 0044-117-959 5653Email address: [email protected]
Mr. H. A. Holt, Laboratory Manager. Contact telephone no: 0044-117-959-5658Email address: [email protected]
-167-
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
Appendix 8: International Standards for Tuberculosis CareIn 2006 the “International Standards for Tuberculosis Care” were published to describe a widely accepted level of care that all practitioners, public and private should seek to achieve in managing patients who have or are suspected of having tuberculosis. The standards are outlined below. The full document is available at www.who.int/tb/publications/2006/istc_report.pdf.
Standards for DiagnosisStandard 1. All persons with otherwise unexplained productive cough lasting two to three weeks or more should be evaluated for tuberculosis.
Standard 2. All patients (adults, adolescents, and children who are capable of producing sputum) suspected of having pulmonary tuberculosis should have at least two and preferably three, sputum specimens obtained for microscopic examination. When possible, at least one early morning specimen should be obtained.
Standard 3. For all patients (adults, adolescents, and children) suspected of having extrapulmonary tuberculosis, appropriate specimens from the suspected sites of involvement should be obtained for microscopy and, where facilities and resources are available, for culture and histopathological examination.
Standard 4. All persons with chest radiographic findings suggestive of tuberculosis should have sputum specimens submitted for microbiological examination.
Standard 5. The diagnosis of sputum smear-negative pulmonary tuberculosis should be based on the following criteria: at least three negative sputum smears (including at least one early morning specimen), chest radiography findings consistent with tuberculosis and lack of response to a trial of broad spectrum antimicrobial agents. (Note: Because the fluoroquinolones are active against M. tuberculosis complex and thus may cause transient improvement in persons with tuberculosis, they should be avoided.) For such patients, if facilities for culture are available, sputum cultures should be obtained. In persons with known or suspected HIV infection, the diagnostic evaluation should be expedited.
Standards for TreatmentStandard 6. The diagnosis of intrathoracic (i.e. pulmonary, pleural, and mediastinal orhilar lymph node) tuberculosis in symptomatic children with negative sputum smears should be based on the finding of chest radiographic abnormalities consistent with tuberculosis and either a history of exposure to an infectious case or evidence of tuberculosis infection (positive TST or interferon gamma release assay). For such patients, if facilities for culture are available, sputum specimens should be obtained (by expectoration, gastric washings, or induced sputum) for culture.
Standard 7. Any practitioner treating a patient for tuberculosis is assuming an importantpublic health responsibility. To fulfill this responsibility the practitioner must not only prescribe an appropriate regimen but, also, be capable of assessing the adherence of the patient to the regimen and addressing poor adherence when it occurs. By so doing, the provider will be able to ensure adherence to the regimen until treatment is completed.
Standard 8. All patients (including those with HIV infection) who have not been treatedpreviously should receive an internationally accepted first-line treatment regimen using drugs of known bioavailability. The initial phase should consist of two months of isoniazid, rifampicin, pyrazinamide, and ethambutol. The preferred continuation phase consists of isoniazid and rifampicin given for four months. Isoniazid and ethambutol given for six months is an alternative continuation phase regimen that may be used when adherence cannot be assessed, but it is associated with a higher rate of failure and
-168-
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
relapse, especially in patients with HIV infection. The doses of antituberculosis drugs used should conform to international recommendations. Fixed-dose combinations of two (isoniazid and rifampicin), three (isoniazid, rifampicin, and pyrazinamide), and four (isoniazid, rifampicin, pyrazinamide, and ethambutol) drugs are highly recommended, especially when medication ingestion is not observed.Standard 9. To foster and assess adherence, a patient-centered approach to administration of drug treatment, based on the patient’s needs and mutual respect between the patient and the provider, should be developed for all patients. Supervision and support should be gender-sensitive and age-specific and should draw on the full range of recommended interventions and available support services, including patient counselling and education. A central element of the patient-centered strategy is the use of measures to assess and promote adherence to the treatment regimen and to address poor adherence when it occurs. These measures should be tailored to the individual patient’s circumstances and be mutually acceptable to the patient and the provider. Such measures may include direct observation of medication ingestion (directly observed therapy, DOT) by a treatment supporter who is acceptable and accountable to the patient and to the health system.
Standard 10. All patients should be monitored for response to therapy, best judged in patients with pulmonary tuberculosis by follow-up sputum microscopy (two specimens) at least at the time of completion of the initial phase of treatment (two months), at five months, and at the end of treatment. Patients who have positive smears during the fifth month of treatment should be considered as treatment failures and have therapy modified appropriately (see Standards 14 and 15). In patients with extrapulmonary tuberculosis and in children, the response to treatment is best assessed clinically. Follow-up radiographic examinations are usually unnecessary and may be misleading.
Standard 11. A written record of all medications given, bacteriologic response, and adverse reactions should be maintained for all patients.
Standard 12. In areas with a high prevalence of HIV infection in the general population and where tuberculosis and HIV infection are likely to co-exist, HIV counselling and testing is indicated for all tuberculosis patients as part of their routine management. In areas with lower prevalence rates of HIV, HIV counselling and testing is indicated for tuberculosis patients with symptoms and/or signs of HIV-related conditions and in tuberculosis patients having a history suggestive of high risk of HIV exposure.
Standard 13. All patients with tuberculosis and HIV infection should be evaluated to determine if antiretroviral therapy is indicated during the course of treatment for tuberculosis. Appropriate arrangements for access to antiretroviral drugs should be made for patients who meet indications for treatment. Given the complexity of co-administration of antituberculosis treatment and antiretroviral therapy, consultation with a physician who is expert in this area is recommended before initiation of concurrent treatment for tuberculosis and HIV infection, regardless of which disease appeared first.However, initiation of treatment for tuberculosis should not be delayed. Patients with tuberculosis and HIV infection should also receive cotrimoxazole as prophylaxis for other infections.
Standard 14. An assessment of the likelihood of drug resistance, based on history of prior treatment, exposure to a possible source case having drug-resistant organisms, and the community prevalence of drug resistance, should be obtained for all patients. Patients who fail treatment and chronic cases should always be assessed for possible drug resistance. For patients in whom drug resistance is considered to be likely, culture and drug susceptibility testing for isoniazid, rifampicin and ethambutol should be performedpromptly.
Standard 15. Patients with tuberculosis caused by drug-resistant (especially multiple drug-resistant [MDR]) organisms should be treated with specialised regimens containing second-line antituberculosis drugs. At least four drugs to which the organisms are known or presumed to be susceptible should be used and treatment should be given for at least 18 months. Patient centered measures are required to ensure adherence. Consultation with a provider experienced in treatment of patients with MDR-tuberculosisshould be obtained.
-169-
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
Standards for Public Health ResponsibilitiesStandard 16. All providers of care for patients with tuberculosis should ensure that persons (especially children under 5 years of age and persons with HIV infection) who are in close contact with patients who have infectious tuberculosis are evaluated and managed in line with international recommendations. Children under 5 years of age and persons with HIV infection who have been in contact with an infectious case should be evaluated for both latent infection with M. tuberculosis and for active tuberculosis.
Standard 17. All providers must report both new and retreatment tuberculosis cases andtheir treatment outcomes to local public health authorities, in conformance with applicable legal requirements and policies.
-170-
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-171-
Appendix 9: DOT referral form-HSE South (Cork and Kerry)
TO/ DIRECTOR OF PUBLIC HEALTH NURSING
REFERRAL REQUEST FOR DIRECTLY OBSERVED THERAPY (TUBERCULOSIS MEDICATION)
Name ________________________________ D.O.B. __________________ Home Address _________________________ Current Address (if different) ___________________ ______________________________________ __________________________________________ ______________________________________ __________________________________________ ______________________________________ ___________________________________________ Contact Number ________________________ Hospital _______________________________ Treating Consultant ______________________ GP _______________________________ Diagnosis ___________________________________________________________________ Date of commencement of TB therapy _____________________________________________ Most recent sputum: Date __________________ Result _________________________ Case Currently Infectious? Yes □ No □ Mask wearing recommended? Yes □ No □ (If yes, for how long? ___________________ ) Reason/s for DOT Request? Poor/Non compliance Yes □ No □ MDR-TB Yes □ No □ TB Relapse Yes □ No □ Homeless Yes □ No □ Other Yes □ No □ (Specify:_____________________) Date Next OPD Appointment ______________________ Patient informed of DOT Request? Yes □ No □ TB Medication ________________________________________________________________ ________________________________________________________________ ________________________________________________________________ ________________________________________________________________ ________________________________________________________________
(Prescription faxed) Signed: _______________________________________________ Date ______________ Referring Medical Consultant. □ c.c. Senior Medical Officer, Cork. Fax No. 021 4927370 □ c.c. Senior Medical Officer, Kerry. Fax No. 066 7184542
North Lee □ South Lee □ North Cork □ West Cork □ Kerry □
Hosp Logo Address
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
App
endi
x 10
: Sta
ndar
d an
d A
irbo
rne
Prec
autio
ns
Stan
dar
d P
reca
utio
ns t
o b
e us
ed b
y al
l HC
Ws
for
all p
atie
nts
in a
ll se
ttin
gs
at a
ll ti
mes
an
d
Air
bo
rne
Pre
caut
ions
, in
add
itio
n to
Sta
ndar
d P
reca
utio
ns, s
houl
d b
e in
stit
uted
whe
n ca
ring
fo
r a
sus
pec
ted
or
confi
rmed
cas
e o
f in
fect
ious
pul
mo
nary
or
lary
ngea
l TB
See
chap
ter
6 fo
r d
efini
tio
n o
f in
fect
ious
cas
eSe
e ch
apte
r 6
for
crit
eria
fo
r d
isco
ntin
uati
on
of
Air
bo
rne
Pre
caut
ions
Stan
dar
d P
reca
utio
ns m
ust
be
cont
inue
d f
or
all p
atie
nts
onc
e A
irb
orn
e P
reca
utio
ns a
re d
isco
ntin
ued
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Occ
upat
iona
l H
ealt
h P
rog
ram
me
All
HC
Ws
sho
uld
be
asse
ssed
by
an o
ccup
atio
nal h
eath
tea
m p
rio
r to
co
mm
enci
ng w
ork
. Thi
s as
sess
men
t sh
oul
d in
clud
e:
Imm
unis
atio
ns (I
rish
gui
del
ines
on
imm
unis
atio
ns r
equi
red
•
for
HC
Ws
are
avai
lab
le a
t w
ww
.hp
sc.ie
/hp
sc/A
-Z/
Vacc
ineP
reve
ntab
le/V
acci
nati
on/
Gui
dan
ce/)
Scre
enin
g H
CW
s w
ho p
erfo
rm e
xpo
sure
pro
ne p
roce
dur
es f
or
•b
loo
d b
orn
e vi
ruse
s. D
oH
C g
uid
elin
es a
vaila
ble
at
ww
w.d
ohc
.ie/
pub
licat
ions
/tra
nsm
issi
on_
of_
blo
od
_bo
rne_
dis
ease
s_20
06.h
tml
Pat
ient
P
lace
men
t
HC
Ws
sho
uld
incl
ude
the
po
tent
ial f
or
tran
smis
sio
n o
f in
fect
ious
ag
ents
in p
atie
nt p
lace
men
t d
ecis
ions
Whe
re p
oss
ible
, pla
ce p
atie
nts
who
co
ntam
inat
e th
e en
viro
nmen
t o
r ca
nno
t m
aint
ain
app
rop
riat
e hy
gie
ne in
iso
lati
on
roo
ms
wit
h en
sui
te
toile
t fa
cilit
ies
and
ant
e ro
om
Pla
ce a
ll p
atie
nts
wit
h su
spec
ted
or
confi
rmed
pul
mo
nary
or
lary
ngea
l TB
in
one
the
fo
llow
ing
air
bo
rne
iso
lati
on
roo
ms.
Ref
er t
o fi
gur
e 6.
1 fo
r ri
sk
asse
ssm
ent
alg
ori
thm
if a
n ai
rbo
rne
iso
lati
on
roo
m is
no
t av
aila
ble
. Ref
er t
o
sect
ion
6.5
for
eng
inee
ring
sta
ndar
ds
Neg
ativ
e p
ress
ure
iso
lati
on
roo
m w
ith
a ha
nd w
ash
sink
, an
ante
ro
om
1.
an
d e
n-su
ite
A n
eutr
al p
ress
ure
des
ign
roo
m, a
s d
etai
led
in H
BN
04
Sup
ple
men
t 1
2.
Pat
ient
s w
ith
kno
wn
or
susp
ecte
d m
ulti
dru
g-r
esis
tant
TB
(M
DR
-TB
) m
ust
be
pla
ced
in a
n ai
rbo
rne
iso
lati
on
roo
m w
hich
may
req
uire
tra
nsfe
r o
f th
e p
atie
nt t
o a
noth
er f
acili
ty
A n
oti
ce s
houl
d b
e p
lace
d o
n th
e d
oo
r o
f th
e is
ola
tio
n ro
om
ad
visi
ng t
hose
en
teri
ng t
o r
epo
rt t
o t
he n
urse
in c
harg
e b
efo
re e
nter
ing
Pat
ient
s sh
oul
d b
e ed
ucat
ed r
egar
din
g t
he r
easo
n/in
dic
atio
n fo
r A
irb
orn
e P
reca
utio
ns a
nd r
eque
sted
no
t to
leav
e th
e ro
om
unl
ess
abso
lute
ly n
eces
sary
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Pat
ient
P
lace
men
t(c
ont
)
HC
Ws
sho
uld
incl
ude
the
po
tent
ial f
or
tran
smis
sio
n o
f in
fect
ious
ag
ents
in p
atie
nt p
lace
men
t d
ecis
ions
Whe
re p
oss
ible
, pla
ce p
atie
nts
who
co
ntam
inat
e th
e en
viro
nmen
t o
r ca
nno
t m
aint
ain
app
rop
riat
e hy
gie
ne in
iso
lati
on
roo
ms
wit
h en
sui
te
toile
t fa
cilit
ies
and
ant
e ro
om
Em
erg
ency
dep
artm
ents
(ED
) wit
hout
an
airb
orn
e is
ola
tio
n ro
om
mus
t ha
ve a
p
roce
ss in
pla
ce t
o p
rio
riti
se t
rans
fer
of
pat
ient
s w
ith
susp
ecte
d o
r co
nfirm
ed
TB t
o a
n ap
pro
pri
ate
roo
m. E
D d
epar
tmen
ts w
itho
ut a
ny a
irb
orn
e is
ola
tio
n ro
om
s sh
oul
d p
lace
a s
urg
ical
mas
k o
n th
e p
atie
nt a
nd p
lace
him
/her
in a
n ex
amin
atio
n ro
om
or
sing
le r
oo
m w
hile
aw
aiti
ng t
rans
fer.
This
ro
om
sho
uld
b
e le
ft v
acan
t fo
r 1
hour
onc
e th
e p
atie
nt is
tra
nsfe
rred
to
allo
w f
or
a fu
ll ex
chan
ge
of
air.
Aer
oso
l-gen
erat
ing
pro
ced
ures
suc
h as
sp
utum
ind
ucti
on
and
the
ad
min
istr
atio
n o
f m
edic
atio
ns b
y ne
bul
iser
mus
t b
e av
oid
ed w
hile
a p
atie
nt
wit
h su
spec
ted
or
confi
rmed
TB
is in
an
op
en b
ay o
r an
unv
enti
late
d a
rea
in
any
war
d
Bro
ncho
sco
py
sho
uld
pre
fera
bly
be
per
form
ed in
an
app
rop
riat
e ne
gat
ive
pre
ssur
e su
ite
wit
h ad
equa
te v
enti
lati
on.
Unn
eces
sary
sta
ff a
nd o
ther
pat
ient
s sh
oul
d b
e ex
clud
ed d
urin
g t
he p
roce
dur
e. If
end
osc
op
y ro
om
s ar
e w
itho
ut a
ir
hand
ling
eq
uip
men
t, t
he p
roce
dur
e sh
oul
d b
e d
one
at
the
end
of
the
list
for
the
day
, or
in t
he p
atie
nt’s
ro
om
. Avo
id p
lace
men
t o
f re
cove
ring
pat
ient
s in
a
mul
ti-b
edd
ed w
ard
po
st p
roce
dur
e.
Pro
ced
ures
on
an e
xtra
pul
mo
nary
TB
op
en a
bsc
ess
or
lesi
on
whe
re
aero
solis
atio
n o
f d
rain
age
fluid
may
occ
ur s
houl
d o
nly
be
und
erta
ken
in a
n ai
rbo
rne
iso
lati
on
roo
m
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Han
dH
ygie
neH
and
hyg
iene
is r
eco
mm
end
ed;
Bef
ore
and
aft
er e
ach
epis
od
e o
f p
atie
nt c
ont
act
•B
etw
een
ind
ivid
ual p
atie
nt c
ont
acts
•A
fter
co
ntac
t w
ith
blo
od
, bo
dy
fluid
s, s
ecre
tio
ns o
r •
excr
etio
ns, w
heth
er o
r no
t g
love
s ar
e w
orn
Aft
er h
and
ling
so
iled
/co
ntam
inat
ed e
qui
pm
ent,
mat
eria
ls o
r •
the
envi
ronm
ent
Imm
edia
tely
bef
ore
glo
ve a
pp
licat
ion
•Im
med
iate
ly a
fter
rem
ovi
ng g
love
s o
r o
ther
pro
tect
ive
•cl
oth
ing
Han
ds
sho
uld
be
dec
ont
amin
ated
usi
ng s
oap
and
wat
er o
r al
coho
l g
el if
phy
sica
lly c
lean
. Ant
isep
tic
soap
sho
uld
be
used
pri
or
to
asep
tic
pro
ced
ures
.
Pat
ient
s sh
oul
d w
ash
thei
r ha
nds
afte
r to
ileti
ng a
nd b
efo
re m
eals
. H
CW
s sh
oul
d a
ssis
t th
ose
pat
ient
s un
able
to
per
form
han
d h
ygie
ne
ind
epen
den
tly.
Vis
ito
rs s
houl
d b
e ed
ucat
ed o
n th
e im
po
rtan
ce o
f ha
nd
dec
ont
amin
atio
n b
efo
re a
nd a
fter
vis
itin
g.
(SA
RI)
Gui
del
ines
on
Han
d H
ygie
ne a
re a
vaila
ble
at
ww
w.h
psc
.ie/
hpsc
/A-Z
/Gas
tro
ente
ric/
Han
dw
ashi
ng/
Ant
isep
tic
soap
or
alco
hol g
el if
han
ds
are
phy
sica
lly c
lean
bef
ore
and
aft
er
pat
ient
car
e
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Pat
ient
M
ove
men
t an
d
Tran
sfer
No
sp
ecia
l pre
caut
ions
rec
om
men
ded
Lim
it m
ove
men
t an
d t
rans
po
rt o
f p
atie
nt t
o e
ssen
tial
pur
po
ses
onl
yP
rio
r to
pat
ient
tra
nsfe
r
Pri
or
to a
ccep
ting
a p
atie
nt w
ith
kno
wn
or
susp
ecte
d in
fect
ious
TB
it is
the
•
resp
ons
ibili
ty o
f th
e re
ceiv
ing
fac
ility
to
ens
ure
com
plia
nce
wit
h is
ola
tio
n ro
om
req
uire
men
ts a
s d
escr
ibed
ab
ove
und
er p
atie
nt p
lace
men
t. It
is
the
resp
ons
ibili
ty o
f th
e fa
cilit
y tr
ansf
erri
ng t
he p
atie
nt t
o p
rovi
de
the
info
rmat
ion.
Info
rm t
rans
po
rt p
erso
nnel
(em
erg
ency
med
ical
tec
hnic
ians
, po
rter
s) a
nd
•th
e re
ceiv
ing
dep
artm
ent
of
the
need
fo
r A
irb
orn
e P
reca
utio
ns
Req
uest
pat
ient
to
wea
r a
surg
ical
mas
k w
hich
sho
uld
be
chan
ged
whe
n •
heav
ily c
ont
amin
ated
wit
h re
spir
ato
ry s
ecre
tio
ns a
nd/o
r w
et o
r if
torn
. In
stru
ct p
atie
nt o
n re
spir
ato
ry h
ygie
ne a
nd c
oug
h et
ique
tte
and
ens
ure
the
pat
ient
has
a s
upp
ly o
f ti
ssue
s.
HC
Ws
sho
uld
rem
ove
co
ntam
inat
ed a
pro
n/g
ow
n/g
love
s (if
wo
rn) a
nd
•m
ask
and
dis
po
se p
rio
r to
tra
nsp
ort
ing
pat
ient
s. S
taff
do
no
t ne
ed t
o
wea
r m
asks
dur
ing
inte
rnal
tra
nsp
ort
atio
n un
less
pat
ient
is u
nab
le t
o w
ear
a su
rgic
al m
ask
(e.g
. co
nfus
ed, r
esp
irat
ory
dis
tres
s).
Am
bul
ance
sta
ff s
houl
d c
ons
ider
the
use
of
FFP
2 o
r FF
P3
mas
ks in
the
•
follo
win
g s
itua
tio
ns: (
a) t
he p
atie
nt is
una
ble
to
wea
r a
surg
ical
mas
k; (b
) it
is a
ntic
ipat
ed t
hat
the
dur
atio
n o
f th
e jo
urne
y w
ill b
e ≥
8 ho
urs
(≥ 4
ho
urs
if H
CW
is im
mun
oco
mp
rom
ised
); (c
) if
the
pat
ient
has
eit
her
MD
R-o
r X
DR
-TB
(co
nsul
t in
fect
ion
pre
vent
ion
and
co
ntro
l tea
m in
thi
s si
tuat
ion)
.
Do
n FF
P2/
3 m
ask
pri
or
to h
and
ling
pat
ient
at
the
tran
spo
rt d
esti
nati
on
•(e
.g. X
-ray
, bro
ncho
sco
py
suit
e)
Tran
spo
rt e
qui
pm
ent
(str
etch
er, b
ed w
heel
chai
r) u
sed
to
tra
nsp
ort
pat
ient
•
mus
t b
e cl
eane
d a
nd d
isin
fect
ed w
ith
a d
eter
gen
t an
d 1
,000
pp
m o
f av
aila
ble
chl
ori
ne b
efo
re u
se o
n an
oth
er p
atie
nt
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Res
pir
ato
ry
Eti
que
tte/
Co
ugh
Eti
que
tte
Ad
min
istr
ativ
eE
duc
ate
HC
Ws
on
the
imp
ort
ance
of
cont
rol m
easu
res
to
•co
ntai
n re
spir
ato
ry s
ecre
tio
ns t
o p
reve
nt d
rop
let
and
co
ntac
t tr
ansm
issi
on
of
resp
irat
ory
pat
hog
ens,
esp
ecia
lly d
urin
g
seas
ona
l out
bre
aks
of
vira
l res
pir
ato
ry t
ract
infe
ctio
ns (e
.g.
influ
enza
, RSV
, etc
) in
the
com
mun
ity
Ens
ure
that
sup
plie
s o
f ti
ssue
s, f
oo
t o
per
atin
g w
aste
bin
s an
d
•ha
nd h
ygie
ne f
acili
ties
are
ava
ilab
le in
all
dep
artm
ents
incl
udin
g
wai
ting
are
as t
hro
ugho
ut t
he f
acili
ty
Info
rmat
ion
for
pat
ient
s/vi
sito
rs/p
ublic
Ed
ucat
e p
atie
nts/
visi
tors
/car
ers
on
resp
irat
ory
eti
que
tte
and
co
ugh
hyg
iene
usi
ng s
om
e o
r al
l of
the
follo
win
g:
Pat
ient
info
rmat
ion
leafl
ets
•W
elco
me
pac
ks•
Po
ster
s in
all
dep
artm
ents
esp
ecia
lly w
aiti
ng a
reas
• A
dd
itio
nal p
reca
utio
ns d
urin
g t
imes
of
incr
ease
d p
reva
lenc
e o
f re
spir
ato
ry in
fect
ions
Dur
ing
per
iod
s o
f in
crea
sed
pre
vale
nce
of
resp
irat
ory
infe
ctio
ns
•in
the
co
mm
unit
y, o
ffer
mas
ks t
o c
oug
hing
pat
ient
s an
d o
ther
sy
mp
tom
atic
per
sons
(e.g
. per
sons
who
acc
om
pan
y ill
pat
ient
s)
upo
n en
try
into
the
fac
ility
and
enc
our
age
them
to
mai
ntai
n sp
ecia
l sep
arat
ion,
idea
lly a
dis
tanc
e o
f at
leas
t 3
feet
, fro
m
oth
ers
in c
om
mo
n w
aiti
ng a
reas
Som
e fa
cilit
ies
may
find
it lo
gis
tica
lly e
asie
r to
inst
itut
e th
is
•re
com
men
dat
ion
year
-ro
und
as
a st
and
ard
of
pra
ctic
e
See
app
end
ix 1
4 fo
r sa
mp
le p
ost
er f
or
resp
irat
ory
eti
que
tte/
coug
h et
ique
tte
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
-172-
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-173-
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Occ
upat
iona
l H
ealt
h P
rog
ram
me
All
HC
Ws
sho
uld
be
asse
ssed
by
an o
ccup
atio
nal h
eath
tea
m p
rio
r to
co
mm
enci
ng w
ork
. Thi
s as
sess
men
t sh
oul
d in
clud
e:
Imm
unis
atio
ns (I
rish
gui
del
ines
on
imm
unis
atio
ns r
equi
red
•
for
HC
Ws
are
avai
lab
le a
t w
ww
.hp
sc.ie
/hp
sc/A
-Z/
Vacc
ineP
reve
ntab
le/V
acci
nati
on/
Gui
dan
ce/)
Scre
enin
g H
CW
s w
ho p
erfo
rm e
xpo
sure
pro
ne p
roce
dur
es f
or
•b
loo
d b
orn
e vi
ruse
s. D
oH
C g
uid
elin
es a
vaila
ble
at
ww
w.d
ohc
.ie/
pub
licat
ions
/tra
nsm
issi
on_
of_
blo
od
_bo
rne_
dis
ease
s_20
06.h
tml
Pat
ient
P
lace
men
t
HC
Ws
sho
uld
incl
ude
the
po
tent
ial f
or
tran
smis
sio
n o
f in
fect
ious
ag
ents
in p
atie
nt p
lace
men
t d
ecis
ions
Whe
re p
oss
ible
, pla
ce p
atie
nts
who
co
ntam
inat
e th
e en
viro
nmen
t o
r ca
nno
t m
aint
ain
app
rop
riat
e hy
gie
ne in
iso
lati
on
roo
ms
wit
h en
sui
te
toile
t fa
cilit
ies
and
ant
e ro
om
Pla
ce a
ll p
atie
nts
wit
h su
spec
ted
or
confi
rmed
pul
mo
nary
or
lary
ngea
l TB
in
one
the
fo
llow
ing
air
bo
rne
iso
lati
on
roo
ms.
Ref
er t
o fi
gur
e 6.
1 fo
r ri
sk
asse
ssm
ent
alg
ori
thm
if a
n ai
rbo
rne
iso
lati
on
roo
m is
no
t av
aila
ble
. Ref
er t
o
sect
ion
6.5
for
eng
inee
ring
sta
ndar
ds
Neg
ativ
e p
ress
ure
iso
lati
on
roo
m w
ith
a ha
nd w
ash
sink
, an
ante
ro
om
1.
an
d e
n-su
ite
A n
eutr
al p
ress
ure
des
ign
roo
m, a
s d
etai
led
in H
BN
04
Sup
ple
men
t 1
2.
Pat
ient
s w
ith
kno
wn
or
susp
ecte
d m
ulti
dru
g-r
esis
tant
TB
(M
DR
-TB
) m
ust
be
pla
ced
in a
n ai
rbo
rne
iso
lati
on
roo
m w
hich
may
req
uire
tra
nsfe
r o
f th
e p
atie
nt t
o a
noth
er f
acili
ty
A n
oti
ce s
houl
d b
e p
lace
d o
n th
e d
oo
r o
f th
e is
ola
tio
n ro
om
ad
visi
ng t
hose
en
teri
ng t
o r
epo
rt t
o t
he n
urse
in c
harg
e b
efo
re e
nter
ing
Pat
ient
s sh
oul
d b
e ed
ucat
ed r
egar
din
g t
he r
easo
n/in
dic
atio
n fo
r A
irb
orn
e P
reca
utio
ns a
nd r
eque
sted
no
t to
leav
e th
e ro
om
unl
ess
abso
lute
ly n
eces
sary
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Pat
ient
P
lace
men
t(c
ont
)
HC
Ws
sho
uld
incl
ude
the
po
tent
ial f
or
tran
smis
sio
n o
f in
fect
ious
ag
ents
in p
atie
nt p
lace
men
t d
ecis
ions
Whe
re p
oss
ible
, pla
ce p
atie
nts
who
co
ntam
inat
e th
e en
viro
nmen
t o
r ca
nno
t m
aint
ain
app
rop
riat
e hy
gie
ne in
iso
lati
on
roo
ms
wit
h en
sui
te
toile
t fa
cilit
ies
and
ant
e ro
om
Em
erg
ency
dep
artm
ents
(ED
) wit
hout
an
airb
orn
e is
ola
tio
n ro
om
mus
t ha
ve a
p
roce
ss in
pla
ce t
o p
rio
riti
se t
rans
fer
of
pat
ient
s w
ith
susp
ecte
d o
r co
nfirm
ed
TB t
o a
n ap
pro
pri
ate
roo
m. E
D d
epar
tmen
ts w
itho
ut a
ny a
irb
orn
e is
ola
tio
n ro
om
s sh
oul
d p
lace
a s
urg
ical
mas
k o
n th
e p
atie
nt a
nd p
lace
him
/her
in a
n ex
amin
atio
n ro
om
or
sing
le r
oo
m w
hile
aw
aiti
ng t
rans
fer.
This
ro
om
sho
uld
b
e le
ft v
acan
t fo
r 1
hour
onc
e th
e p
atie
nt is
tra
nsfe
rred
to
allo
w f
or
a fu
ll ex
chan
ge
of
air.
Aer
oso
l-gen
erat
ing
pro
ced
ures
suc
h as
sp
utum
ind
ucti
on
and
the
ad
min
istr
atio
n o
f m
edic
atio
ns b
y ne
bul
iser
mus
t b
e av
oid
ed w
hile
a p
atie
nt
wit
h su
spec
ted
or
confi
rmed
TB
is in
an
op
en b
ay o
r an
unv
enti
late
d a
rea
in
any
war
d
Bro
ncho
sco
py
sho
uld
pre
fera
bly
be
per
form
ed in
an
app
rop
riat
e ne
gat
ive
pre
ssur
e su
ite
wit
h ad
equa
te v
enti
lati
on.
Unn
eces
sary
sta
ff a
nd o
ther
pat
ient
s sh
oul
d b
e ex
clud
ed d
urin
g t
he p
roce
dur
e. If
end
osc
op
y ro
om
s ar
e w
itho
ut a
ir
hand
ling
eq
uip
men
t, t
he p
roce
dur
e sh
oul
d b
e d
one
at
the
end
of
the
list
for
the
day
, or
in t
he p
atie
nt’s
ro
om
. Avo
id p
lace
men
t o
f re
cove
ring
pat
ient
s in
a
mul
ti-b
edd
ed w
ard
po
st p
roce
dur
e.
Pro
ced
ures
on
an e
xtra
pul
mo
nary
TB
op
en a
bsc
ess
or
lesi
on
whe
re
aero
solis
atio
n o
f d
rain
age
fluid
may
occ
ur s
houl
d o
nly
be
und
erta
ken
in a
n ai
rbo
rne
iso
lati
on
roo
m
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Han
dH
ygie
neH
and
hyg
iene
is r
eco
mm
end
ed;
Bef
ore
and
aft
er e
ach
epis
od
e o
f p
atie
nt c
ont
act
•B
etw
een
ind
ivid
ual p
atie
nt c
ont
acts
•A
fter
co
ntac
t w
ith
blo
od
, bo
dy
fluid
s, s
ecre
tio
ns o
r •
excr
etio
ns, w
heth
er o
r no
t g
love
s ar
e w
orn
Aft
er h
and
ling
so
iled
/co
ntam
inat
ed e
qui
pm
ent,
mat
eria
ls o
r •
the
envi
ronm
ent
Imm
edia
tely
bef
ore
glo
ve a
pp
licat
ion
•Im
med
iate
ly a
fter
rem
ovi
ng g
love
s o
r o
ther
pro
tect
ive
•cl
oth
ing
Han
ds
sho
uld
be
dec
ont
amin
ated
usi
ng s
oap
and
wat
er o
r al
coho
l g
el if
phy
sica
lly c
lean
. Ant
isep
tic
soap
sho
uld
be
used
pri
or
to
asep
tic
pro
ced
ures
.
Pat
ient
s sh
oul
d w
ash
thei
r ha
nds
afte
r to
ileti
ng a
nd b
efo
re m
eals
. H
CW
s sh
oul
d a
ssis
t th
ose
pat
ient
s un
able
to
per
form
han
d h
ygie
ne
ind
epen
den
tly.
Vis
ito
rs s
houl
d b
e ed
ucat
ed o
n th
e im
po
rtan
ce o
f ha
nd
dec
ont
amin
atio
n b
efo
re a
nd a
fter
vis
itin
g.
(SA
RI)
Gui
del
ines
on
Han
d H
ygie
ne a
re a
vaila
ble
at
ww
w.h
psc
.ie/
hpsc
/A-Z
/Gas
tro
ente
ric/
Han
dw
ashi
ng/
Ant
isep
tic
soap
or
alco
hol g
el if
han
ds
are
phy
sica
lly c
lean
bef
ore
and
aft
er
pat
ient
car
e
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Pat
ient
M
ove
men
t an
d
Tran
sfer
No
sp
ecia
l pre
caut
ions
rec
om
men
ded
Lim
it m
ove
men
t an
d t
rans
po
rt o
f p
atie
nt t
o e
ssen
tial
pur
po
ses
onl
yP
rio
r to
pat
ient
tra
nsfe
r
Pri
or
to a
ccep
ting
a p
atie
nt w
ith
kno
wn
or
susp
ecte
d in
fect
ious
TB
it is
the
•
resp
ons
ibili
ty o
f th
e re
ceiv
ing
fac
ility
to
ens
ure
com
plia
nce
wit
h is
ola
tio
n ro
om
req
uire
men
ts a
s d
escr
ibed
ab
ove
und
er p
atie
nt p
lace
men
t. It
is
the
resp
ons
ibili
ty o
f th
e fa
cilit
y tr
ansf
erri
ng t
he p
atie
nt t
o p
rovi
de
the
info
rmat
ion.
Info
rm t
rans
po
rt p
erso
nnel
(em
erg
ency
med
ical
tec
hnic
ians
, po
rter
s) a
nd
•th
e re
ceiv
ing
dep
artm
ent
of
the
need
fo
r A
irb
orn
e P
reca
utio
ns
Req
uest
pat
ient
to
wea
r a
surg
ical
mas
k w
hich
sho
uld
be
chan
ged
whe
n •
heav
ily c
ont
amin
ated
wit
h re
spir
ato
ry s
ecre
tio
ns a
nd/o
r w
et o
r if
torn
. In
stru
ct p
atie
nt o
n re
spir
ato
ry h
ygie
ne a
nd c
oug
h et
ique
tte
and
ens
ure
the
pat
ient
has
a s
upp
ly o
f ti
ssue
s.
HC
Ws
sho
uld
rem
ove
co
ntam
inat
ed a
pro
n/g
ow
n/g
love
s (if
wo
rn) a
nd
•m
ask
and
dis
po
se p
rio
r to
tra
nsp
ort
ing
pat
ient
s. S
taff
do
no
t ne
ed t
o
wea
r m
asks
dur
ing
inte
rnal
tra
nsp
ort
atio
n un
less
pat
ient
is u
nab
le t
o w
ear
a su
rgic
al m
ask
(e.g
. co
nfus
ed, r
esp
irat
ory
dis
tres
s).
Am
bul
ance
sta
ff s
houl
d c
ons
ider
the
use
of
FFP
2 o
r FF
P3
mas
ks in
the
•
follo
win
g s
itua
tio
ns: (
a) t
he p
atie
nt is
una
ble
to
wea
r a
surg
ical
mas
k; (b
) it
is a
ntic
ipat
ed t
hat
the
dur
atio
n o
f th
e jo
urne
y w
ill b
e ≥
8 ho
urs
(≥ 4
ho
urs
if H
CW
is im
mun
oco
mp
rom
ised
); (c
) if
the
pat
ient
has
eit
her
MD
R-o
r X
DR
-TB
(co
nsul
t in
fect
ion
pre
vent
ion
and
co
ntro
l tea
m in
thi
s si
tuat
ion)
.
Do
n FF
P2/
3 m
ask
pri
or
to h
and
ling
pat
ient
at
the
tran
spo
rt d
esti
nati
on
•(e
.g. X
-ray
, bro
ncho
sco
py
suit
e)
Tran
spo
rt e
qui
pm
ent
(str
etch
er, b
ed w
heel
chai
r) u
sed
to
tra
nsp
ort
pat
ient
•
mus
t b
e cl
eane
d a
nd d
isin
fect
ed w
ith
a d
eter
gen
t an
d 1
,000
pp
m o
f av
aila
ble
chl
ori
ne b
efo
re u
se o
n an
oth
er p
atie
nt
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Res
pir
ato
ry
Eti
que
tte/
Co
ugh
Eti
que
tte
Ad
min
istr
ativ
eE
duc
ate
HC
Ws
on
the
imp
ort
ance
of
cont
rol m
easu
res
to
•co
ntai
n re
spir
ato
ry s
ecre
tio
ns t
o p
reve
nt d
rop
let
and
co
ntac
t tr
ansm
issi
on
of
resp
irat
ory
pat
hog
ens,
esp
ecia
lly d
urin
g
seas
ona
l out
bre
aks
of
vira
l res
pir
ato
ry t
ract
infe
ctio
ns (e
.g.
influ
enza
, RSV
, etc
) in
the
com
mun
ity
Ens
ure
that
sup
plie
s o
f ti
ssue
s, f
oo
t o
per
atin
g w
aste
bin
s an
d
•ha
nd h
ygie
ne f
acili
ties
are
ava
ilab
le in
all
dep
artm
ents
incl
udin
g
wai
ting
are
as t
hro
ugho
ut t
he f
acili
ty
Info
rmat
ion
for
pat
ient
s/vi
sito
rs/p
ublic
Ed
ucat
e p
atie
nts/
visi
tors
/car
ers
on
resp
irat
ory
eti
que
tte
and
co
ugh
hyg
iene
usi
ng s
om
e o
r al
l of
the
follo
win
g:
Pat
ient
info
rmat
ion
leafl
ets
•W
elco
me
pac
ks•
Po
ster
s in
all
dep
artm
ents
esp
ecia
lly w
aiti
ng a
reas
• A
dd
itio
nal p
reca
utio
ns d
urin
g t
imes
of
incr
ease
d p
reva
lenc
e o
f re
spir
ato
ry in
fect
ions
Dur
ing
per
iod
s o
f in
crea
sed
pre
vale
nce
of
resp
irat
ory
infe
ctio
ns
•in
the
co
mm
unit
y, o
ffer
mas
ks t
o c
oug
hing
pat
ient
s an
d o
ther
sy
mp
tom
atic
per
sons
(e.g
. per
sons
who
acc
om
pan
y ill
pat
ient
s)
upo
n en
try
into
the
fac
ility
and
enc
our
age
them
to
mai
ntai
n sp
ecia
l sep
arat
ion,
idea
lly a
dis
tanc
e o
f at
leas
t 3
feet
, fro
m
oth
ers
in c
om
mo
n w
aiti
ng a
reas
Som
e fa
cilit
ies
may
find
it lo
gis
tica
lly e
asie
r to
inst
itut
e th
is
•re
com
men
dat
ion
year
-ro
und
as
a st
and
ard
of
pra
ctic
e
See
app
end
ix 1
4 fo
r sa
mp
le p
ost
er f
or
resp
irat
ory
eti
que
tte/
coug
h et
ique
tte
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Occ
upat
iona
l H
ealt
h P
rog
ram
me
All
HC
Ws
sho
uld
be
asse
ssed
by
an o
ccup
atio
nal h
eath
tea
m p
rio
r to
co
mm
enci
ng w
ork
. Thi
s as
sess
men
t sh
oul
d in
clud
e:
Imm
unis
atio
ns (I
rish
gui
del
ines
on
imm
unis
atio
ns r
equi
red
•
for
HC
Ws
are
avai
lab
le a
t w
ww
.hp
sc.ie
/hp
sc/A
-Z/
Vacc
ineP
reve
ntab
le/V
acci
nati
on/
Gui
dan
ce/)
Scre
enin
g H
CW
s w
ho p
erfo
rm e
xpo
sure
pro
ne p
roce
dur
es f
or
•b
loo
d b
orn
e vi
ruse
s. D
oH
C g
uid
elin
es a
vaila
ble
at
ww
w.d
ohc
.ie/
pub
licat
ions
/tra
nsm
issi
on_
of_
blo
od
_bo
rne_
dis
ease
s_20
06.h
tml
Pat
ient
P
lace
men
t
HC
Ws
sho
uld
incl
ude
the
po
tent
ial f
or
tran
smis
sio
n o
f in
fect
ious
ag
ents
in p
atie
nt p
lace
men
t d
ecis
ions
Whe
re p
oss
ible
, pla
ce p
atie
nts
who
co
ntam
inat
e th
e en
viro
nmen
t o
r ca
nno
t m
aint
ain
app
rop
riat
e hy
gie
ne in
iso
lati
on
roo
ms
wit
h en
sui
te
toile
t fa
cilit
ies
and
ant
e ro
om
Pla
ce a
ll p
atie
nts
wit
h su
spec
ted
or
confi
rmed
pul
mo
nary
or
lary
ngea
l TB
in
one
the
fo
llow
ing
air
bo
rne
iso
lati
on
roo
ms.
Ref
er t
o fi
gur
e 6.
1 fo
r ri
sk
asse
ssm
ent
alg
ori
thm
if a
n ai
rbo
rne
iso
lati
on
roo
m is
no
t av
aila
ble
. Ref
er t
o
sect
ion
6.5
for
eng
inee
ring
sta
ndar
ds
Neg
ativ
e p
ress
ure
iso
lati
on
roo
m w
ith
a ha
nd w
ash
sink
, an
ante
ro
om
1.
an
d e
n-su
ite
A n
eutr
al p
ress
ure
des
ign
roo
m, a
s d
etai
led
in H
BN
04
Sup
ple
men
t 1
2.
Pat
ient
s w
ith
kno
wn
or
susp
ecte
d m
ulti
dru
g-r
esis
tant
TB
(M
DR
-TB
) m
ust
be
pla
ced
in a
n ai
rbo
rne
iso
lati
on
roo
m w
hich
may
req
uire
tra
nsfe
r o
f th
e p
atie
nt t
o a
noth
er f
acili
ty
A n
oti
ce s
houl
d b
e p
lace
d o
n th
e d
oo
r o
f th
e is
ola
tio
n ro
om
ad
visi
ng t
hose
en
teri
ng t
o r
epo
rt t
o t
he n
urse
in c
harg
e b
efo
re e
nter
ing
Pat
ient
s sh
oul
d b
e ed
ucat
ed r
egar
din
g t
he r
easo
n/in
dic
atio
n fo
r A
irb
orn
e P
reca
utio
ns a
nd r
eque
sted
no
t to
leav
e th
e ro
om
unl
ess
abso
lute
ly n
eces
sary
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Pat
ient
P
lace
men
t(c
ont
)
HC
Ws
sho
uld
incl
ude
the
po
tent
ial f
or
tran
smis
sio
n o
f in
fect
ious
ag
ents
in p
atie
nt p
lace
men
t d
ecis
ions
Whe
re p
oss
ible
, pla
ce p
atie
nts
who
co
ntam
inat
e th
e en
viro
nmen
t o
r ca
nno
t m
aint
ain
app
rop
riat
e hy
gie
ne in
iso
lati
on
roo
ms
wit
h en
sui
te
toile
t fa
cilit
ies
and
ant
e ro
om
Em
erg
ency
dep
artm
ents
(ED
) wit
hout
an
airb
orn
e is
ola
tio
n ro
om
mus
t ha
ve a
p
roce
ss in
pla
ce t
o p
rio
riti
se t
rans
fer
of
pat
ient
s w
ith
susp
ecte
d o
r co
nfirm
ed
TB t
o a
n ap
pro
pri
ate
roo
m. E
D d
epar
tmen
ts w
itho
ut a
ny a
irb
orn
e is
ola
tio
n ro
om
s sh
oul
d p
lace
a s
urg
ical
mas
k o
n th
e p
atie
nt a
nd p
lace
him
/her
in a
n ex
amin
atio
n ro
om
or
sing
le r
oo
m w
hile
aw
aiti
ng t
rans
fer.
This
ro
om
sho
uld
b
e le
ft v
acan
t fo
r 1
hour
onc
e th
e p
atie
nt is
tra
nsfe
rred
to
allo
w f
or
a fu
ll ex
chan
ge
of
air.
Aer
oso
l-gen
erat
ing
pro
ced
ures
suc
h as
sp
utum
ind
ucti
on
and
the
ad
min
istr
atio
n o
f m
edic
atio
ns b
y ne
bul
iser
mus
t b
e av
oid
ed w
hile
a p
atie
nt
wit
h su
spec
ted
or
confi
rmed
TB
is in
an
op
en b
ay o
r an
unv
enti
late
d a
rea
in
any
war
d
Bro
ncho
sco
py
sho
uld
pre
fera
bly
be
per
form
ed in
an
app
rop
riat
e ne
gat
ive
pre
ssur
e su
ite
wit
h ad
equa
te v
enti
lati
on.
Unn
eces
sary
sta
ff a
nd o
ther
pat
ient
s sh
oul
d b
e ex
clud
ed d
urin
g t
he p
roce
dur
e. If
end
osc
op
y ro
om
s ar
e w
itho
ut a
ir
hand
ling
eq
uip
men
t, t
he p
roce
dur
e sh
oul
d b
e d
one
at
the
end
of
the
list
for
the
day
, or
in t
he p
atie
nt’s
ro
om
. Avo
id p
lace
men
t o
f re
cove
ring
pat
ient
s in
a
mul
ti-b
edd
ed w
ard
po
st p
roce
dur
e.
Pro
ced
ures
on
an e
xtra
pul
mo
nary
TB
op
en a
bsc
ess
or
lesi
on
whe
re
aero
solis
atio
n o
f d
rain
age
fluid
may
occ
ur s
houl
d o
nly
be
und
erta
ken
in a
n ai
rbo
rne
iso
lati
on
roo
m
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Han
dH
ygie
neH
and
hyg
iene
is r
eco
mm
end
ed;
Bef
ore
and
aft
er e
ach
epis
od
e o
f p
atie
nt c
ont
act
•B
etw
een
ind
ivid
ual p
atie
nt c
ont
acts
•A
fter
co
ntac
t w
ith
blo
od
, bo
dy
fluid
s, s
ecre
tio
ns o
r •
excr
etio
ns, w
heth
er o
r no
t g
love
s ar
e w
orn
Aft
er h
and
ling
so
iled
/co
ntam
inat
ed e
qui
pm
ent,
mat
eria
ls o
r •
the
envi
ronm
ent
Imm
edia
tely
bef
ore
glo
ve a
pp
licat
ion
•Im
med
iate
ly a
fter
rem
ovi
ng g
love
s o
r o
ther
pro
tect
ive
•cl
oth
ing
Han
ds
sho
uld
be
dec
ont
amin
ated
usi
ng s
oap
and
wat
er o
r al
coho
l g
el if
phy
sica
lly c
lean
. Ant
isep
tic
soap
sho
uld
be
used
pri
or
to
asep
tic
pro
ced
ures
.
Pat
ient
s sh
oul
d w
ash
thei
r ha
nds
afte
r to
ileti
ng a
nd b
efo
re m
eals
. H
CW
s sh
oul
d a
ssis
t th
ose
pat
ient
s un
able
to
per
form
han
d h
ygie
ne
ind
epen
den
tly.
Vis
ito
rs s
houl
d b
e ed
ucat
ed o
n th
e im
po
rtan
ce o
f ha
nd
dec
ont
amin
atio
n b
efo
re a
nd a
fter
vis
itin
g.
(SA
RI)
Gui
del
ines
on
Han
d H
ygie
ne a
re a
vaila
ble
at
ww
w.h
psc
.ie/
hpsc
/A-Z
/Gas
tro
ente
ric/
Han
dw
ashi
ng/
Ant
isep
tic
soap
or
alco
hol g
el if
han
ds
are
phy
sica
lly c
lean
bef
ore
and
aft
er
pat
ient
car
e
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Pat
ient
M
ove
men
t an
d
Tran
sfer
No
sp
ecia
l pre
caut
ions
rec
om
men
ded
Lim
it m
ove
men
t an
d t
rans
po
rt o
f p
atie
nt t
o e
ssen
tial
pur
po
ses
onl
yP
rio
r to
pat
ient
tra
nsfe
r
Pri
or
to a
ccep
ting
a p
atie
nt w
ith
kno
wn
or
susp
ecte
d in
fect
ious
TB
it is
the
•
resp
ons
ibili
ty o
f th
e re
ceiv
ing
fac
ility
to
ens
ure
com
plia
nce
wit
h is
ola
tio
n ro
om
req
uire
men
ts a
s d
escr
ibed
ab
ove
und
er p
atie
nt p
lace
men
t. It
is
the
resp
ons
ibili
ty o
f th
e fa
cilit
y tr
ansf
erri
ng t
he p
atie
nt t
o p
rovi
de
the
info
rmat
ion.
Info
rm t
rans
po
rt p
erso
nnel
(em
erg
ency
med
ical
tec
hnic
ians
, po
rter
s) a
nd
•th
e re
ceiv
ing
dep
artm
ent
of
the
need
fo
r A
irb
orn
e P
reca
utio
ns
Req
uest
pat
ient
to
wea
r a
surg
ical
mas
k w
hich
sho
uld
be
chan
ged
whe
n •
heav
ily c
ont
amin
ated
wit
h re
spir
ato
ry s
ecre
tio
ns a
nd/o
r w
et o
r if
torn
. In
stru
ct p
atie
nt o
n re
spir
ato
ry h
ygie
ne a
nd c
oug
h et
ique
tte
and
ens
ure
the
pat
ient
has
a s
upp
ly o
f ti
ssue
s.
HC
Ws
sho
uld
rem
ove
co
ntam
inat
ed a
pro
n/g
ow
n/g
love
s (if
wo
rn) a
nd
•m
ask
and
dis
po
se p
rio
r to
tra
nsp
ort
ing
pat
ient
s. S
taff
do
no
t ne
ed t
o
wea
r m
asks
dur
ing
inte
rnal
tra
nsp
ort
atio
n un
less
pat
ient
is u
nab
le t
o w
ear
a su
rgic
al m
ask
(e.g
. co
nfus
ed, r
esp
irat
ory
dis
tres
s).
Am
bul
ance
sta
ff s
houl
d c
ons
ider
the
use
of
FFP
2 o
r FF
P3
mas
ks in
the
•
follo
win
g s
itua
tio
ns: (
a) t
he p
atie
nt is
una
ble
to
wea
r a
surg
ical
mas
k; (b
) it
is a
ntic
ipat
ed t
hat
the
dur
atio
n o
f th
e jo
urne
y w
ill b
e ≥
8 ho
urs
(≥ 4
ho
urs
if H
CW
is im
mun
oco
mp
rom
ised
); (c
) if
the
pat
ient
has
eit
her
MD
R-o
r X
DR
-TB
(co
nsul
t in
fect
ion
pre
vent
ion
and
co
ntro
l tea
m in
thi
s si
tuat
ion)
.
Do
n FF
P2/
3 m
ask
pri
or
to h
and
ling
pat
ient
at
the
tran
spo
rt d
esti
nati
on
•(e
.g. X
-ray
, bro
ncho
sco
py
suit
e)
Tran
spo
rt e
qui
pm
ent
(str
etch
er, b
ed w
heel
chai
r) u
sed
to
tra
nsp
ort
pat
ient
•
mus
t b
e cl
eane
d a
nd d
isin
fect
ed w
ith
a d
eter
gen
t an
d 1
,000
pp
m o
f av
aila
ble
chl
ori
ne b
efo
re u
se o
n an
oth
er p
atie
nt
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Res
pir
ato
ry
Eti
que
tte/
Co
ugh
Eti
que
tte
Ad
min
istr
ativ
eE
duc
ate
HC
Ws
on
the
imp
ort
ance
of
cont
rol m
easu
res
to
•co
ntai
n re
spir
ato
ry s
ecre
tio
ns t
o p
reve
nt d
rop
let
and
co
ntac
t tr
ansm
issi
on
of
resp
irat
ory
pat
hog
ens,
esp
ecia
lly d
urin
g
seas
ona
l out
bre
aks
of
vira
l res
pir
ato
ry t
ract
infe
ctio
ns (e
.g.
influ
enza
, RSV
, etc
) in
the
com
mun
ity
Ens
ure
that
sup
plie
s o
f ti
ssue
s, f
oo
t o
per
atin
g w
aste
bin
s an
d
•ha
nd h
ygie
ne f
acili
ties
are
ava
ilab
le in
all
dep
artm
ents
incl
udin
g
wai
ting
are
as t
hro
ugho
ut t
he f
acili
ty
Info
rmat
ion
for
pat
ient
s/vi
sito
rs/p
ublic
Ed
ucat
e p
atie
nts/
visi
tors
/car
ers
on
resp
irat
ory
eti
que
tte
and
co
ugh
hyg
iene
usi
ng s
om
e o
r al
l of
the
follo
win
g:
Pat
ient
info
rmat
ion
leafl
ets
•W
elco
me
pac
ks•
Po
ster
s in
all
dep
artm
ents
esp
ecia
lly w
aiti
ng a
reas
• A
dd
itio
nal p
reca
utio
ns d
urin
g t
imes
of
incr
ease
d p
reva
lenc
e o
f re
spir
ato
ry in
fect
ions
Dur
ing
per
iod
s o
f in
crea
sed
pre
vale
nce
of
resp
irat
ory
infe
ctio
ns
•in
the
co
mm
unit
y, o
ffer
mas
ks t
o c
oug
hing
pat
ient
s an
d o
ther
sy
mp
tom
atic
per
sons
(e.g
. per
sons
who
acc
om
pan
y ill
pat
ient
s)
upo
n en
try
into
the
fac
ility
and
enc
our
age
them
to
mai
ntai
n sp
ecia
l sep
arat
ion,
idea
lly a
dis
tanc
e o
f at
leas
t 3
feet
, fro
m
oth
ers
in c
om
mo
n w
aiti
ng a
reas
Som
e fa
cilit
ies
may
find
it lo
gis
tica
lly e
asie
r to
inst
itut
e th
is
•re
com
men
dat
ion
year
-ro
und
as
a st
and
ard
of
pra
ctic
e
See
app
end
ix 1
4 fo
r sa
mp
le p
ost
er f
or
resp
irat
ory
eti
que
tte/
coug
h et
ique
tte
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed-174-
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-175-
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Occ
upat
iona
l H
ealt
h P
rog
ram
me
All
HC
Ws
sho
uld
be
asse
ssed
by
an o
ccup
atio
nal h
eath
tea
m p
rio
r to
co
mm
enci
ng w
ork
. Thi
s as
sess
men
t sh
oul
d in
clud
e:
Imm
unis
atio
ns (I
rish
gui
del
ines
on
imm
unis
atio
ns r
equi
red
•
for
HC
Ws
are
avai
lab
le a
t w
ww
.hp
sc.ie
/hp
sc/A
-Z/
Vacc
ineP
reve
ntab
le/V
acci
nati
on/
Gui
dan
ce/)
Scre
enin
g H
CW
s w
ho p
erfo
rm e
xpo
sure
pro
ne p
roce
dur
es f
or
•b
loo
d b
orn
e vi
ruse
s. D
oH
C g
uid
elin
es a
vaila
ble
at
ww
w.d
ohc
.ie/
pub
licat
ions
/tra
nsm
issi
on_
of_
blo
od
_bo
rne_
dis
ease
s_20
06.h
tml
Pat
ient
P
lace
men
t
HC
Ws
sho
uld
incl
ude
the
po
tent
ial f
or
tran
smis
sio
n o
f in
fect
ious
ag
ents
in p
atie
nt p
lace
men
t d
ecis
ions
Whe
re p
oss
ible
, pla
ce p
atie
nts
who
co
ntam
inat
e th
e en
viro
nmen
t o
r ca
nno
t m
aint
ain
app
rop
riat
e hy
gie
ne in
iso
lati
on
roo
ms
wit
h en
sui
te
toile
t fa
cilit
ies
and
ant
e ro
om
Pla
ce a
ll p
atie
nts
wit
h su
spec
ted
or
confi
rmed
pul
mo
nary
or
lary
ngea
l TB
in
one
the
fo
llow
ing
air
bo
rne
iso
lati
on
roo
ms.
Ref
er t
o fi
gur
e 6.
1 fo
r ri
sk
asse
ssm
ent
alg
ori
thm
if a
n ai
rbo
rne
iso
lati
on
roo
m is
no
t av
aila
ble
. Ref
er t
o
sect
ion
6.5
for
eng
inee
ring
sta
ndar
ds
Neg
ativ
e p
ress
ure
iso
lati
on
roo
m w
ith
a ha
nd w
ash
sink
, an
ante
ro
om
1.
an
d e
n-su
ite
A n
eutr
al p
ress
ure
des
ign
roo
m, a
s d
etai
led
in H
BN
04
Sup
ple
men
t 1
2.
Pat
ient
s w
ith
kno
wn
or
susp
ecte
d m
ulti
dru
g-r
esis
tant
TB
(M
DR
-TB
) m
ust
be
pla
ced
in a
n ai
rbo
rne
iso
lati
on
roo
m w
hich
may
req
uire
tra
nsfe
r o
f th
e p
atie
nt t
o a
noth
er f
acili
ty
A n
oti
ce s
houl
d b
e p
lace
d o
n th
e d
oo
r o
f th
e is
ola
tio
n ro
om
ad
visi
ng t
hose
en
teri
ng t
o r
epo
rt t
o t
he n
urse
in c
harg
e b
efo
re e
nter
ing
Pat
ient
s sh
oul
d b
e ed
ucat
ed r
egar
din
g t
he r
easo
n/in
dic
atio
n fo
r A
irb
orn
e P
reca
utio
ns a
nd r
eque
sted
no
t to
leav
e th
e ro
om
unl
ess
abso
lute
ly n
eces
sary
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Pat
ient
P
lace
men
t(c
ont
)
HC
Ws
sho
uld
incl
ude
the
po
tent
ial f
or
tran
smis
sio
n o
f in
fect
ious
ag
ents
in p
atie
nt p
lace
men
t d
ecis
ions
Whe
re p
oss
ible
, pla
ce p
atie
nts
who
co
ntam
inat
e th
e en
viro
nmen
t o
r ca
nno
t m
aint
ain
app
rop
riat
e hy
gie
ne in
iso
lati
on
roo
ms
wit
h en
sui
te
toile
t fa
cilit
ies
and
ant
e ro
om
Em
erg
ency
dep
artm
ents
(ED
) wit
hout
an
airb
orn
e is
ola
tio
n ro
om
mus
t ha
ve a
p
roce
ss in
pla
ce t
o p
rio
riti
se t
rans
fer
of
pat
ient
s w
ith
susp
ecte
d o
r co
nfirm
ed
TB t
o a
n ap
pro
pri
ate
roo
m. E
D d
epar
tmen
ts w
itho
ut a
ny a
irb
orn
e is
ola
tio
n ro
om
s sh
oul
d p
lace
a s
urg
ical
mas
k o
n th
e p
atie
nt a
nd p
lace
him
/her
in a
n ex
amin
atio
n ro
om
or
sing
le r
oo
m w
hile
aw
aiti
ng t
rans
fer.
This
ro
om
sho
uld
b
e le
ft v
acan
t fo
r 1
hour
onc
e th
e p
atie
nt is
tra
nsfe
rred
to
allo
w f
or
a fu
ll ex
chan
ge
of
air.
Aer
oso
l-gen
erat
ing
pro
ced
ures
suc
h as
sp
utum
ind
ucti
on
and
the
ad
min
istr
atio
n o
f m
edic
atio
ns b
y ne
bul
iser
mus
t b
e av
oid
ed w
hile
a p
atie
nt
wit
h su
spec
ted
or
confi
rmed
TB
is in
an
op
en b
ay o
r an
unv
enti
late
d a
rea
in
any
war
d
Bro
ncho
sco
py
sho
uld
pre
fera
bly
be
per
form
ed in
an
app
rop
riat
e ne
gat
ive
pre
ssur
e su
ite
wit
h ad
equa
te v
enti
lati
on.
Unn
eces
sary
sta
ff a
nd o
ther
pat
ient
s sh
oul
d b
e ex
clud
ed d
urin
g t
he p
roce
dur
e. If
end
osc
op
y ro
om
s ar
e w
itho
ut a
ir
hand
ling
eq
uip
men
t, t
he p
roce
dur
e sh
oul
d b
e d
one
at
the
end
of
the
list
for
the
day
, or
in t
he p
atie
nt’s
ro
om
. Avo
id p
lace
men
t o
f re
cove
ring
pat
ient
s in
a
mul
ti-b
edd
ed w
ard
po
st p
roce
dur
e.
Pro
ced
ures
on
an e
xtra
pul
mo
nary
TB
op
en a
bsc
ess
or
lesi
on
whe
re
aero
solis
atio
n o
f d
rain
age
fluid
may
occ
ur s
houl
d o
nly
be
und
erta
ken
in a
n ai
rbo
rne
iso
lati
on
roo
m
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Han
dH
ygie
neH
and
hyg
iene
is r
eco
mm
end
ed;
Bef
ore
and
aft
er e
ach
epis
od
e o
f p
atie
nt c
ont
act
•B
etw
een
ind
ivid
ual p
atie
nt c
ont
acts
•A
fter
co
ntac
t w
ith
blo
od
, bo
dy
fluid
s, s
ecre
tio
ns o
r •
excr
etio
ns, w
heth
er o
r no
t g
love
s ar
e w
orn
Aft
er h
and
ling
so
iled
/co
ntam
inat
ed e
qui
pm
ent,
mat
eria
ls o
r •
the
envi
ronm
ent
Imm
edia
tely
bef
ore
glo
ve a
pp
licat
ion
•Im
med
iate
ly a
fter
rem
ovi
ng g
love
s o
r o
ther
pro
tect
ive
•cl
oth
ing
Han
ds
sho
uld
be
dec
ont
amin
ated
usi
ng s
oap
and
wat
er o
r al
coho
l g
el if
phy
sica
lly c
lean
. Ant
isep
tic
soap
sho
uld
be
used
pri
or
to
asep
tic
pro
ced
ures
.
Pat
ient
s sh
oul
d w
ash
thei
r ha
nds
afte
r to
ileti
ng a
nd b
efo
re m
eals
. H
CW
s sh
oul
d a
ssis
t th
ose
pat
ient
s un
able
to
per
form
han
d h
ygie
ne
ind
epen
den
tly.
Vis
ito
rs s
houl
d b
e ed
ucat
ed o
n th
e im
po
rtan
ce o
f ha
nd
dec
ont
amin
atio
n b
efo
re a
nd a
fter
vis
itin
g.
(SA
RI)
Gui
del
ines
on
Han
d H
ygie
ne a
re a
vaila
ble
at
ww
w.h
psc
.ie/
hpsc
/A-Z
/Gas
tro
ente
ric/
Han
dw
ashi
ng/
Ant
isep
tic
soap
or
alco
hol g
el if
han
ds
are
phy
sica
lly c
lean
bef
ore
and
aft
er
pat
ient
car
e
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Pat
ient
M
ove
men
t an
d
Tran
sfer
No
sp
ecia
l pre
caut
ions
rec
om
men
ded
Lim
it m
ove
men
t an
d t
rans
po
rt o
f p
atie
nt t
o e
ssen
tial
pur
po
ses
onl
yP
rio
r to
pat
ient
tra
nsfe
r
Pri
or
to a
ccep
ting
a p
atie
nt w
ith
kno
wn
or
susp
ecte
d in
fect
ious
TB
it is
the
•
resp
ons
ibili
ty o
f th
e re
ceiv
ing
fac
ility
to
ens
ure
com
plia
nce
wit
h is
ola
tio
n ro
om
req
uire
men
ts a
s d
escr
ibed
ab
ove
und
er p
atie
nt p
lace
men
t. It
is
the
resp
ons
ibili
ty o
f th
e fa
cilit
y tr
ansf
erri
ng t
he p
atie
nt t
o p
rovi
de
the
info
rmat
ion.
Info
rm t
rans
po
rt p
erso
nnel
(em
erg
ency
med
ical
tec
hnic
ians
, po
rter
s) a
nd
•th
e re
ceiv
ing
dep
artm
ent
of
the
need
fo
r A
irb
orn
e P
reca
utio
ns
Req
uest
pat
ient
to
wea
r a
surg
ical
mas
k w
hich
sho
uld
be
chan
ged
whe
n •
heav
ily c
ont
amin
ated
wit
h re
spir
ato
ry s
ecre
tio
ns a
nd/o
r w
et o
r if
torn
. In
stru
ct p
atie
nt o
n re
spir
ato
ry h
ygie
ne a
nd c
oug
h et
ique
tte
and
ens
ure
the
pat
ient
has
a s
upp
ly o
f ti
ssue
s.
HC
Ws
sho
uld
rem
ove
co
ntam
inat
ed a
pro
n/g
ow
n/g
love
s (if
wo
rn) a
nd
•m
ask
and
dis
po
se p
rio
r to
tra
nsp
ort
ing
pat
ient
s. S
taff
do
no
t ne
ed t
o
wea
r m
asks
dur
ing
inte
rnal
tra
nsp
ort
atio
n un
less
pat
ient
is u
nab
le t
o w
ear
a su
rgic
al m
ask
(e.g
. co
nfus
ed, r
esp
irat
ory
dis
tres
s).
Am
bul
ance
sta
ff s
houl
d c
ons
ider
the
use
of
FFP
2 o
r FF
P3
mas
ks in
the
•
follo
win
g s
itua
tio
ns: (
a) t
he p
atie
nt is
una
ble
to
wea
r a
surg
ical
mas
k; (b
) it
is a
ntic
ipat
ed t
hat
the
dur
atio
n o
f th
e jo
urne
y w
ill b
e ≥
8 ho
urs
(≥ 4
ho
urs
if H
CW
is im
mun
oco
mp
rom
ised
); (c
) if
the
pat
ient
has
eit
her
MD
R-o
r X
DR
-TB
(co
nsul
t in
fect
ion
pre
vent
ion
and
co
ntro
l tea
m in
thi
s si
tuat
ion)
.
Do
n FF
P2/
3 m
ask
pri
or
to h
and
ling
pat
ient
at
the
tran
spo
rt d
esti
nati
on
•(e
.g. X
-ray
, bro
ncho
sco
py
suit
e)
Tran
spo
rt e
qui
pm
ent
(str
etch
er, b
ed w
heel
chai
r) u
sed
to
tra
nsp
ort
pat
ient
•
mus
t b
e cl
eane
d a
nd d
isin
fect
ed w
ith
a d
eter
gen
t an
d 1
,000
pp
m o
f av
aila
ble
chl
ori
ne b
efo
re u
se o
n an
oth
er p
atie
nt
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Res
pir
ato
ry
Eti
que
tte/
Co
ugh
Eti
que
tte
Ad
min
istr
ativ
eE
duc
ate
HC
Ws
on
the
imp
ort
ance
of
cont
rol m
easu
res
to
•co
ntai
n re
spir
ato
ry s
ecre
tio
ns t
o p
reve
nt d
rop
let
and
co
ntac
t tr
ansm
issi
on
of
resp
irat
ory
pat
hog
ens,
esp
ecia
lly d
urin
g
seas
ona
l out
bre
aks
of
vira
l res
pir
ato
ry t
ract
infe
ctio
ns (e
.g.
influ
enza
, RSV
, etc
) in
the
com
mun
ity
Ens
ure
that
sup
plie
s o
f ti
ssue
s, f
oo
t o
per
atin
g w
aste
bin
s an
d
•ha
nd h
ygie
ne f
acili
ties
are
ava
ilab
le in
all
dep
artm
ents
incl
udin
g
wai
ting
are
as t
hro
ugho
ut t
he f
acili
ty
Info
rmat
ion
for
pat
ient
s/vi
sito
rs/p
ublic
Ed
ucat
e p
atie
nts/
visi
tors
/car
ers
on
resp
irat
ory
eti
que
tte
and
co
ugh
hyg
iene
usi
ng s
om
e o
r al
l of
the
follo
win
g:
Pat
ient
info
rmat
ion
leafl
ets
•W
elco
me
pac
ks•
Po
ster
s in
all
dep
artm
ents
esp
ecia
lly w
aiti
ng a
reas
• A
dd
itio
nal p
reca
utio
ns d
urin
g t
imes
of
incr
ease
d p
reva
lenc
e o
f re
spir
ato
ry in
fect
ions
Dur
ing
per
iod
s o
f in
crea
sed
pre
vale
nce
of
resp
irat
ory
infe
ctio
ns
•in
the
co
mm
unit
y, o
ffer
mas
ks t
o c
oug
hing
pat
ient
s an
d o
ther
sy
mp
tom
atic
per
sons
(e.g
. per
sons
who
acc
om
pan
y ill
pat
ient
s)
upo
n en
try
into
the
fac
ility
and
enc
our
age
them
to
mai
ntai
n sp
ecia
l sep
arat
ion,
idea
lly a
dis
tanc
e o
f at
leas
t 3
feet
, fro
m
oth
ers
in c
om
mo
n w
aiti
ng a
reas
Som
e fa
cilit
ies
may
find
it lo
gis
tica
lly e
asie
r to
inst
itut
e th
is
•re
com
men
dat
ion
year
-ro
und
as
a st
and
ard
of
pra
ctic
e
See
app
end
ix 1
4 fo
r sa
mp
le p
ost
er f
or
resp
irat
ory
eti
que
tte/
coug
h et
ique
tte
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Occ
upat
iona
l H
ealt
h P
rog
ram
me
All
HC
Ws
sho
uld
be
asse
ssed
by
an o
ccup
atio
nal h
eath
tea
m p
rio
r to
co
mm
enci
ng w
ork
. Thi
s as
sess
men
t sh
oul
d in
clud
e:
Imm
unis
atio
ns (I
rish
gui
del
ines
on
imm
unis
atio
ns r
equi
red
•
for
HC
Ws
are
avai
lab
le a
t w
ww
.hp
sc.ie
/hp
sc/A
-Z/
Vacc
ineP
reve
ntab
le/V
acci
nati
on/
Gui
dan
ce/)
Scre
enin
g H
CW
s w
ho p
erfo
rm e
xpo
sure
pro
ne p
roce
dur
es f
or
•b
loo
d b
orn
e vi
ruse
s. D
oH
C g
uid
elin
es a
vaila
ble
at
ww
w.d
ohc
.ie/
pub
licat
ions
/tra
nsm
issi
on_
of_
blo
od
_bo
rne_
dis
ease
s_20
06.h
tml
Pat
ient
P
lace
men
t
HC
Ws
sho
uld
incl
ude
the
po
tent
ial f
or
tran
smis
sio
n o
f in
fect
ious
ag
ents
in p
atie
nt p
lace
men
t d
ecis
ions
Whe
re p
oss
ible
, pla
ce p
atie
nts
who
co
ntam
inat
e th
e en
viro
nmen
t o
r ca
nno
t m
aint
ain
app
rop
riat
e hy
gie
ne in
iso
lati
on
roo
ms
wit
h en
sui
te
toile
t fa
cilit
ies
and
ant
e ro
om
Pla
ce a
ll p
atie
nts
wit
h su
spec
ted
or
confi
rmed
pul
mo
nary
or
lary
ngea
l TB
in
one
the
fo
llow
ing
air
bo
rne
iso
lati
on
roo
ms.
Ref
er t
o fi
gur
e 6.
1 fo
r ri
sk
asse
ssm
ent
alg
ori
thm
if a
n ai
rbo
rne
iso
lati
on
roo
m is
no
t av
aila
ble
. Ref
er t
o
sect
ion
6.5
for
eng
inee
ring
sta
ndar
ds
Neg
ativ
e p
ress
ure
iso
lati
on
roo
m w
ith
a ha
nd w
ash
sink
, an
ante
ro
om
1.
an
d e
n-su
ite
A n
eutr
al p
ress
ure
des
ign
roo
m, a
s d
etai
led
in H
BN
04
Sup
ple
men
t 1
2.
Pat
ient
s w
ith
kno
wn
or
susp
ecte
d m
ulti
dru
g-r
esis
tant
TB
(M
DR
-TB
) m
ust
be
pla
ced
in a
n ai
rbo
rne
iso
lati
on
roo
m w
hich
may
req
uire
tra
nsfe
r o
f th
e p
atie
nt t
o a
noth
er f
acili
ty
A n
oti
ce s
houl
d b
e p
lace
d o
n th
e d
oo
r o
f th
e is
ola
tio
n ro
om
ad
visi
ng t
hose
en
teri
ng t
o r
epo
rt t
o t
he n
urse
in c
harg
e b
efo
re e
nter
ing
Pat
ient
s sh
oul
d b
e ed
ucat
ed r
egar
din
g t
he r
easo
n/in
dic
atio
n fo
r A
irb
orn
e P
reca
utio
ns a
nd r
eque
sted
no
t to
leav
e th
e ro
om
unl
ess
abso
lute
ly n
eces
sary
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Pat
ient
P
lace
men
t(c
ont
)
HC
Ws
sho
uld
incl
ude
the
po
tent
ial f
or
tran
smis
sio
n o
f in
fect
ious
ag
ents
in p
atie
nt p
lace
men
t d
ecis
ions
Whe
re p
oss
ible
, pla
ce p
atie
nts
who
co
ntam
inat
e th
e en
viro
nmen
t o
r ca
nno
t m
aint
ain
app
rop
riat
e hy
gie
ne in
iso
lati
on
roo
ms
wit
h en
sui
te
toile
t fa
cilit
ies
and
ant
e ro
om
Em
erg
ency
dep
artm
ents
(ED
) wit
hout
an
airb
orn
e is
ola
tio
n ro
om
mus
t ha
ve a
p
roce
ss in
pla
ce t
o p
rio
riti
se t
rans
fer
of
pat
ient
s w
ith
susp
ecte
d o
r co
nfirm
ed
TB t
o a
n ap
pro
pri
ate
roo
m. E
D d
epar
tmen
ts w
itho
ut a
ny a
irb
orn
e is
ola
tio
n ro
om
s sh
oul
d p
lace
a s
urg
ical
mas
k o
n th
e p
atie
nt a
nd p
lace
him
/her
in a
n ex
amin
atio
n ro
om
or
sing
le r
oo
m w
hile
aw
aiti
ng t
rans
fer.
This
ro
om
sho
uld
b
e le
ft v
acan
t fo
r 1
hour
onc
e th
e p
atie
nt is
tra
nsfe
rred
to
allo
w f
or
a fu
ll ex
chan
ge
of
air.
Aer
oso
l-gen
erat
ing
pro
ced
ures
suc
h as
sp
utum
ind
ucti
on
and
the
ad
min
istr
atio
n o
f m
edic
atio
ns b
y ne
bul
iser
mus
t b
e av
oid
ed w
hile
a p
atie
nt
wit
h su
spec
ted
or
confi
rmed
TB
is in
an
op
en b
ay o
r an
unv
enti
late
d a
rea
in
any
war
d
Bro
ncho
sco
py
sho
uld
pre
fera
bly
be
per
form
ed in
an
app
rop
riat
e ne
gat
ive
pre
ssur
e su
ite
wit
h ad
equa
te v
enti
lati
on.
Unn
eces
sary
sta
ff a
nd o
ther
pat
ient
s sh
oul
d b
e ex
clud
ed d
urin
g t
he p
roce
dur
e. If
end
osc
op
y ro
om
s ar
e w
itho
ut a
ir
hand
ling
eq
uip
men
t, t
he p
roce
dur
e sh
oul
d b
e d
one
at
the
end
of
the
list
for
the
day
, or
in t
he p
atie
nt’s
ro
om
. Avo
id p
lace
men
t o
f re
cove
ring
pat
ient
s in
a
mul
ti-b
edd
ed w
ard
po
st p
roce
dur
e.
Pro
ced
ures
on
an e
xtra
pul
mo
nary
TB
op
en a
bsc
ess
or
lesi
on
whe
re
aero
solis
atio
n o
f d
rain
age
fluid
may
occ
ur s
houl
d o
nly
be
und
erta
ken
in a
n ai
rbo
rne
iso
lati
on
roo
m
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Han
dH
ygie
neH
and
hyg
iene
is r
eco
mm
end
ed;
Bef
ore
and
aft
er e
ach
epis
od
e o
f p
atie
nt c
ont
act
•B
etw
een
ind
ivid
ual p
atie
nt c
ont
acts
•A
fter
co
ntac
t w
ith
blo
od
, bo
dy
fluid
s, s
ecre
tio
ns o
r •
excr
etio
ns, w
heth
er o
r no
t g
love
s ar
e w
orn
Aft
er h
and
ling
so
iled
/co
ntam
inat
ed e
qui
pm
ent,
mat
eria
ls o
r •
the
envi
ronm
ent
Imm
edia
tely
bef
ore
glo
ve a
pp
licat
ion
•Im
med
iate
ly a
fter
rem
ovi
ng g
love
s o
r o
ther
pro
tect
ive
•cl
oth
ing
Han
ds
sho
uld
be
dec
ont
amin
ated
usi
ng s
oap
and
wat
er o
r al
coho
l g
el if
phy
sica
lly c
lean
. Ant
isep
tic
soap
sho
uld
be
used
pri
or
to
asep
tic
pro
ced
ures
.
Pat
ient
s sh
oul
d w
ash
thei
r ha
nds
afte
r to
ileti
ng a
nd b
efo
re m
eals
. H
CW
s sh
oul
d a
ssis
t th
ose
pat
ient
s un
able
to
per
form
han
d h
ygie
ne
ind
epen
den
tly.
Vis
ito
rs s
houl
d b
e ed
ucat
ed o
n th
e im
po
rtan
ce o
f ha
nd
dec
ont
amin
atio
n b
efo
re a
nd a
fter
vis
itin
g.
(SA
RI)
Gui
del
ines
on
Han
d H
ygie
ne a
re a
vaila
ble
at
ww
w.h
psc
.ie/
hpsc
/A-Z
/Gas
tro
ente
ric/
Han
dw
ashi
ng/
Ant
isep
tic
soap
or
alco
hol g
el if
han
ds
are
phy
sica
lly c
lean
bef
ore
and
aft
er
pat
ient
car
e
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Pat
ient
M
ove
men
t an
d
Tran
sfer
No
sp
ecia
l pre
caut
ions
rec
om
men
ded
Lim
it m
ove
men
t an
d t
rans
po
rt o
f p
atie
nt t
o e
ssen
tial
pur
po
ses
onl
yP
rio
r to
pat
ient
tra
nsfe
r
Pri
or
to a
ccep
ting
a p
atie
nt w
ith
kno
wn
or
susp
ecte
d in
fect
ious
TB
it is
the
•
resp
ons
ibili
ty o
f th
e re
ceiv
ing
fac
ility
to
ens
ure
com
plia
nce
wit
h is
ola
tio
n ro
om
req
uire
men
ts a
s d
escr
ibed
ab
ove
und
er p
atie
nt p
lace
men
t. It
is
the
resp
ons
ibili
ty o
f th
e fa
cilit
y tr
ansf
erri
ng t
he p
atie
nt t
o p
rovi
de
the
info
rmat
ion.
Info
rm t
rans
po
rt p
erso
nnel
(em
erg
ency
med
ical
tec
hnic
ians
, po
rter
s) a
nd
•th
e re
ceiv
ing
dep
artm
ent
of
the
need
fo
r A
irb
orn
e P
reca
utio
ns
Req
uest
pat
ient
to
wea
r a
surg
ical
mas
k w
hich
sho
uld
be
chan
ged
whe
n •
heav
ily c
ont
amin
ated
wit
h re
spir
ato
ry s
ecre
tio
ns a
nd/o
r w
et o
r if
torn
. In
stru
ct p
atie
nt o
n re
spir
ato
ry h
ygie
ne a
nd c
oug
h et
ique
tte
and
ens
ure
the
pat
ient
has
a s
upp
ly o
f ti
ssue
s.
HC
Ws
sho
uld
rem
ove
co
ntam
inat
ed a
pro
n/g
ow
n/g
love
s (if
wo
rn) a
nd
•m
ask
and
dis
po
se p
rio
r to
tra
nsp
ort
ing
pat
ient
s. S
taff
do
no
t ne
ed t
o
wea
r m
asks
dur
ing
inte
rnal
tra
nsp
ort
atio
n un
less
pat
ient
is u
nab
le t
o w
ear
a su
rgic
al m
ask
(e.g
. co
nfus
ed, r
esp
irat
ory
dis
tres
s).
Am
bul
ance
sta
ff s
houl
d c
ons
ider
the
use
of
FFP
2 o
r FF
P3
mas
ks in
the
•
follo
win
g s
itua
tio
ns: (
a) t
he p
atie
nt is
una
ble
to
wea
r a
surg
ical
mas
k; (b
) it
is a
ntic
ipat
ed t
hat
the
dur
atio
n o
f th
e jo
urne
y w
ill b
e ≥
8 ho
urs
(≥ 4
ho
urs
if H
CW
is im
mun
oco
mp
rom
ised
); (c
) if
the
pat
ient
has
eit
her
MD
R-o
r X
DR
-TB
(co
nsul
t in
fect
ion
pre
vent
ion
and
co
ntro
l tea
m in
thi
s si
tuat
ion)
.
Do
n FF
P2/
3 m
ask
pri
or
to h
and
ling
pat
ient
at
the
tran
spo
rt d
esti
nati
on
•(e
.g. X
-ray
, bro
ncho
sco
py
suit
e)
Tran
spo
rt e
qui
pm
ent
(str
etch
er, b
ed w
heel
chai
r) u
sed
to
tra
nsp
ort
pat
ient
•
mus
t b
e cl
eane
d a
nd d
isin
fect
ed w
ith
a d
eter
gen
t an
d 1
,000
pp
m o
f av
aila
ble
chl
ori
ne b
efo
re u
se o
n an
oth
er p
atie
nt
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Res
pir
ato
ry
Eti
que
tte/
Co
ugh
Eti
que
tte
Ad
min
istr
ativ
eE
duc
ate
HC
Ws
on
the
imp
ort
ance
of
cont
rol m
easu
res
to
•co
ntai
n re
spir
ato
ry s
ecre
tio
ns t
o p
reve
nt d
rop
let
and
co
ntac
t tr
ansm
issi
on
of
resp
irat
ory
pat
hog
ens,
esp
ecia
lly d
urin
g
seas
ona
l out
bre
aks
of
vira
l res
pir
ato
ry t
ract
infe
ctio
ns (e
.g.
influ
enza
, RSV
, etc
) in
the
com
mun
ity
Ens
ure
that
sup
plie
s o
f ti
ssue
s, f
oo
t o
per
atin
g w
aste
bin
s an
d
•ha
nd h
ygie
ne f
acili
ties
are
ava
ilab
le in
all
dep
artm
ents
incl
udin
g
wai
ting
are
as t
hro
ugho
ut t
he f
acili
ty
Info
rmat
ion
for
pat
ient
s/vi
sito
rs/p
ublic
Ed
ucat
e p
atie
nts/
visi
tors
/car
ers
on
resp
irat
ory
eti
que
tte
and
co
ugh
hyg
iene
usi
ng s
om
e o
r al
l of
the
follo
win
g:
Pat
ient
info
rmat
ion
leafl
ets
•W
elco
me
pac
ks•
Po
ster
s in
all
dep
artm
ents
esp
ecia
lly w
aiti
ng a
reas
• A
dd
itio
nal p
reca
utio
ns d
urin
g t
imes
of
incr
ease
d p
reva
lenc
e o
f re
spir
ato
ry in
fect
ions
Dur
ing
per
iod
s o
f in
crea
sed
pre
vale
nce
of
resp
irat
ory
infe
ctio
ns
•in
the
co
mm
unit
y, o
ffer
mas
ks t
o c
oug
hing
pat
ient
s an
d o
ther
sy
mp
tom
atic
per
sons
(e.g
. per
sons
who
acc
om
pan
y ill
pat
ient
s)
upo
n en
try
into
the
fac
ility
and
enc
our
age
them
to
mai
ntai
n sp
ecia
l sep
arat
ion,
idea
lly a
dis
tanc
e o
f at
leas
t 3
feet
, fro
m
oth
ers
in c
om
mo
n w
aiti
ng a
reas
Som
e fa
cilit
ies
may
find
it lo
gis
tica
lly e
asie
r to
inst
itut
e th
is
•re
com
men
dat
ion
year
-ro
und
as
a st
and
ard
of
pra
ctic
e
See
app
end
ix 1
4 fo
r sa
mp
le p
ost
er f
or
resp
irat
ory
eti
que
tte/
coug
h et
ique
tte
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
-176-
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-177-
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Typ
e an
d s
elec
tio
n o
f P
PE
PP
E c
ons
ists
of:
G
love
s,•
Ap
rons
/go
wns
•E
ye, n
asal
and
mo
uth
pro
tect
ion
• Eac
h H
CW
sho
uld
mak
e an
ris
k as
sess
men
t o
f th
e p
lann
ed p
roce
dur
e an
d s
elec
t P
PE
dep
end
ing
on;
The
natu
re o
f th
e p
roce
dur
e•
The
risk
of
exp
osu
re t
o b
loo
d a
nd b
od
y flu
ids
•Th
e ri
sk o
f co
ntam
inat
ion
•
Ad
dit
iona
l res
pir
ato
ry p
rote
ctio
n re
qui
red
(s
ee f
acia
l pro
tect
ion
sect
ion)
Glo
ves
Glo
ves
sho
uld
be
sing
le u
se it
ems
and
sho
uld
co
nfo
rm t
o E
uro
pea
n C
om
mun
ity
Stan
dar
ds
Glo
ves
are
reco
mm
end
ed;
For
all a
ctiv
itie
s th
at c
arry
a r
isk
of
exp
osu
re t
o b
loo
d, b
od
y flu
ids,
•
secr
etio
ns o
r ex
cret
ions
, sha
rps
or
cont
amin
ated
inst
rum
ents
Whe
n to
uchi
ng m
uco
us m
emb
rane
s an
d n
on-
inta
ct s
kin
•W
hen
hand
ling
co
ntam
inat
ed e
qui
pm
ent
• Glo
ves
sho
uld
be;
Sing
le u
se o
nly
•St
erile
if c
ont
act
anti
cip
ated
wit
h st
erile
bo
dy
site
•
Put
on
imm
edia
tely
bef
ore
an
epis
od
e o
f p
atie
nt c
ont
act
and
•
rem
ove
as
soo
n as
the
act
ivit
y is
co
mp
lete
dC
hang
ed w
hen
cari
ng f
or
diff
eren
t p
atie
nts
and
bet
wee
n d
iffer
ent
•ca
re a
ctiv
itie
s o
n th
e sa
me
pat
ient
Dis
po
sed
of
as h
ealt
h ca
re r
isk
was
te if
co
ntam
inat
ed w
ith
blo
od
or
•b
od
y flu
ids
fro
m p
atie
nts
wit
h su
spec
ted
or
kno
wn
infe
ctio
n.
Han
d h
ygie
ne s
houl
d b
e p
erfo
rmed
bef
ore
do
nnin
g a
nd im
med
iate
ly
follo
win
g r
emo
val o
f g
love
s
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Face
pro
tect
ion
Face
pro
tect
ion
sho
uld
be
wo
rn w
here
:
Ther
e is
a r
isk
of
blo
od
, bo
dy
fluid
s,
•se
cret
ions
or
excr
etio
ns s
pla
shin
g in
to t
he
face
or
eyes
Whe
n p
laci
ng a
cat
hete
r o
r in
ject
ing
into
•
the
spin
al o
r ep
idur
al s
pac
e.
Face
pro
tect
ion
cons
ists
of
one
of
the
follo
win
g:
Flui
d r
epel
lent
mas
k w
ith
sep
arat
e •
go
gg
les
Res
pir
ato
ry m
ask
(FFP
2/3)
•Fa
ce s
hiel
d•
Flui
d r
epel
lent
mas
k w
ith
eye
shie
ld.
• Face
pro
tect
ion
sho
uld
be:
Sing
le u
se o
r si
ngle
per
son
use
(fac
e •
shie
lds
and
go
gg
les
can
be
reus
ed
by
the
sam
e H
CW
but
the
y m
ust
be
adeq
uate
ly c
lean
ed a
nd d
isin
fect
ed a
s p
er m
anuf
actu
rer’s
inst
ruct
ions
aft
er e
ach
use.
In a
dd
itio
n to
eye
pro
tect
ion
as r
equi
red
fo
r St
and
ard
Pre
caut
ions
HC
Ws
and
vis
ito
rs s
houl
d d
on
corr
ectl
y fit
ted
: FF
P2
mas
ks b
efo
re e
nter
ing
the
iso
lati
on
roo
m o
f a
susp
ecte
d o
r co
nfirm
ed
•in
fect
ious
TB
cas
e w
here
MD
R-T
B n
ot
susp
ecte
dFF
P3
mas
k d
urin
g h
igh
risk
pro
ced
ures
fo
r al
l pat
ient
s w
here
TB
is s
usp
ecte
d
•o
r co
nfirm
ed (s
usce
pti
ble
or
MD
R) s
uch
as:
Sput
um in
duc
tio
no
C
oug
h p
rod
ucin
g p
roce
dur
es (e
.g. a
dm
inis
teri
ng a
ero
solis
ed
o
med
icat
ions
, bro
ncho
sco
py,
air
way
suc
tio
ning
, end
otr
ache
al in
tub
atio
n)P
roce
dur
es w
here
aer
oso
lisat
ion
of
dra
inag
e flu
id f
rom
an
absc
ess/
o
lesi
ons
may
occ
urFF
P3
mas
ks b
efo
re e
nter
ing
the
iso
lati
on
roo
m o
f a
susp
ecte
d o
r kn
ow
n ca
se
•o
f M
DR
-TB
or
XD
R-T
B
To p
rese
rve
pri
vacy
and
co
nfid
enti
alit
y re
stri
ctin
g v
isit
ing
to
imm
edia
te f
amily
sh
oul
d b
e d
iscu
ssed
wit
h th
e p
atie
nt
All
HC
Ws
who
may
be
req
uire
d t
o u
se r
esp
irat
ory
mas
ks (F
FP2
& F
FP3)
dur
ing
th
e co
urse
of
thei
r w
ork
sho
uld
be
fit t
este
d b
y a
trai
ned
pro
fess
iona
l wit
hin
each
o
rgan
isat
ion
HC
Ws
sho
uld
fit
chec
k th
e m
ask
each
tim
e it
is w
orn
to
che
ck t
he s
eal
HC
Ws
visi
ting
a p
atie
nt in
the
ir o
wn
hom
e sh
oul
d w
ear
a FF
P2
or
FFP
3 m
ask
whi
le
the
pat
ient
is in
fect
ious
(see
cha
pte
r 6
on
Infe
ctio
n P
reve
ntio
n an
d C
ont
rol f
or
dis
cont
inua
tio
n o
f A
irb
orn
e P
reca
utio
ns).
Pat
ient
pri
vacy
mus
t b
e m
aint
aine
d if
m
ask
is w
orn
in t
he h
om
e.
All
mas
ks s
houl
d b
e re
mo
ved
in t
he a
nte
roo
m o
r im
med
iate
ly o
utsi
de
the
sing
le
roo
m if
the
re is
no
ant
e ro
om
Dis
card
mas
k in
to h
ealt
hcar
e ri
sk w
aste
Dec
ont
amin
ate
hand
s im
med
iate
ly a
fter
rem
ovi
ng m
ask
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Ap
rons
or
go
wns
Dis
po
sab
le a
pro
ns s
houl
d b
e w
orn
whe
re t
here
is a
ris
k th
at t
he f
ront
of
unifo
rm/c
loth
ing
may
bec
om
e ex
po
sed
to
blo
od
, bo
dy
fluid
s, e
xcre
tio
ns
or
secr
etio
ns
Long
sle
eved
flui
d r
epel
lent
go
wns
may
be
req
uire
d if
the
re is
a r
isk
that
uni
form
/clo
thin
g a
nd s
kin
may
be
exp
ose
d t
o b
loo
d, b
od
y flu
ids,
ex
cret
ions
or
secr
etio
ns
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Rem
ova
l of
PP
ER
emo
ve P
PE
whe
n p
roce
dur
e is
co
mp
lete
. PP
E s
houl
d b
e re
mo
ved
in
the
fo
llow
ing
ord
er a
nd d
isp
ose
d o
f in
to h
ealt
hcar
e ri
sk w
aste
if
cont
amin
ated
wit
h b
loo
d a
nd/o
r b
od
y flu
ids
Glo
ves
•A
pro
n/g
ow
n•
Dec
ont
amin
ate
hand
s •
Eye
wea
r•
Mas
k (h
and
le b
y th
e m
ask
stra
ps
to a
void
to
uchi
ng t
he f
ront
)•
Dec
ont
amin
ate
hand
s•
All
mas
ks s
houl
d b
e d
isca
rded
into
hea
lthc
are
risk
was
te
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Env
iro
nmen
tal
Dec
ont
amin
atio
nR
out
ine
envi
ronm
enta
l cle
anin
g is
req
uire
d t
o m
inim
ise
the
num
ber
of
mic
ro-o
rgan
ism
s in
the
en
viro
nmen
t.
Par
ticu
lar
atte
ntio
n sh
oul
d b
e g
iven
to
fre
que
ntly
to
uche
d s
urfa
ces
and
tho
se m
ost
like
ly
to b
e co
ntam
inat
ed w
ith
blo
od
or
bo
dy
fluid
s e.
g. b
edra
ils, m
attr
ess,
bed
sid
e ta
ble
s,
com
mo
des
, do
ork
nob
s, s
inks
, sur
face
s an
d e
qui
pm
ent
clo
se t
o t
he p
atie
nt
Che
mic
al d
isin
fect
ants
are
no
t re
com
men
ded
fo
r ro
utin
e en
viro
nmen
tal c
lean
ing
Whe
n us
ing
dis
infe
ctan
ts, s
taff
sho
uld
fo
llow
the
man
ufac
ture
r’s in
stru
ctio
ns f
or
dilu
tio
n an
d
cont
act
tim
es
Ref
er t
o N
atio
nal H
osp
ital
Offi
ce C
lean
ing
Man
ual 2
00
6
Pat
ient
car
e en
viro
nmen
t b
e cl
eane
d a
nd
dis
infe
cted
wit
h a
det
erg
ent
and
100
0pp
m
of
avai
lab
le c
hlo
rine
dai
ly b
efo
re u
se o
n an
oth
er p
atie
nt if
co
ntam
inat
ed w
ith
resp
irat
ory
sec
reti
ons
. P
PE
sho
uld
be
wo
rn
for
all c
lean
ing
pro
ced
ures
as
per
pag
e 18
0-18
2.
Ro
om
sho
uld
rem
ain
vaca
nt f
or
one
ho
ur
wit
h w
ind
ow
s o
pen
bef
ore
re-
use
Pat
ient
Car
e E
qui
pm
ent
&D
eco
ntam
inat
ion
of
Med
ical
Dev
ices
Med
ical
dev
ices
des
igna
ted
as
“Sin
gle
Use
Onl
y” m
ust
not
be
rep
roce
ssed
or
reus
ed u
nder
an
y ci
rcum
stan
ces
(MD
A D
B 2
000)
, (M
DD
) 93/
42/E
EC
No
n-cr
itic
al e
qui
pm
ent
No
n-cr
itic
al e
qui
pm
ent
refe
rs t
o e
qui
pm
ent
that
is e
ithe
r no
t in
co
ntac
t w
ith
a p
atie
nt o
r in
co
ntac
t w
ith
heal
thy
skin
. Suc
h eq
uip
men
t sh
oul
d b
e:In
a s
tate
of
go
od
rep
air
in o
rder
to
fac
ilita
te e
ffec
tive
cle
anin
g•
Mus
t b
e th
oro
ughl
y cl
eane
d p
rio
r to
use
on
ano
ther
pat
ient
/res
iden
t. If
so
iled
wit
h •
blo
od
or
bo
dy
fluid
s, d
isin
fect
usi
ng a
chl
ori
ne-r
elea
sing
so
luti
on
of
1000
pp
m, o
r eq
uiva
lent
acc
ord
ing
to
man
ufac
ture
r’s in
stru
ctio
ns, r
inse
and
dry
.
Reu
sab
le in
vasi
ve m
edic
al d
evic
es (
RIM
D)
RIM
D r
efer
s to
eq
uip
men
t th
at is
cla
ssifi
ed a
s se
mi-c
riti
cal o
r cr
itic
al. R
IMD
s ar
e in
co
ntac
t w
ith
ster
ile b
od
y si
tes,
muc
ous
mem
bra
nes
and
bre
aks
in t
he s
kin.
HC
Ws
mus
t en
sure
tha
t R
IMD
s ar
e no
t us
ed f
or
ano
ther
pat
ient
unt
il th
ey h
ave
bee
n cl
eane
d a
nd r
epro
cess
ed
app
rop
riat
ely.
(HSE
Co
de
of
Pra
ctic
e fo
r D
eco
ntam
inat
ion
of
Reu
sab
le In
vasi
ve M
edic
al D
evic
es 2
007)
ww
w.h
se.ie
/eng
/Pub
licat
ions
/Ho
spit
als/
Co
de_
of_
Pra
ctic
e_fo
r_D
eco
ntam
inat
ion_
of_
Reu
sab
le_I
nvas
ive_
Med
ical
_Dev
ices
_.ht
ml
ww
w.h
psc
.ie/h
psc
/A-Z
/Mic
rob
iolo
gyA
ntim
icro
bia
lRes
ista
nce/
CJD
/Gui
dan
ce/
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Man
agem
ent
of
Hea
lth
Car
e R
isk
Was
te
Dis
po
se o
f he
alth
care
ris
k w
aste
in a
cco
rdan
ce w
ith
the
Dep
artm
ent
of
Hea
lth
& C
hild
ren’
s (D
oH
C) G
uid
elin
es f
or
Was
te D
isp
osa
l, w
hich
out
lines
the
cat
ego
risa
tio
n an
d s
egre
gat
ion
of
heal
thca
re w
aste
.
Dis
po
sal o
f sh
arp
s;Sy
ring
es a
nd n
eed
les
sho
uld
be
dis
po
sed
of
as a
sin
gle
uni
t•
Use
d s
harp
s sh
oul
d b
e ca
refu
lly d
isca
rded
into
des
igna
ted
sha
rps
bin
at
the
po
int
of
use
•Sh
arp
s b
in s
houl
d b
e se
cure
ly s
tore
d o
ut o
f re
ach
of
clie
nts,
vis
ito
rs a
nd c
hild
ren
•N
eed
les
sho
uld
no
t b
e re
-cap
ped
, ben
t, b
roke
n o
r d
isas
sem
ble
d•
Shar
ps
sho
uld
no
t b
e p
asse
d f
rom
per
son-
to-p
erso
n b
y ha
nd•
Do
HC
Gui
del
ines
on
Dis
po
sal o
f H
ealt
hcar
e R
isk
Was
te a
re a
vaila
ble
at
ww
w.d
ohc
.ie/p
ublic
atio
ns/s
egre
gat
ion_
pac
kag
ing
.htm
l
Was
te c
ont
amin
ated
wit
h sp
utum
fro
m a
su
spec
ted
or
kno
wn
TB p
atie
nt s
houl
d b
e d
isp
ose
d o
f as
hea
lthc
are
risk
was
te w
ithi
n a
heal
thca
re f
acili
ty
Res
pir
ato
ry m
asks
sho
uld
be
dis
po
sed
of
into
Hea
lthc
are
risk
was
te
Man
agem
ent
of
need
le s
tick
in
juri
es (
NSI
) an
d
blo
od
and
bo
dy
flui
d e
xpo
sure
All
faci
litie
s m
ust
have
a lo
cal g
uid
elin
e o
n th
e m
anag
emen
t o
f ne
edle
sti
ck in
juri
es a
nd b
loo
d
and
bo
dy
fluid
exp
osu
re. T
his
gui
del
ine
sho
uld
incl
ude;
Firs
t ai
d•
Ris
k as
sess
men
t an
d s
cree
ning
of
sour
ce p
atie
nt (i
f kn
ow
n)•
Ris
k as
sess
men
t f
or
chem
op
rop
hyla
xis
•C
oun
selli
ng a
nd f
ollo
w u
p t
esti
ng
•
Furt
her
info
rmat
ion
fro
m
ww
w.d
ohc
.ie/p
ublic
atio
ns/t
rans
mis
sio
n_o
f_b
loo
d_b
orn
e_d
isea
ses_
2006
.htm
l
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Typ
e an
d s
elec
tio
n o
f P
PE
PP
E c
ons
ists
of:
G
love
s,•
Ap
rons
/go
wns
•E
ye, n
asal
and
mo
uth
pro
tect
ion
• Eac
h H
CW
sho
uld
mak
e an
ris
k as
sess
men
t o
f th
e p
lann
ed p
roce
dur
e an
d s
elec
t P
PE
dep
end
ing
on;
The
natu
re o
f th
e p
roce
dur
e•
The
risk
of
exp
osu
re t
o b
loo
d a
nd b
od
y flu
ids
•Th
e ri
sk o
f co
ntam
inat
ion
•
Ad
dit
iona
l res
pir
ato
ry p
rote
ctio
n re
qui
red
(s
ee f
acia
l pro
tect
ion
sect
ion)
Glo
ves
Glo
ves
sho
uld
be
sing
le u
se it
ems
and
sho
uld
co
nfo
rm t
o E
uro
pea
n C
om
mun
ity
Stan
dar
ds
Glo
ves
are
reco
mm
end
ed;
For
all a
ctiv
itie
s th
at c
arry
a r
isk
of
exp
osu
re t
o b
loo
d, b
od
y flu
ids,
•
secr
etio
ns o
r ex
cret
ions
, sha
rps
or
cont
amin
ated
inst
rum
ents
Whe
n to
uchi
ng m
uco
us m
emb
rane
s an
d n
on-
inta
ct s
kin
•W
hen
hand
ling
co
ntam
inat
ed e
qui
pm
ent
• Glo
ves
sho
uld
be;
Sing
le u
se o
nly
•St
erile
if c
ont
act
anti
cip
ated
wit
h st
erile
bo
dy
site
•
Put
on
imm
edia
tely
bef
ore
an
epis
od
e o
f p
atie
nt c
ont
act
and
•
rem
ove
as
soo
n as
the
act
ivit
y is
co
mp
lete
dC
hang
ed w
hen
cari
ng f
or
diff
eren
t p
atie
nts
and
bet
wee
n d
iffer
ent
•ca
re a
ctiv
itie
s o
n th
e sa
me
pat
ient
Dis
po
sed
of
as h
ealt
h ca
re r
isk
was
te if
co
ntam
inat
ed w
ith
blo
od
or
•b
od
y flu
ids
fro
m p
atie
nts
wit
h su
spec
ted
or
kno
wn
infe
ctio
n.
Han
d h
ygie
ne s
houl
d b
e p
erfo
rmed
bef
ore
do
nnin
g a
nd im
med
iate
ly
follo
win
g r
emo
val o
f g
love
s
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Face
pro
tect
ion
Face
pro
tect
ion
sho
uld
be
wo
rn w
here
:
Ther
e is
a r
isk
of
blo
od
, bo
dy
fluid
s,
•se
cret
ions
or
excr
etio
ns s
pla
shin
g in
to t
he
face
or
eyes
Whe
n p
laci
ng a
cat
hete
r o
r in
ject
ing
into
•
the
spin
al o
r ep
idur
al s
pac
e.
Face
pro
tect
ion
cons
ists
of
one
of
the
follo
win
g:
Flui
d r
epel
lent
mas
k w
ith
sep
arat
e •
go
gg
les
Res
pir
ato
ry m
ask
(FFP
2/3)
•Fa
ce s
hiel
d•
Flui
d r
epel
lent
mas
k w
ith
eye
shie
ld.
• Face
pro
tect
ion
sho
uld
be:
Sing
le u
se o
r si
ngle
per
son
use
(fac
e •
shie
lds
and
go
gg
les
can
be
reus
ed
by
the
sam
e H
CW
but
the
y m
ust
be
adeq
uate
ly c
lean
ed a
nd d
isin
fect
ed a
s p
er m
anuf
actu
rer’s
inst
ruct
ions
aft
er e
ach
use.
In a
dd
itio
n to
eye
pro
tect
ion
as r
equi
red
fo
r St
and
ard
Pre
caut
ions
HC
Ws
and
vis
ito
rs s
houl
d d
on
corr
ectl
y fit
ted
: FF
P2
mas
ks b
efo
re e
nter
ing
the
iso
lati
on
roo
m o
f a
susp
ecte
d o
r co
nfirm
ed
•in
fect
ious
TB
cas
e w
here
MD
R-T
B n
ot
susp
ecte
dFF
P3
mas
k d
urin
g h
igh
risk
pro
ced
ures
fo
r al
l pat
ient
s w
here
TB
is s
usp
ecte
d
•o
r co
nfirm
ed (s
usce
pti
ble
or
MD
R) s
uch
as:
Sput
um in
duc
tio
no
C
oug
h p
rod
ucin
g p
roce
dur
es (e
.g. a
dm
inis
teri
ng a
ero
solis
ed
o
med
icat
ions
, bro
ncho
sco
py,
air
way
suc
tio
ning
, end
otr
ache
al in
tub
atio
n)P
roce
dur
es w
here
aer
oso
lisat
ion
of
dra
inag
e flu
id f
rom
an
absc
ess/
o
lesi
ons
may
occ
urFF
P3
mas
ks b
efo
re e
nter
ing
the
iso
lati
on
roo
m o
f a
susp
ecte
d o
r kn
ow
n ca
se
•o
f M
DR
-TB
or
XD
R-T
B
To p
rese
rve
pri
vacy
and
co
nfid
enti
alit
y re
stri
ctin
g v
isit
ing
to
imm
edia
te f
amily
sh
oul
d b
e d
iscu
ssed
wit
h th
e p
atie
nt
All
HC
Ws
who
may
be
req
uire
d t
o u
se r
esp
irat
ory
mas
ks (F
FP2
& F
FP3)
dur
ing
th
e co
urse
of
thei
r w
ork
sho
uld
be
fit t
este
d b
y a
trai
ned
pro
fess
iona
l wit
hin
each
o
rgan
isat
ion
HC
Ws
sho
uld
fit
chec
k th
e m
ask
each
tim
e it
is w
orn
to
che
ck t
he s
eal
HC
Ws
visi
ting
a p
atie
nt in
the
ir o
wn
hom
e sh
oul
d w
ear
a FF
P2
or
FFP
3 m
ask
whi
le
the
pat
ient
is in
fect
ious
(see
cha
pte
r 6
on
Infe
ctio
n P
reve
ntio
n an
d C
ont
rol f
or
dis
cont
inua
tio
n o
f A
irb
orn
e P
reca
utio
ns).
Pat
ient
pri
vacy
mus
t b
e m
aint
aine
d if
m
ask
is w
orn
in t
he h
om
e.
All
mas
ks s
houl
d b
e re
mo
ved
in t
he a
nte
roo
m o
r im
med
iate
ly o
utsi
de
the
sing
le
roo
m if
the
re is
no
ant
e ro
om
Dis
card
mas
k in
to h
ealt
hcar
e ri
sk w
aste
Dec
ont
amin
ate
hand
s im
med
iate
ly a
fter
rem
ovi
ng m
ask
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Ap
rons
or
go
wns
Dis
po
sab
le a
pro
ns s
houl
d b
e w
orn
whe
re t
here
is a
ris
k th
at t
he f
ront
of
unifo
rm/c
loth
ing
may
bec
om
e ex
po
sed
to
blo
od
, bo
dy
fluid
s, e
xcre
tio
ns
or
secr
etio
ns
Long
sle
eved
flui
d r
epel
lent
go
wns
may
be
req
uire
d if
the
re is
a r
isk
that
uni
form
/clo
thin
g a
nd s
kin
may
be
exp
ose
d t
o b
loo
d, b
od
y flu
ids,
ex
cret
ions
or
secr
etio
ns
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Rem
ova
l of
PP
ER
emo
ve P
PE
whe
n p
roce
dur
e is
co
mp
lete
. PP
E s
houl
d b
e re
mo
ved
in
the
fo
llow
ing
ord
er a
nd d
isp
ose
d o
f in
to h
ealt
hcar
e ri
sk w
aste
if
cont
amin
ated
wit
h b
loo
d a
nd/o
r b
od
y flu
ids
Glo
ves
•A
pro
n/g
ow
n•
Dec
ont
amin
ate
hand
s •
Eye
wea
r•
Mas
k (h
and
le b
y th
e m
ask
stra
ps
to a
void
to
uchi
ng t
he f
ront
)•
Dec
ont
amin
ate
hand
s•
All
mas
ks s
houl
d b
e d
isca
rded
into
hea
lthc
are
risk
was
te
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Env
iro
nmen
tal
Dec
ont
amin
atio
nR
out
ine
envi
ronm
enta
l cle
anin
g is
req
uire
d t
o m
inim
ise
the
num
ber
of
mic
ro-o
rgan
ism
s in
the
en
viro
nmen
t.
Par
ticu
lar
atte
ntio
n sh
oul
d b
e g
iven
to
fre
que
ntly
to
uche
d s
urfa
ces
and
tho
se m
ost
like
ly
to b
e co
ntam
inat
ed w
ith
blo
od
or
bo
dy
fluid
s e.
g. b
edra
ils, m
attr
ess,
bed
sid
e ta
ble
s,
com
mo
des
, do
ork
nob
s, s
inks
, sur
face
s an
d e
qui
pm
ent
clo
se t
o t
he p
atie
nt
Che
mic
al d
isin
fect
ants
are
no
t re
com
men
ded
fo
r ro
utin
e en
viro
nmen
tal c
lean
ing
Whe
n us
ing
dis
infe
ctan
ts, s
taff
sho
uld
fo
llow
the
man
ufac
ture
r’s in
stru
ctio
ns f
or
dilu
tio
n an
d
cont
act
tim
es
Ref
er t
o N
atio
nal H
osp
ital
Offi
ce C
lean
ing
Man
ual 2
00
6
Pat
ient
car
e en
viro
nmen
t b
e cl
eane
d a
nd
dis
infe
cted
wit
h a
det
erg
ent
and
100
0pp
m
of
avai
lab
le c
hlo
rine
dai
ly b
efo
re u
se o
n an
oth
er p
atie
nt if
co
ntam
inat
ed w
ith
resp
irat
ory
sec
reti
ons
. P
PE
sho
uld
be
wo
rn
for
all c
lean
ing
pro
ced
ures
as
per
pag
e 18
0-18
2.
Ro
om
sho
uld
rem
ain
vaca
nt f
or
one
ho
ur
wit
h w
ind
ow
s o
pen
bef
ore
re-
use
Pat
ient
Car
e E
qui
pm
ent
&D
eco
ntam
inat
ion
of
Med
ical
Dev
ices
Med
ical
dev
ices
des
igna
ted
as
“Sin
gle
Use
Onl
y” m
ust
not
be
rep
roce
ssed
or
reus
ed u
nder
an
y ci
rcum
stan
ces
(MD
A D
B 2
000)
, (M
DD
) 93/
42/E
EC
No
n-cr
itic
al e
qui
pm
ent
No
n-cr
itic
al e
qui
pm
ent
refe
rs t
o e
qui
pm
ent
that
is e
ithe
r no
t in
co
ntac
t w
ith
a p
atie
nt o
r in
co
ntac
t w
ith
heal
thy
skin
. Suc
h eq
uip
men
t sh
oul
d b
e:In
a s
tate
of
go
od
rep
air
in o
rder
to
fac
ilita
te e
ffec
tive
cle
anin
g•
Mus
t b
e th
oro
ughl
y cl
eane
d p
rio
r to
use
on
ano
ther
pat
ient
/res
iden
t. If
so
iled
wit
h •
blo
od
or
bo
dy
fluid
s, d
isin
fect
usi
ng a
chl
ori
ne-r
elea
sing
so
luti
on
of
1000
pp
m, o
r eq
uiva
lent
acc
ord
ing
to
man
ufac
ture
r’s in
stru
ctio
ns, r
inse
and
dry
.
Reu
sab
le in
vasi
ve m
edic
al d
evic
es (
RIM
D)
RIM
D r
efer
s to
eq
uip
men
t th
at is
cla
ssifi
ed a
s se
mi-c
riti
cal o
r cr
itic
al. R
IMD
s ar
e in
co
ntac
t w
ith
ster
ile b
od
y si
tes,
muc
ous
mem
bra
nes
and
bre
aks
in t
he s
kin.
HC
Ws
mus
t en
sure
tha
t R
IMD
s ar
e no
t us
ed f
or
ano
ther
pat
ient
unt
il th
ey h
ave
bee
n cl
eane
d a
nd r
epro
cess
ed
app
rop
riat
ely.
(HSE
Co
de
of
Pra
ctic
e fo
r D
eco
ntam
inat
ion
of
Reu
sab
le In
vasi
ve M
edic
al D
evic
es 2
007)
ww
w.h
se.ie
/eng
/Pub
licat
ions
/Ho
spit
als/
Co
de_
of_
Pra
ctic
e_fo
r_D
eco
ntam
inat
ion_
of_
Reu
sab
le_I
nvas
ive_
Med
ical
_Dev
ices
_.ht
ml
ww
w.h
psc
.ie/h
psc
/A-Z
/Mic
rob
iolo
gyA
ntim
icro
bia
lRes
ista
nce/
CJD
/Gui
dan
ce/
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Man
agem
ent
of
Hea
lth
Car
e R
isk
Was
te
Dis
po
se o
f he
alth
care
ris
k w
aste
in a
cco
rdan
ce w
ith
the
Dep
artm
ent
of
Hea
lth
& C
hild
ren’
s (D
oH
C) G
uid
elin
es f
or
Was
te D
isp
osa
l, w
hich
out
lines
the
cat
ego
risa
tio
n an
d s
egre
gat
ion
of
heal
thca
re w
aste
.
Dis
po
sal o
f sh
arp
s;Sy
ring
es a
nd n
eed
les
sho
uld
be
dis
po
sed
of
as a
sin
gle
uni
t•
Use
d s
harp
s sh
oul
d b
e ca
refu
lly d
isca
rded
into
des
igna
ted
sha
rps
bin
at
the
po
int
of
use
•Sh
arp
s b
in s
houl
d b
e se
cure
ly s
tore
d o
ut o
f re
ach
of
clie
nts,
vis
ito
rs a
nd c
hild
ren
•N
eed
les
sho
uld
no
t b
e re
-cap
ped
, ben
t, b
roke
n o
r d
isas
sem
ble
d•
Shar
ps
sho
uld
no
t b
e p
asse
d f
rom
per
son-
to-p
erso
n b
y ha
nd•
Do
HC
Gui
del
ines
on
Dis
po
sal o
f H
ealt
hcar
e R
isk
Was
te a
re a
vaila
ble
at
ww
w.d
ohc
.ie/p
ublic
atio
ns/s
egre
gat
ion_
pac
kag
ing
.htm
l
Was
te c
ont
amin
ated
wit
h sp
utum
fro
m a
su
spec
ted
or
kno
wn
TB p
atie
nt s
houl
d b
e d
isp
ose
d o
f as
hea
lthc
are
risk
was
te w
ithi
n a
heal
thca
re f
acili
ty
Res
pir
ato
ry m
asks
sho
uld
be
dis
po
sed
of
into
Hea
lthc
are
risk
was
te
Man
agem
ent
of
need
le s
tick
in
juri
es (
NSI
) an
d
blo
od
and
bo
dy
flui
d e
xpo
sure
All
faci
litie
s m
ust
have
a lo
cal g
uid
elin
e o
n th
e m
anag
emen
t o
f ne
edle
sti
ck in
juri
es a
nd b
loo
d
and
bo
dy
fluid
exp
osu
re. T
his
gui
del
ine
sho
uld
incl
ude;
Firs
t ai
d•
Ris
k as
sess
men
t an
d s
cree
ning
of
sour
ce p
atie
nt (i
f kn
ow
n)•
Ris
k as
sess
men
t f
or
chem
op
rop
hyla
xis
•C
oun
selli
ng a
nd f
ollo
w u
p t
esti
ng
•
Furt
her
info
rmat
ion
fro
m
ww
w.d
ohc
.ie/p
ublic
atio
ns/t
rans
mis
sio
n_o
f_b
loo
d_b
orn
e_d
isea
ses_
2006
.htm
l
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
-178-
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-179-
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Typ
e an
d s
elec
tio
n o
f P
PE
PP
E c
ons
ists
of:
G
love
s,•
Ap
rons
/go
wns
•E
ye, n
asal
and
mo
uth
pro
tect
ion
• Eac
h H
CW
sho
uld
mak
e an
ris
k as
sess
men
t o
f th
e p
lann
ed p
roce
dur
e an
d s
elec
t P
PE
dep
end
ing
on;
The
natu
re o
f th
e p
roce
dur
e•
The
risk
of
exp
osu
re t
o b
loo
d a
nd b
od
y flu
ids
•Th
e ri
sk o
f co
ntam
inat
ion
•
Ad
dit
iona
l res
pir
ato
ry p
rote
ctio
n re
qui
red
(s
ee f
acia
l pro
tect
ion
sect
ion)
Glo
ves
Glo
ves
sho
uld
be
sing
le u
se it
ems
and
sho
uld
co
nfo
rm t
o E
uro
pea
n C
om
mun
ity
Stan
dar
ds
Glo
ves
are
reco
mm
end
ed;
For
all a
ctiv
itie
s th
at c
arry
a r
isk
of
exp
osu
re t
o b
loo
d, b
od
y flu
ids,
•
secr
etio
ns o
r ex
cret
ions
, sha
rps
or
cont
amin
ated
inst
rum
ents
Whe
n to
uchi
ng m
uco
us m
emb
rane
s an
d n
on-
inta
ct s
kin
•W
hen
hand
ling
co
ntam
inat
ed e
qui
pm
ent
• Glo
ves
sho
uld
be;
Sing
le u
se o
nly
•St
erile
if c
ont
act
anti
cip
ated
wit
h st
erile
bo
dy
site
•
Put
on
imm
edia
tely
bef
ore
an
epis
od
e o
f p
atie
nt c
ont
act
and
•
rem
ove
as
soo
n as
the
act
ivit
y is
co
mp
lete
dC
hang
ed w
hen
cari
ng f
or
diff
eren
t p
atie
nts
and
bet
wee
n d
iffer
ent
•ca
re a
ctiv
itie
s o
n th
e sa
me
pat
ient
Dis
po
sed
of
as h
ealt
h ca
re r
isk
was
te if
co
ntam
inat
ed w
ith
blo
od
or
•b
od
y flu
ids
fro
m p
atie
nts
wit
h su
spec
ted
or
kno
wn
infe
ctio
n.
Han
d h
ygie
ne s
houl
d b
e p
erfo
rmed
bef
ore
do
nnin
g a
nd im
med
iate
ly
follo
win
g r
emo
val o
f g
love
s
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Face
pro
tect
ion
Face
pro
tect
ion
sho
uld
be
wo
rn w
here
:
Ther
e is
a r
isk
of
blo
od
, bo
dy
fluid
s,
•se
cret
ions
or
excr
etio
ns s
pla
shin
g in
to t
he
face
or
eyes
Whe
n p
laci
ng a
cat
hete
r o
r in
ject
ing
into
•
the
spin
al o
r ep
idur
al s
pac
e.
Face
pro
tect
ion
cons
ists
of
one
of
the
follo
win
g:
Flui
d r
epel
lent
mas
k w
ith
sep
arat
e •
go
gg
les
Res
pir
ato
ry m
ask
(FFP
2/3)
•Fa
ce s
hiel
d•
Flui
d r
epel
lent
mas
k w
ith
eye
shie
ld.
• Face
pro
tect
ion
sho
uld
be:
Sing
le u
se o
r si
ngle
per
son
use
(fac
e •
shie
lds
and
go
gg
les
can
be
reus
ed
by
the
sam
e H
CW
but
the
y m
ust
be
adeq
uate
ly c
lean
ed a
nd d
isin
fect
ed a
s p
er m
anuf
actu
rer’s
inst
ruct
ions
aft
er e
ach
use.
In a
dd
itio
n to
eye
pro
tect
ion
as r
equi
red
fo
r St
and
ard
Pre
caut
ions
HC
Ws
and
vis
ito
rs s
houl
d d
on
corr
ectl
y fit
ted
: FF
P2
mas
ks b
efo
re e
nter
ing
the
iso
lati
on
roo
m o
f a
susp
ecte
d o
r co
nfirm
ed
•in
fect
ious
TB
cas
e w
here
MD
R-T
B n
ot
susp
ecte
dFF
P3
mas
k d
urin
g h
igh
risk
pro
ced
ures
fo
r al
l pat
ient
s w
here
TB
is s
usp
ecte
d
•o
r co
nfirm
ed (s
usce
pti
ble
or
MD
R) s
uch
as:
Sput
um in
duc
tio
no
C
oug
h p
rod
ucin
g p
roce
dur
es (e
.g. a
dm
inis
teri
ng a
ero
solis
ed
o
med
icat
ions
, bro
ncho
sco
py,
air
way
suc
tio
ning
, end
otr
ache
al in
tub
atio
n)P
roce
dur
es w
here
aer
oso
lisat
ion
of
dra
inag
e flu
id f
rom
an
absc
ess/
o
lesi
ons
may
occ
urFF
P3
mas
ks b
efo
re e
nter
ing
the
iso
lati
on
roo
m o
f a
susp
ecte
d o
r kn
ow
n ca
se
•o
f M
DR
-TB
or
XD
R-T
B
To p
rese
rve
pri
vacy
and
co
nfid
enti
alit
y re
stri
ctin
g v
isit
ing
to
imm
edia
te f
amily
sh
oul
d b
e d
iscu
ssed
wit
h th
e p
atie
nt
All
HC
Ws
who
may
be
req
uire
d t
o u
se r
esp
irat
ory
mas
ks (F
FP2
& F
FP3)
dur
ing
th
e co
urse
of
thei
r w
ork
sho
uld
be
fit t
este
d b
y a
trai
ned
pro
fess
iona
l wit
hin
each
o
rgan
isat
ion
HC
Ws
sho
uld
fit
chec
k th
e m
ask
each
tim
e it
is w
orn
to
che
ck t
he s
eal
HC
Ws
visi
ting
a p
atie
nt in
the
ir o
wn
hom
e sh
oul
d w
ear
a FF
P2
or
FFP
3 m
ask
whi
le
the
pat
ient
is in
fect
ious
(see
cha
pte
r 6
on
Infe
ctio
n P
reve
ntio
n an
d C
ont
rol f
or
dis
cont
inua
tio
n o
f A
irb
orn
e P
reca
utio
ns).
Pat
ient
pri
vacy
mus
t b
e m
aint
aine
d if
m
ask
is w
orn
in t
he h
om
e.
All
mas
ks s
houl
d b
e re
mo
ved
in t
he a
nte
roo
m o
r im
med
iate
ly o
utsi
de
the
sing
le
roo
m if
the
re is
no
ant
e ro
om
Dis
card
mas
k in
to h
ealt
hcar
e ri
sk w
aste
Dec
ont
amin
ate
hand
s im
med
iate
ly a
fter
rem
ovi
ng m
ask
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Ap
rons
or
go
wns
Dis
po
sab
le a
pro
ns s
houl
d b
e w
orn
whe
re t
here
is a
ris
k th
at t
he f
ront
of
unifo
rm/c
loth
ing
may
bec
om
e ex
po
sed
to
blo
od
, bo
dy
fluid
s, e
xcre
tio
ns
or
secr
etio
ns
Long
sle
eved
flui
d r
epel
lent
go
wns
may
be
req
uire
d if
the
re is
a r
isk
that
uni
form
/clo
thin
g a
nd s
kin
may
be
exp
ose
d t
o b
loo
d, b
od
y flu
ids,
ex
cret
ions
or
secr
etio
ns
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Rem
ova
l of
PP
ER
emo
ve P
PE
whe
n p
roce
dur
e is
co
mp
lete
. PP
E s
houl
d b
e re
mo
ved
in
the
fo
llow
ing
ord
er a
nd d
isp
ose
d o
f in
to h
ealt
hcar
e ri
sk w
aste
if
cont
amin
ated
wit
h b
loo
d a
nd/o
r b
od
y flu
ids
Glo
ves
•A
pro
n/g
ow
n•
Dec
ont
amin
ate
hand
s •
Eye
wea
r•
Mas
k (h
and
le b
y th
e m
ask
stra
ps
to a
void
to
uchi
ng t
he f
ront
)•
Dec
ont
amin
ate
hand
s•
All
mas
ks s
houl
d b
e d
isca
rded
into
hea
lthc
are
risk
was
te
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Env
iro
nmen
tal
Dec
ont
amin
atio
nR
out
ine
envi
ronm
enta
l cle
anin
g is
req
uire
d t
o m
inim
ise
the
num
ber
of
mic
ro-o
rgan
ism
s in
the
en
viro
nmen
t.
Par
ticu
lar
atte
ntio
n sh
oul
d b
e g
iven
to
fre
que
ntly
to
uche
d s
urfa
ces
and
tho
se m
ost
like
ly
to b
e co
ntam
inat
ed w
ith
blo
od
or
bo
dy
fluid
s e.
g. b
edra
ils, m
attr
ess,
bed
sid
e ta
ble
s,
com
mo
des
, do
ork
nob
s, s
inks
, sur
face
s an
d e
qui
pm
ent
clo
se t
o t
he p
atie
nt
Che
mic
al d
isin
fect
ants
are
no
t re
com
men
ded
fo
r ro
utin
e en
viro
nmen
tal c
lean
ing
Whe
n us
ing
dis
infe
ctan
ts, s
taff
sho
uld
fo
llow
the
man
ufac
ture
r’s in
stru
ctio
ns f
or
dilu
tio
n an
d
cont
act
tim
es
Ref
er t
o N
atio
nal H
osp
ital
Offi
ce C
lean
ing
Man
ual 2
00
6
Pat
ient
car
e en
viro
nmen
t b
e cl
eane
d a
nd
dis
infe
cted
wit
h a
det
erg
ent
and
100
0pp
m
of
avai
lab
le c
hlo
rine
dai
ly b
efo
re u
se o
n an
oth
er p
atie
nt if
co
ntam
inat
ed w
ith
resp
irat
ory
sec
reti
ons
. P
PE
sho
uld
be
wo
rn
for
all c
lean
ing
pro
ced
ures
as
per
pag
e 18
0-18
2.
Ro
om
sho
uld
rem
ain
vaca
nt f
or
one
ho
ur
wit
h w
ind
ow
s o
pen
bef
ore
re-
use
Pat
ient
Car
e E
qui
pm
ent
&D
eco
ntam
inat
ion
of
Med
ical
Dev
ices
Med
ical
dev
ices
des
igna
ted
as
“Sin
gle
Use
Onl
y” m
ust
not
be
rep
roce
ssed
or
reus
ed u
nder
an
y ci
rcum
stan
ces
(MD
A D
B 2
000)
, (M
DD
) 93/
42/E
EC
No
n-cr
itic
al e
qui
pm
ent
No
n-cr
itic
al e
qui
pm
ent
refe
rs t
o e
qui
pm
ent
that
is e
ithe
r no
t in
co
ntac
t w
ith
a p
atie
nt o
r in
co
ntac
t w
ith
heal
thy
skin
. Suc
h eq
uip
men
t sh
oul
d b
e:In
a s
tate
of
go
od
rep
air
in o
rder
to
fac
ilita
te e
ffec
tive
cle
anin
g•
Mus
t b
e th
oro
ughl
y cl
eane
d p
rio
r to
use
on
ano
ther
pat
ient
/res
iden
t. If
so
iled
wit
h •
blo
od
or
bo
dy
fluid
s, d
isin
fect
usi
ng a
chl
ori
ne-r
elea
sing
so
luti
on
of
1000
pp
m, o
r eq
uiva
lent
acc
ord
ing
to
man
ufac
ture
r’s in
stru
ctio
ns, r
inse
and
dry
.
Reu
sab
le in
vasi
ve m
edic
al d
evic
es (
RIM
D)
RIM
D r
efer
s to
eq
uip
men
t th
at is
cla
ssifi
ed a
s se
mi-c
riti
cal o
r cr
itic
al. R
IMD
s ar
e in
co
ntac
t w
ith
ster
ile b
od
y si
tes,
muc
ous
mem
bra
nes
and
bre
aks
in t
he s
kin.
HC
Ws
mus
t en
sure
tha
t R
IMD
s ar
e no
t us
ed f
or
ano
ther
pat
ient
unt
il th
ey h
ave
bee
n cl
eane
d a
nd r
epro
cess
ed
app
rop
riat
ely.
(HSE
Co
de
of
Pra
ctic
e fo
r D
eco
ntam
inat
ion
of
Reu
sab
le In
vasi
ve M
edic
al D
evic
es 2
007)
ww
w.h
se.ie
/eng
/Pub
licat
ions
/Ho
spit
als/
Co
de_
of_
Pra
ctic
e_fo
r_D
eco
ntam
inat
ion_
of_
Reu
sab
le_I
nvas
ive_
Med
ical
_Dev
ices
_.ht
ml
ww
w.h
psc
.ie/h
psc
/A-Z
/Mic
rob
iolo
gyA
ntim
icro
bia
lRes
ista
nce/
CJD
/Gui
dan
ce/
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Man
agem
ent
of
Hea
lth
Car
e R
isk
Was
te
Dis
po
se o
f he
alth
care
ris
k w
aste
in a
cco
rdan
ce w
ith
the
Dep
artm
ent
of
Hea
lth
& C
hild
ren’
s (D
oH
C) G
uid
elin
es f
or
Was
te D
isp
osa
l, w
hich
out
lines
the
cat
ego
risa
tio
n an
d s
egre
gat
ion
of
heal
thca
re w
aste
.
Dis
po
sal o
f sh
arp
s;Sy
ring
es a
nd n
eed
les
sho
uld
be
dis
po
sed
of
as a
sin
gle
uni
t•
Use
d s
harp
s sh
oul
d b
e ca
refu
lly d
isca
rded
into
des
igna
ted
sha
rps
bin
at
the
po
int
of
use
•Sh
arp
s b
in s
houl
d b
e se
cure
ly s
tore
d o
ut o
f re
ach
of
clie
nts,
vis
ito
rs a
nd c
hild
ren
•N
eed
les
sho
uld
no
t b
e re
-cap
ped
, ben
t, b
roke
n o
r d
isas
sem
ble
d•
Shar
ps
sho
uld
no
t b
e p
asse
d f
rom
per
son-
to-p
erso
n b
y ha
nd•
Do
HC
Gui
del
ines
on
Dis
po
sal o
f H
ealt
hcar
e R
isk
Was
te a
re a
vaila
ble
at
ww
w.d
ohc
.ie/p
ublic
atio
ns/s
egre
gat
ion_
pac
kag
ing
.htm
l
Was
te c
ont
amin
ated
wit
h sp
utum
fro
m a
su
spec
ted
or
kno
wn
TB p
atie
nt s
houl
d b
e d
isp
ose
d o
f as
hea
lthc
are
risk
was
te w
ithi
n a
heal
thca
re f
acili
ty
Res
pir
ato
ry m
asks
sho
uld
be
dis
po
sed
of
into
Hea
lthc
are
risk
was
te
Man
agem
ent
of
need
le s
tick
in
juri
es (
NSI
) an
d
blo
od
and
bo
dy
flui
d e
xpo
sure
All
faci
litie
s m
ust
have
a lo
cal g
uid
elin
e o
n th
e m
anag
emen
t o
f ne
edle
sti
ck in
juri
es a
nd b
loo
d
and
bo
dy
fluid
exp
osu
re. T
his
gui
del
ine
sho
uld
incl
ude;
Firs
t ai
d•
Ris
k as
sess
men
t an
d s
cree
ning
of
sour
ce p
atie
nt (i
f kn
ow
n)•
Ris
k as
sess
men
t f
or
chem
op
rop
hyla
xis
•C
oun
selli
ng a
nd f
ollo
w u
p t
esti
ng
•
Furt
her
info
rmat
ion
fro
m
ww
w.d
ohc
.ie/p
ublic
atio
ns/t
rans
mis
sio
n_o
f_b
loo
d_b
orn
e_d
isea
ses_
2006
.htm
l
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Typ
e an
d s
elec
tio
n o
f P
PE
PP
E c
ons
ists
of:
G
love
s,•
Ap
rons
/go
wns
•E
ye, n
asal
and
mo
uth
pro
tect
ion
• Eac
h H
CW
sho
uld
mak
e an
ris
k as
sess
men
t o
f th
e p
lann
ed p
roce
dur
e an
d s
elec
t P
PE
dep
end
ing
on;
The
natu
re o
f th
e p
roce
dur
e•
The
risk
of
exp
osu
re t
o b
loo
d a
nd b
od
y flu
ids
•Th
e ri
sk o
f co
ntam
inat
ion
•
Ad
dit
iona
l res
pir
ato
ry p
rote
ctio
n re
qui
red
(s
ee f
acia
l pro
tect
ion
sect
ion)
Glo
ves
Glo
ves
sho
uld
be
sing
le u
se it
ems
and
sho
uld
co
nfo
rm t
o E
uro
pea
n C
om
mun
ity
Stan
dar
ds
Glo
ves
are
reco
mm
end
ed;
For
all a
ctiv
itie
s th
at c
arry
a r
isk
of
exp
osu
re t
o b
loo
d, b
od
y flu
ids,
•
secr
etio
ns o
r ex
cret
ions
, sha
rps
or
cont
amin
ated
inst
rum
ents
Whe
n to
uchi
ng m
uco
us m
emb
rane
s an
d n
on-
inta
ct s
kin
•W
hen
hand
ling
co
ntam
inat
ed e
qui
pm
ent
• Glo
ves
sho
uld
be;
Sing
le u
se o
nly
•St
erile
if c
ont
act
anti
cip
ated
wit
h st
erile
bo
dy
site
•
Put
on
imm
edia
tely
bef
ore
an
epis
od
e o
f p
atie
nt c
ont
act
and
•
rem
ove
as
soo
n as
the
act
ivit
y is
co
mp
lete
dC
hang
ed w
hen
cari
ng f
or
diff
eren
t p
atie
nts
and
bet
wee
n d
iffer
ent
•ca
re a
ctiv
itie
s o
n th
e sa
me
pat
ient
Dis
po
sed
of
as h
ealt
h ca
re r
isk
was
te if
co
ntam
inat
ed w
ith
blo
od
or
•b
od
y flu
ids
fro
m p
atie
nts
wit
h su
spec
ted
or
kno
wn
infe
ctio
n.
Han
d h
ygie
ne s
houl
d b
e p
erfo
rmed
bef
ore
do
nnin
g a
nd im
med
iate
ly
follo
win
g r
emo
val o
f g
love
s
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Face
pro
tect
ion
Face
pro
tect
ion
sho
uld
be
wo
rn w
here
:
Ther
e is
a r
isk
of
blo
od
, bo
dy
fluid
s,
•se
cret
ions
or
excr
etio
ns s
pla
shin
g in
to t
he
face
or
eyes
Whe
n p
laci
ng a
cat
hete
r o
r in
ject
ing
into
•
the
spin
al o
r ep
idur
al s
pac
e.
Face
pro
tect
ion
cons
ists
of
one
of
the
follo
win
g:
Flui
d r
epel
lent
mas
k w
ith
sep
arat
e •
go
gg
les
Res
pir
ato
ry m
ask
(FFP
2/3)
•Fa
ce s
hiel
d•
Flui
d r
epel
lent
mas
k w
ith
eye
shie
ld.
• Face
pro
tect
ion
sho
uld
be:
Sing
le u
se o
r si
ngle
per
son
use
(fac
e •
shie
lds
and
go
gg
les
can
be
reus
ed
by
the
sam
e H
CW
but
the
y m
ust
be
adeq
uate
ly c
lean
ed a
nd d
isin
fect
ed a
s p
er m
anuf
actu
rer’s
inst
ruct
ions
aft
er e
ach
use.
In a
dd
itio
n to
eye
pro
tect
ion
as r
equi
red
fo
r St
and
ard
Pre
caut
ions
HC
Ws
and
vis
ito
rs s
houl
d d
on
corr
ectl
y fit
ted
: FF
P2
mas
ks b
efo
re e
nter
ing
the
iso
lati
on
roo
m o
f a
susp
ecte
d o
r co
nfirm
ed
•in
fect
ious
TB
cas
e w
here
MD
R-T
B n
ot
susp
ecte
dFF
P3
mas
k d
urin
g h
igh
risk
pro
ced
ures
fo
r al
l pat
ient
s w
here
TB
is s
usp
ecte
d
•o
r co
nfirm
ed (s
usce
pti
ble
or
MD
R) s
uch
as:
Sput
um in
duc
tio
no
C
oug
h p
rod
ucin
g p
roce
dur
es (e
.g. a
dm
inis
teri
ng a
ero
solis
ed
o
med
icat
ions
, bro
ncho
sco
py,
air
way
suc
tio
ning
, end
otr
ache
al in
tub
atio
n)P
roce
dur
es w
here
aer
oso
lisat
ion
of
dra
inag
e flu
id f
rom
an
absc
ess/
o
lesi
ons
may
occ
urFF
P3
mas
ks b
efo
re e
nter
ing
the
iso
lati
on
roo
m o
f a
susp
ecte
d o
r kn
ow
n ca
se
•o
f M
DR
-TB
or
XD
R-T
B
To p
rese
rve
pri
vacy
and
co
nfid
enti
alit
y re
stri
ctin
g v
isit
ing
to
imm
edia
te f
amily
sh
oul
d b
e d
iscu
ssed
wit
h th
e p
atie
nt
All
HC
Ws
who
may
be
req
uire
d t
o u
se r
esp
irat
ory
mas
ks (F
FP2
& F
FP3)
dur
ing
th
e co
urse
of
thei
r w
ork
sho
uld
be
fit t
este
d b
y a
trai
ned
pro
fess
iona
l wit
hin
each
o
rgan
isat
ion
HC
Ws
sho
uld
fit
chec
k th
e m
ask
each
tim
e it
is w
orn
to
che
ck t
he s
eal
HC
Ws
visi
ting
a p
atie
nt in
the
ir o
wn
hom
e sh
oul
d w
ear
a FF
P2
or
FFP
3 m
ask
whi
le
the
pat
ient
is in
fect
ious
(see
cha
pte
r 6
on
Infe
ctio
n P
reve
ntio
n an
d C
ont
rol f
or
dis
cont
inua
tio
n o
f A
irb
orn
e P
reca
utio
ns).
Pat
ient
pri
vacy
mus
t b
e m
aint
aine
d if
m
ask
is w
orn
in t
he h
om
e.
All
mas
ks s
houl
d b
e re
mo
ved
in t
he a
nte
roo
m o
r im
med
iate
ly o
utsi
de
the
sing
le
roo
m if
the
re is
no
ant
e ro
om
Dis
card
mas
k in
to h
ealt
hcar
e ri
sk w
aste
Dec
ont
amin
ate
hand
s im
med
iate
ly a
fter
rem
ovi
ng m
ask
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Ap
rons
or
go
wns
Dis
po
sab
le a
pro
ns s
houl
d b
e w
orn
whe
re t
here
is a
ris
k th
at t
he f
ront
of
unifo
rm/c
loth
ing
may
bec
om
e ex
po
sed
to
blo
od
, bo
dy
fluid
s, e
xcre
tio
ns
or
secr
etio
ns
Long
sle
eved
flui
d r
epel
lent
go
wns
may
be
req
uire
d if
the
re is
a r
isk
that
uni
form
/clo
thin
g a
nd s
kin
may
be
exp
ose
d t
o b
loo
d, b
od
y flu
ids,
ex
cret
ions
or
secr
etio
ns
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Rem
ova
l of
PP
ER
emo
ve P
PE
whe
n p
roce
dur
e is
co
mp
lete
. PP
E s
houl
d b
e re
mo
ved
in
the
fo
llow
ing
ord
er a
nd d
isp
ose
d o
f in
to h
ealt
hcar
e ri
sk w
aste
if
cont
amin
ated
wit
h b
loo
d a
nd/o
r b
od
y flu
ids
Glo
ves
•A
pro
n/g
ow
n•
Dec
ont
amin
ate
hand
s •
Eye
wea
r•
Mas
k (h
and
le b
y th
e m
ask
stra
ps
to a
void
to
uchi
ng t
he f
ront
)•
Dec
ont
amin
ate
hand
s•
All
mas
ks s
houl
d b
e d
isca
rded
into
hea
lthc
are
risk
was
te
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Env
iro
nmen
tal
Dec
ont
amin
atio
nR
out
ine
envi
ronm
enta
l cle
anin
g is
req
uire
d t
o m
inim
ise
the
num
ber
of
mic
ro-o
rgan
ism
s in
the
en
viro
nmen
t.
Par
ticu
lar
atte
ntio
n sh
oul
d b
e g
iven
to
fre
que
ntly
to
uche
d s
urfa
ces
and
tho
se m
ost
like
ly
to b
e co
ntam
inat
ed w
ith
blo
od
or
bo
dy
fluid
s e.
g. b
edra
ils, m
attr
ess,
bed
sid
e ta
ble
s,
com
mo
des
, do
ork
nob
s, s
inks
, sur
face
s an
d e
qui
pm
ent
clo
se t
o t
he p
atie
nt
Che
mic
al d
isin
fect
ants
are
no
t re
com
men
ded
fo
r ro
utin
e en
viro
nmen
tal c
lean
ing
Whe
n us
ing
dis
infe
ctan
ts, s
taff
sho
uld
fo
llow
the
man
ufac
ture
r’s in
stru
ctio
ns f
or
dilu
tio
n an
d
cont
act
tim
es
Ref
er t
o N
atio
nal H
osp
ital
Offi
ce C
lean
ing
Man
ual 2
00
6
Pat
ient
car
e en
viro
nmen
t b
e cl
eane
d a
nd
dis
infe
cted
wit
h a
det
erg
ent
and
100
0pp
m
of
avai
lab
le c
hlo
rine
dai
ly b
efo
re u
se o
n an
oth
er p
atie
nt if
co
ntam
inat
ed w
ith
resp
irat
ory
sec
reti
ons
. P
PE
sho
uld
be
wo
rn
for
all c
lean
ing
pro
ced
ures
as
per
pag
e 18
0-18
2.
Ro
om
sho
uld
rem
ain
vaca
nt f
or
one
ho
ur
wit
h w
ind
ow
s o
pen
bef
ore
re-
use
Pat
ient
Car
e E
qui
pm
ent
&D
eco
ntam
inat
ion
of
Med
ical
Dev
ices
Med
ical
dev
ices
des
igna
ted
as
“Sin
gle
Use
Onl
y” m
ust
not
be
rep
roce
ssed
or
reus
ed u
nder
an
y ci
rcum
stan
ces
(MD
A D
B 2
000)
, (M
DD
) 93/
42/E
EC
No
n-cr
itic
al e
qui
pm
ent
No
n-cr
itic
al e
qui
pm
ent
refe
rs t
o e
qui
pm
ent
that
is e
ithe
r no
t in
co
ntac
t w
ith
a p
atie
nt o
r in
co
ntac
t w
ith
heal
thy
skin
. Suc
h eq
uip
men
t sh
oul
d b
e:In
a s
tate
of
go
od
rep
air
in o
rder
to
fac
ilita
te e
ffec
tive
cle
anin
g•
Mus
t b
e th
oro
ughl
y cl
eane
d p
rio
r to
use
on
ano
ther
pat
ient
/res
iden
t. If
so
iled
wit
h •
blo
od
or
bo
dy
fluid
s, d
isin
fect
usi
ng a
chl
ori
ne-r
elea
sing
so
luti
on
of
1000
pp
m, o
r eq
uiva
lent
acc
ord
ing
to
man
ufac
ture
r’s in
stru
ctio
ns, r
inse
and
dry
.
Reu
sab
le in
vasi
ve m
edic
al d
evic
es (
RIM
D)
RIM
D r
efer
s to
eq
uip
men
t th
at is
cla
ssifi
ed a
s se
mi-c
riti
cal o
r cr
itic
al. R
IMD
s ar
e in
co
ntac
t w
ith
ster
ile b
od
y si
tes,
muc
ous
mem
bra
nes
and
bre
aks
in t
he s
kin.
HC
Ws
mus
t en
sure
tha
t R
IMD
s ar
e no
t us
ed f
or
ano
ther
pat
ient
unt
il th
ey h
ave
bee
n cl
eane
d a
nd r
epro
cess
ed
app
rop
riat
ely.
(HSE
Co
de
of
Pra
ctic
e fo
r D
eco
ntam
inat
ion
of
Reu
sab
le In
vasi
ve M
edic
al D
evic
es 2
007)
ww
w.h
se.ie
/eng
/Pub
licat
ions
/Ho
spit
als/
Co
de_
of_
Pra
ctic
e_fo
r_D
eco
ntam
inat
ion_
of_
Reu
sab
le_I
nvas
ive_
Med
ical
_Dev
ices
_.ht
ml
ww
w.h
psc
.ie/h
psc
/A-Z
/Mic
rob
iolo
gyA
ntim
icro
bia
lRes
ista
nce/
CJD
/Gui
dan
ce/
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Man
agem
ent
of
Hea
lth
Car
e R
isk
Was
te
Dis
po
se o
f he
alth
care
ris
k w
aste
in a
cco
rdan
ce w
ith
the
Dep
artm
ent
of
Hea
lth
& C
hild
ren’
s (D
oH
C) G
uid
elin
es f
or
Was
te D
isp
osa
l, w
hich
out
lines
the
cat
ego
risa
tio
n an
d s
egre
gat
ion
of
heal
thca
re w
aste
.
Dis
po
sal o
f sh
arp
s;Sy
ring
es a
nd n
eed
les
sho
uld
be
dis
po
sed
of
as a
sin
gle
uni
t•
Use
d s
harp
s sh
oul
d b
e ca
refu
lly d
isca
rded
into
des
igna
ted
sha
rps
bin
at
the
po
int
of
use
•Sh
arp
s b
in s
houl
d b
e se
cure
ly s
tore
d o
ut o
f re
ach
of
clie
nts,
vis
ito
rs a
nd c
hild
ren
•N
eed
les
sho
uld
no
t b
e re
-cap
ped
, ben
t, b
roke
n o
r d
isas
sem
ble
d•
Shar
ps
sho
uld
no
t b
e p
asse
d f
rom
per
son-
to-p
erso
n b
y ha
nd•
Do
HC
Gui
del
ines
on
Dis
po
sal o
f H
ealt
hcar
e R
isk
Was
te a
re a
vaila
ble
at
ww
w.d
ohc
.ie/p
ublic
atio
ns/s
egre
gat
ion_
pac
kag
ing
.htm
l
Was
te c
ont
amin
ated
wit
h sp
utum
fro
m a
su
spec
ted
or
kno
wn
TB p
atie
nt s
houl
d b
e d
isp
ose
d o
f as
hea
lthc
are
risk
was
te w
ithi
n a
heal
thca
re f
acili
ty
Res
pir
ato
ry m
asks
sho
uld
be
dis
po
sed
of
into
Hea
lthc
are
risk
was
te
Man
agem
ent
of
need
le s
tick
in
juri
es (
NSI
) an
d
blo
od
and
bo
dy
flui
d e
xpo
sure
All
faci
litie
s m
ust
have
a lo
cal g
uid
elin
e o
n th
e m
anag
emen
t o
f ne
edle
sti
ck in
juri
es a
nd b
loo
d
and
bo
dy
fluid
exp
osu
re. T
his
gui
del
ine
sho
uld
incl
ude;
Firs
t ai
d•
Ris
k as
sess
men
t an
d s
cree
ning
of
sour
ce p
atie
nt (i
f kn
ow
n)•
Ris
k as
sess
men
t f
or
chem
op
rop
hyla
xis
•C
oun
selli
ng a
nd f
ollo
w u
p t
esti
ng
•
Furt
her
info
rmat
ion
fro
m
ww
w.d
ohc
.ie/p
ublic
atio
ns/t
rans
mis
sio
n_o
f_b
loo
d_b
orn
e_d
isea
ses_
2006
.htm
l
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
-180-
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-181-
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Typ
e an
d s
elec
tio
n o
f P
PE
PP
E c
ons
ists
of:
G
love
s,•
Ap
rons
/go
wns
•E
ye, n
asal
and
mo
uth
pro
tect
ion
• Eac
h H
CW
sho
uld
mak
e an
ris
k as
sess
men
t o
f th
e p
lann
ed p
roce
dur
e an
d s
elec
t P
PE
dep
end
ing
on;
The
natu
re o
f th
e p
roce
dur
e•
The
risk
of
exp
osu
re t
o b
loo
d a
nd b
od
y flu
ids
•Th
e ri
sk o
f co
ntam
inat
ion
•
Ad
dit
iona
l res
pir
ato
ry p
rote
ctio
n re
qui
red
(s
ee f
acia
l pro
tect
ion
sect
ion)
Glo
ves
Glo
ves
sho
uld
be
sing
le u
se it
ems
and
sho
uld
co
nfo
rm t
o E
uro
pea
n C
om
mun
ity
Stan
dar
ds
Glo
ves
are
reco
mm
end
ed;
For
all a
ctiv
itie
s th
at c
arry
a r
isk
of
exp
osu
re t
o b
loo
d, b
od
y flu
ids,
•
secr
etio
ns o
r ex
cret
ions
, sha
rps
or
cont
amin
ated
inst
rum
ents
Whe
n to
uchi
ng m
uco
us m
emb
rane
s an
d n
on-
inta
ct s
kin
•W
hen
hand
ling
co
ntam
inat
ed e
qui
pm
ent
• Glo
ves
sho
uld
be;
Sing
le u
se o
nly
•St
erile
if c
ont
act
anti
cip
ated
wit
h st
erile
bo
dy
site
•
Put
on
imm
edia
tely
bef
ore
an
epis
od
e o
f p
atie
nt c
ont
act
and
•
rem
ove
as
soo
n as
the
act
ivit
y is
co
mp
lete
dC
hang
ed w
hen
cari
ng f
or
diff
eren
t p
atie
nts
and
bet
wee
n d
iffer
ent
•ca
re a
ctiv
itie
s o
n th
e sa
me
pat
ient
Dis
po
sed
of
as h
ealt
h ca
re r
isk
was
te if
co
ntam
inat
ed w
ith
blo
od
or
•b
od
y flu
ids
fro
m p
atie
nts
wit
h su
spec
ted
or
kno
wn
infe
ctio
n.
Han
d h
ygie
ne s
houl
d b
e p
erfo
rmed
bef
ore
do
nnin
g a
nd im
med
iate
ly
follo
win
g r
emo
val o
f g
love
s
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Face
pro
tect
ion
Face
pro
tect
ion
sho
uld
be
wo
rn w
here
:
Ther
e is
a r
isk
of
blo
od
, bo
dy
fluid
s,
•se
cret
ions
or
excr
etio
ns s
pla
shin
g in
to t
he
face
or
eyes
Whe
n p
laci
ng a
cat
hete
r o
r in
ject
ing
into
•
the
spin
al o
r ep
idur
al s
pac
e.
Face
pro
tect
ion
cons
ists
of
one
of
the
follo
win
g:
Flui
d r
epel
lent
mas
k w
ith
sep
arat
e •
go
gg
les
Res
pir
ato
ry m
ask
(FFP
2/3)
•Fa
ce s
hiel
d•
Flui
d r
epel
lent
mas
k w
ith
eye
shie
ld.
• Face
pro
tect
ion
sho
uld
be:
Sing
le u
se o
r si
ngle
per
son
use
(fac
e •
shie
lds
and
go
gg
les
can
be
reus
ed
by
the
sam
e H
CW
but
the
y m
ust
be
adeq
uate
ly c
lean
ed a
nd d
isin
fect
ed a
s p
er m
anuf
actu
rer’s
inst
ruct
ions
aft
er e
ach
use.
In a
dd
itio
n to
eye
pro
tect
ion
as r
equi
red
fo
r St
and
ard
Pre
caut
ions
HC
Ws
and
vis
ito
rs s
houl
d d
on
corr
ectl
y fit
ted
: FF
P2
mas
ks b
efo
re e
nter
ing
the
iso
lati
on
roo
m o
f a
susp
ecte
d o
r co
nfirm
ed
•in
fect
ious
TB
cas
e w
here
MD
R-T
B n
ot
susp
ecte
dFF
P3
mas
k d
urin
g h
igh
risk
pro
ced
ures
fo
r al
l pat
ient
s w
here
TB
is s
usp
ecte
d
•o
r co
nfirm
ed (s
usce
pti
ble
or
MD
R) s
uch
as:
Sput
um in
duc
tio
no
C
oug
h p
rod
ucin
g p
roce
dur
es (e
.g. a
dm
inis
teri
ng a
ero
solis
ed
o
med
icat
ions
, bro
ncho
sco
py,
air
way
suc
tio
ning
, end
otr
ache
al in
tub
atio
n)P
roce
dur
es w
here
aer
oso
lisat
ion
of
dra
inag
e flu
id f
rom
an
absc
ess/
o
lesi
ons
may
occ
urFF
P3
mas
ks b
efo
re e
nter
ing
the
iso
lati
on
roo
m o
f a
susp
ecte
d o
r kn
ow
n ca
se
•o
f M
DR
-TB
or
XD
R-T
B
To p
rese
rve
pri
vacy
and
co
nfid
enti
alit
y re
stri
ctin
g v
isit
ing
to
imm
edia
te f
amily
sh
oul
d b
e d
iscu
ssed
wit
h th
e p
atie
nt
All
HC
Ws
who
may
be
req
uire
d t
o u
se r
esp
irat
ory
mas
ks (F
FP2
& F
FP3)
dur
ing
th
e co
urse
of
thei
r w
ork
sho
uld
be
fit t
este
d b
y a
trai
ned
pro
fess
iona
l wit
hin
each
o
rgan
isat
ion
HC
Ws
sho
uld
fit
chec
k th
e m
ask
each
tim
e it
is w
orn
to
che
ck t
he s
eal
HC
Ws
visi
ting
a p
atie
nt in
the
ir o
wn
hom
e sh
oul
d w
ear
a FF
P2
or
FFP
3 m
ask
whi
le
the
pat
ient
is in
fect
ious
(see
cha
pte
r 6
on
Infe
ctio
n P
reve
ntio
n an
d C
ont
rol f
or
dis
cont
inua
tio
n o
f A
irb
orn
e P
reca
utio
ns).
Pat
ient
pri
vacy
mus
t b
e m
aint
aine
d if
m
ask
is w
orn
in t
he h
om
e.
All
mas
ks s
houl
d b
e re
mo
ved
in t
he a
nte
roo
m o
r im
med
iate
ly o
utsi
de
the
sing
le
roo
m if
the
re is
no
ant
e ro
om
Dis
card
mas
k in
to h
ealt
hcar
e ri
sk w
aste
Dec
ont
amin
ate
hand
s im
med
iate
ly a
fter
rem
ovi
ng m
ask
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Ap
rons
or
go
wns
Dis
po
sab
le a
pro
ns s
houl
d b
e w
orn
whe
re t
here
is a
ris
k th
at t
he f
ront
of
unifo
rm/c
loth
ing
may
bec
om
e ex
po
sed
to
blo
od
, bo
dy
fluid
s, e
xcre
tio
ns
or
secr
etio
ns
Long
sle
eved
flui
d r
epel
lent
go
wns
may
be
req
uire
d if
the
re is
a r
isk
that
uni
form
/clo
thin
g a
nd s
kin
may
be
exp
ose
d t
o b
loo
d, b
od
y flu
ids,
ex
cret
ions
or
secr
etio
ns
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Rem
ova
l of
PP
ER
emo
ve P
PE
whe
n p
roce
dur
e is
co
mp
lete
. PP
E s
houl
d b
e re
mo
ved
in
the
fo
llow
ing
ord
er a
nd d
isp
ose
d o
f in
to h
ealt
hcar
e ri
sk w
aste
if
cont
amin
ated
wit
h b
loo
d a
nd/o
r b
od
y flu
ids
Glo
ves
•A
pro
n/g
ow
n•
Dec
ont
amin
ate
hand
s •
Eye
wea
r•
Mas
k (h
and
le b
y th
e m
ask
stra
ps
to a
void
to
uchi
ng t
he f
ront
)•
Dec
ont
amin
ate
hand
s•
All
mas
ks s
houl
d b
e d
isca
rded
into
hea
lthc
are
risk
was
te
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Env
iro
nmen
tal
Dec
ont
amin
atio
nR
out
ine
envi
ronm
enta
l cle
anin
g is
req
uire
d t
o m
inim
ise
the
num
ber
of
mic
ro-o
rgan
ism
s in
the
en
viro
nmen
t.
Par
ticu
lar
atte
ntio
n sh
oul
d b
e g
iven
to
fre
que
ntly
to
uche
d s
urfa
ces
and
tho
se m
ost
like
ly
to b
e co
ntam
inat
ed w
ith
blo
od
or
bo
dy
fluid
s e.
g. b
edra
ils, m
attr
ess,
bed
sid
e ta
ble
s,
com
mo
des
, do
ork
nob
s, s
inks
, sur
face
s an
d e
qui
pm
ent
clo
se t
o t
he p
atie
nt
Che
mic
al d
isin
fect
ants
are
no
t re
com
men
ded
fo
r ro
utin
e en
viro
nmen
tal c
lean
ing
Whe
n us
ing
dis
infe
ctan
ts, s
taff
sho
uld
fo
llow
the
man
ufac
ture
r’s in
stru
ctio
ns f
or
dilu
tio
n an
d
cont
act
tim
es
Ref
er t
o N
atio
nal H
osp
ital
Offi
ce C
lean
ing
Man
ual 2
00
6
Pat
ient
car
e en
viro
nmen
t b
e cl
eane
d a
nd
dis
infe
cted
wit
h a
det
erg
ent
and
100
0pp
m
of
avai
lab
le c
hlo
rine
dai
ly b
efo
re u
se o
n an
oth
er p
atie
nt if
co
ntam
inat
ed w
ith
resp
irat
ory
sec
reti
ons
. P
PE
sho
uld
be
wo
rn
for
all c
lean
ing
pro
ced
ures
as
per
pag
e 18
0-18
2.
Ro
om
sho
uld
rem
ain
vaca
nt f
or
one
ho
ur
wit
h w
ind
ow
s o
pen
bef
ore
re-
use
Pat
ient
Car
e E
qui
pm
ent
&D
eco
ntam
inat
ion
of
Med
ical
Dev
ices
Med
ical
dev
ices
des
igna
ted
as
“Sin
gle
Use
Onl
y” m
ust
not
be
rep
roce
ssed
or
reus
ed u
nder
an
y ci
rcum
stan
ces
(MD
A D
B 2
000)
, (M
DD
) 93/
42/E
EC
No
n-cr
itic
al e
qui
pm
ent
No
n-cr
itic
al e
qui
pm
ent
refe
rs t
o e
qui
pm
ent
that
is e
ithe
r no
t in
co
ntac
t w
ith
a p
atie
nt o
r in
co
ntac
t w
ith
heal
thy
skin
. Suc
h eq
uip
men
t sh
oul
d b
e:In
a s
tate
of
go
od
rep
air
in o
rder
to
fac
ilita
te e
ffec
tive
cle
anin
g•
Mus
t b
e th
oro
ughl
y cl
eane
d p
rio
r to
use
on
ano
ther
pat
ient
/res
iden
t. If
so
iled
wit
h •
blo
od
or
bo
dy
fluid
s, d
isin
fect
usi
ng a
chl
ori
ne-r
elea
sing
so
luti
on
of
1000
pp
m, o
r eq
uiva
lent
acc
ord
ing
to
man
ufac
ture
r’s in
stru
ctio
ns, r
inse
and
dry
.
Reu
sab
le in
vasi
ve m
edic
al d
evic
es (
RIM
D)
RIM
D r
efer
s to
eq
uip
men
t th
at is
cla
ssifi
ed a
s se
mi-c
riti
cal o
r cr
itic
al. R
IMD
s ar
e in
co
ntac
t w
ith
ster
ile b
od
y si
tes,
muc
ous
mem
bra
nes
and
bre
aks
in t
he s
kin.
HC
Ws
mus
t en
sure
tha
t R
IMD
s ar
e no
t us
ed f
or
ano
ther
pat
ient
unt
il th
ey h
ave
bee
n cl
eane
d a
nd r
epro
cess
ed
app
rop
riat
ely.
(HSE
Co
de
of
Pra
ctic
e fo
r D
eco
ntam
inat
ion
of
Reu
sab
le In
vasi
ve M
edic
al D
evic
es 2
007)
ww
w.h
se.ie
/eng
/Pub
licat
ions
/Ho
spit
als/
Co
de_
of_
Pra
ctic
e_fo
r_D
eco
ntam
inat
ion_
of_
Reu
sab
le_I
nvas
ive_
Med
ical
_Dev
ices
_.ht
ml
ww
w.h
psc
.ie/h
psc
/A-Z
/Mic
rob
iolo
gyA
ntim
icro
bia
lRes
ista
nce/
CJD
/Gui
dan
ce/
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Man
agem
ent
of
Hea
lth
Car
e R
isk
Was
te
Dis
po
se o
f he
alth
care
ris
k w
aste
in a
cco
rdan
ce w
ith
the
Dep
artm
ent
of
Hea
lth
& C
hild
ren’
s (D
oH
C) G
uid
elin
es f
or
Was
te D
isp
osa
l, w
hich
out
lines
the
cat
ego
risa
tio
n an
d s
egre
gat
ion
of
heal
thca
re w
aste
.
Dis
po
sal o
f sh
arp
s;Sy
ring
es a
nd n
eed
les
sho
uld
be
dis
po
sed
of
as a
sin
gle
uni
t•
Use
d s
harp
s sh
oul
d b
e ca
refu
lly d
isca
rded
into
des
igna
ted
sha
rps
bin
at
the
po
int
of
use
•Sh
arp
s b
in s
houl
d b
e se
cure
ly s
tore
d o
ut o
f re
ach
of
clie
nts,
vis
ito
rs a
nd c
hild
ren
•N
eed
les
sho
uld
no
t b
e re
-cap
ped
, ben
t, b
roke
n o
r d
isas
sem
ble
d•
Shar
ps
sho
uld
no
t b
e p
asse
d f
rom
per
son-
to-p
erso
n b
y ha
nd•
Do
HC
Gui
del
ines
on
Dis
po
sal o
f H
ealt
hcar
e R
isk
Was
te a
re a
vaila
ble
at
ww
w.d
ohc
.ie/p
ublic
atio
ns/s
egre
gat
ion_
pac
kag
ing
.htm
l
Was
te c
ont
amin
ated
wit
h sp
utum
fro
m a
su
spec
ted
or
kno
wn
TB p
atie
nt s
houl
d b
e d
isp
ose
d o
f as
hea
lthc
are
risk
was
te w
ithi
n a
heal
thca
re f
acili
ty
Res
pir
ato
ry m
asks
sho
uld
be
dis
po
sed
of
into
Hea
lthc
are
risk
was
te
Man
agem
ent
of
need
le s
tick
in
juri
es (
NSI
) an
d
blo
od
and
bo
dy
flui
d e
xpo
sure
All
faci
litie
s m
ust
have
a lo
cal g
uid
elin
e o
n th
e m
anag
emen
t o
f ne
edle
sti
ck in
juri
es a
nd b
loo
d
and
bo
dy
fluid
exp
osu
re. T
his
gui
del
ine
sho
uld
incl
ude;
Firs
t ai
d•
Ris
k as
sess
men
t an
d s
cree
ning
of
sour
ce p
atie
nt (i
f kn
ow
n)•
Ris
k as
sess
men
t f
or
chem
op
rop
hyla
xis
•C
oun
selli
ng a
nd f
ollo
w u
p t
esti
ng
•
Furt
her
info
rmat
ion
fro
m
ww
w.d
ohc
.ie/p
ublic
atio
ns/t
rans
mis
sio
n_o
f_b
loo
d_b
orn
e_d
isea
ses_
2006
.htm
l
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
Laun
dry
car
eLa
und
ry s
houl
d b
e ha
ndle
d a
nd t
rans
po
rted
in a
man
ner
that
pre
vent
s tr
ansm
issi
on
of
mic
ro-o
rgan
ism
s to
o
ther
pat
ient
s, H
CW
s o
r th
e en
viro
nmen
t
Staf
f ha
ndlin
g s
oile
d li
nen
sho
uld
wea
r g
love
s an
d a
dis
po
sab
le p
last
ic a
pro
n
Seg
reg
atio
n an
d t
rans
po
rtat
ion
of
used
laun
dry
sho
uld
be
in a
cco
rdan
ce w
ith
the
gui
del
ines
fro
m t
he
Soci
ety
of
Line
n Se
rvic
es a
nd L
aund
ry M
anag
ers
(200
8)
Staf
f sh
oul
d n
ot
man
ually
slu
ice
or
soak
so
iled
or
infe
cted
line
n/cl
oth
ing
Line
n sh
oul
d b
e he
at d
isin
fect
ed d
urin
g t
he w
ash
pro
cess
by
rais
ing
the
tem
per
atur
e to
eit
her
65°C
fo
r no
t le
ss t
han
10 m
inut
es o
r p
refe
rab
ly 7
1°C
fo
r no
t le
ss t
han
3 m
inut
es. D
isin
fect
ion
of
heat
lab
ile m
ater
ials
(a
cco
rdin
g t
o m
anuf
actu
rer
inst
ruct
ions
) can
be
achi
eved
at
low
tem
per
atur
es b
y in
tro
duc
ing
150
pp
m o
f ch
lori
ne in
to t
he p
enul
tim
ate
rins
e.
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Spill
ages
Spill
ages
of
blo
od
, uri
ne, f
aece
s o
r vo
mit
sho
uld
be
dea
lt w
ith
imm
edia
tely
wea
ring
pro
tect
ive
clo
thin
g
For
spill
ages
of
bo
dy
fluid
(e.g
. uri
ne, f
aece
s o
r vo
mit
);So
ak u
p a
s m
uch
of
the
visi
ble
mat
eria
l as
po
ssib
le w
ith
dis
po
sab
le p
aper
to
wel
s•
Dis
po
se o
f th
e so
iled
pap
er t
ow
els
acco
rdin
g t
o n
atio
nal g
uid
elin
es
•C
lean
the
are
a us
ing
war
m w
ater
and
gen
eral
pur
po
se n
eutr
al d
eter
gen
t•
Dis
infe
ct u
sing
a c
hlo
rine
-rel
easi
ng s
olu
tio
n o
f 1,
000p
pm
, rin
se a
nd d
ry
•D
isca
rd g
love
s an
d a
pro
n ac
cord
ing
to
nat
iona
l gui
del
ines
•
Dec
ont
amin
ate
hand
s
•D
o n
ot
app
ly c
hlo
rine
-bas
ed d
isin
fect
ants
dire
ctly
ont
o s
pill
ages
of
urin
e as
it m
ay r
esul
t in
the
•
rele
ase
of
chlo
rine
vap
our
For
blo
od
sp
illag
es;
Dec
ont
amin
ate
all b
loo
d s
pill
s w
ith
a ch
lori
ne b
ased
dis
infe
ctan
t (e
.g. p
ow
der
, gra
nule
s o
r liq
uid
•
cont
aini
ng 1
0,00
0pp
m a
vaila
ble
chl
ori
ne) o
r su
itab
le a
lter
nati
ve, i
n lin
e w
ith
the
man
ufac
ture
r’s
inst
ruct
ions
and
loca
l po
licy
Wip
e up
the
sp
illag
e w
ith
dis
po
sab
le p
aper
to
wel
s an
d d
isca
rd in
to a
yel
low
hea
lthc
are
risk
bag
•
or
rig
id c
ont
aine
r W
ash
the
area
wit
h a
gen
eral
pur
po
se n
eutr
al d
eter
gen
t an
d w
ater
•D
isca
rd g
love
s an
d a
pro
n in
to h
ealt
hcar
e ri
sk b
ag•
Dec
ont
amin
ate
hand
s •
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Safe
In
ject
ion
Pra
ctic
es
Ad
min
istr
atio
n E
duc
ate
all H
CW
s w
ho a
dm
inis
ter
inje
ctio
ns o
n th
e im
po
rtan
ce o
f sa
fe in
ject
ion
pra
ctic
esA
ll fa
cilit
ies
sho
uld
hav
e a
gui
del
ine
on
the
use
of
mul
ti-d
ose
via
ls.
Pre
par
atio
n o
f In
ject
ions
All
inje
ctio
ns s
houl
d b
e p
rep
ared
in a
cle
an a
rea.
Thi
s ar
ea m
ust
not
be
used
fo
r d
isp
osi
ng o
f us
ed n
eed
les
and
syr
ing
es, h
and
ling
blo
od
sam
ple
s o
r an
y m
ater
ial c
ont
amin
ated
wit
h b
loo
d o
r b
od
y flu
ids
An
asep
tic
tech
niq
ue m
ust
be
used
whe
n d
raw
ing
up
inje
ctio
nsN
eed
les,
syr
ing
es a
nd c
annu
lae
are
ster
ile, s
ing
le u
se it
ems;
the
y m
ust
not
be
reus
ed f
or
ano
ther
pat
ient
no
r to
acc
ess
a m
edic
atio
n o
r so
luti
on
that
mig
ht b
e us
ed f
or
a su
bse
que
nt p
atie
ntU
se s
ing
le d
ose
via
ls w
here
ver
po
ssib
leD
o n
ot
use
sing
le d
ose
via
ls f
or
mul
tip
le p
atie
nts
Do
no
t co
mb
ine
left
ove
rs f
or
late
r us
e
Mul
ti-d
ose
via
lsM
ulti
-do
se v
ials
sho
uld
onl
y b
e us
ed w
hen
abso
lute
ly n
eces
sary
Res
tric
t w
here
ver
po
ssib
le t
he u
se o
f m
ulti
-do
se v
ials
to
a s
ing
le p
atie
ntLa
bel
via
l wit
h p
atie
nt’s
nam
e an
d d
ate
op
ened
Dis
card
if s
teri
lity
is c
om
pro
mis
ed o
r q
uest
iona
ble
Do
no
t le
ave
mul
ti-d
ose
via
ls a
t a
pat
ient
’s b
edsi
de
Use
a s
teri
le s
yrin
ge
and
nee
dle
eve
ry t
ime
a m
edic
atio
n vi
al is
acc
esse
d e
ven
if it
is a
2nd
do
se o
f th
e sa
me
dru
g f
or
the
sam
e p
atie
nt.
Infu
sio
ns a
nd in
trav
eno
us s
ets
Do
no
t us
e b
ags
or
bo
ttle
s o
f in
trav
eno
us fl
uid
s as
a c
om
mo
n so
urce
of
sup
ply
fo
r m
ulti
ple
pat
ient
s
Intr
aven
ous
flui
ds
and
intr
aven
ous
set
s ar
e si
ngle
use
ste
rile
item
s fo
r us
e b
y a
sing
le p
atie
ntC
ons
ider
a s
yrin
ge
or
need
le/c
annu
la c
ont
amin
ated
onc
e it
has
bee
n us
ed t
o e
nter
or
conn
ect
to a
pat
ient
’s
intr
aven
ous
infu
sio
n b
ag o
r ad
min
istr
atio
n se
t.
No
ad
dit
iona
l pre
caut
ions
nec
essa
ry
Pra
ctic
es
for
lum
bar
p
unct
ure
pro
ced
ures
Whe
n in
sert
ing
a c
athe
ter,
inje
ctin
g m
ater
ial/
chem
oth
erap
y in
to t
he s
pin
al c
anal
or
sub
dur
al s
pac
e,
heal
thca
re w
ork
ers
sho
uld
wea
r a
surg
ical
mas
k an
d a
dhe
re t
o a
sep
tic
tech
niq
ue.
No
ad
dit
iona
l pre
caut
ions
nec
essa
ry
-182-
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Typ
e an
d s
elec
tio
n o
f P
PE
PP
E c
ons
ists
of:
G
love
s,•
Ap
rons
/go
wns
•E
ye, n
asal
and
mo
uth
pro
tect
ion
• Eac
h H
CW
sho
uld
mak
e an
ris
k as
sess
men
t o
f th
e p
lann
ed p
roce
dur
e an
d s
elec
t P
PE
dep
end
ing
on;
The
natu
re o
f th
e p
roce
dur
e•
The
risk
of
exp
osu
re t
o b
loo
d a
nd b
od
y flu
ids
•Th
e ri
sk o
f co
ntam
inat
ion
•
Ad
dit
iona
l res
pir
ato
ry p
rote
ctio
n re
qui
red
(s
ee f
acia
l pro
tect
ion
sect
ion)
Glo
ves
Glo
ves
sho
uld
be
sing
le u
se it
ems
and
sho
uld
co
nfo
rm t
o E
uro
pea
n C
om
mun
ity
Stan
dar
ds
Glo
ves
are
reco
mm
end
ed;
For
all a
ctiv
itie
s th
at c
arry
a r
isk
of
exp
osu
re t
o b
loo
d, b
od
y flu
ids,
•
secr
etio
ns o
r ex
cret
ions
, sha
rps
or
cont
amin
ated
inst
rum
ents
Whe
n to
uchi
ng m
uco
us m
emb
rane
s an
d n
on-
inta
ct s
kin
•W
hen
hand
ling
co
ntam
inat
ed e
qui
pm
ent
• Glo
ves
sho
uld
be;
Sing
le u
se o
nly
•St
erile
if c
ont
act
anti
cip
ated
wit
h st
erile
bo
dy
site
•
Put
on
imm
edia
tely
bef
ore
an
epis
od
e o
f p
atie
nt c
ont
act
and
•
rem
ove
as
soo
n as
the
act
ivit
y is
co
mp
lete
dC
hang
ed w
hen
cari
ng f
or
diff
eren
t p
atie
nts
and
bet
wee
n d
iffer
ent
•ca
re a
ctiv
itie
s o
n th
e sa
me
pat
ient
Dis
po
sed
of
as h
ealt
h ca
re r
isk
was
te if
co
ntam
inat
ed w
ith
blo
od
or
•b
od
y flu
ids
fro
m p
atie
nts
wit
h su
spec
ted
or
kno
wn
infe
ctio
n.
Han
d h
ygie
ne s
houl
d b
e p
erfo
rmed
bef
ore
do
nnin
g a
nd im
med
iate
ly
follo
win
g r
emo
val o
f g
love
s
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Face
pro
tect
ion
Face
pro
tect
ion
sho
uld
be
wo
rn w
here
:
Ther
e is
a r
isk
of
blo
od
, bo
dy
fluid
s,
•se
cret
ions
or
excr
etio
ns s
pla
shin
g in
to t
he
face
or
eyes
Whe
n p
laci
ng a
cat
hete
r o
r in
ject
ing
into
•
the
spin
al o
r ep
idur
al s
pac
e.
Face
pro
tect
ion
cons
ists
of
one
of
the
follo
win
g:
Flui
d r
epel
lent
mas
k w
ith
sep
arat
e •
go
gg
les
Res
pir
ato
ry m
ask
(FFP
2/3)
•Fa
ce s
hiel
d•
Flui
d r
epel
lent
mas
k w
ith
eye
shie
ld.
• Face
pro
tect
ion
sho
uld
be:
Sing
le u
se o
r si
ngle
per
son
use
(fac
e •
shie
lds
and
go
gg
les
can
be
reus
ed
by
the
sam
e H
CW
but
the
y m
ust
be
adeq
uate
ly c
lean
ed a
nd d
isin
fect
ed a
s p
er m
anuf
actu
rer’s
inst
ruct
ions
aft
er e
ach
use.
In a
dd
itio
n to
eye
pro
tect
ion
as r
equi
red
fo
r St
and
ard
Pre
caut
ions
HC
Ws
and
vis
ito
rs s
houl
d d
on
corr
ectl
y fit
ted
: FF
P2
mas
ks b
efo
re e
nter
ing
the
iso
lati
on
roo
m o
f a
susp
ecte
d o
r co
nfirm
ed
•in
fect
ious
TB
cas
e w
here
MD
R-T
B n
ot
susp
ecte
dFF
P3
mas
k d
urin
g h
igh
risk
pro
ced
ures
fo
r al
l pat
ient
s w
here
TB
is s
usp
ecte
d
•o
r co
nfirm
ed (s
usce
pti
ble
or
MD
R) s
uch
as:
Sput
um in
duc
tio
no
C
oug
h p
rod
ucin
g p
roce
dur
es (e
.g. a
dm
inis
teri
ng a
ero
solis
ed
o
med
icat
ions
, bro
ncho
sco
py,
air
way
suc
tio
ning
, end
otr
ache
al in
tub
atio
n)P
roce
dur
es w
here
aer
oso
lisat
ion
of
dra
inag
e flu
id f
rom
an
absc
ess/
o
lesi
ons
may
occ
urFF
P3
mas
ks b
efo
re e
nter
ing
the
iso
lati
on
roo
m o
f a
susp
ecte
d o
r kn
ow
n ca
se
•o
f M
DR
-TB
or
XD
R-T
B
To p
rese
rve
pri
vacy
and
co
nfid
enti
alit
y re
stri
ctin
g v
isit
ing
to
imm
edia
te f
amily
sh
oul
d b
e d
iscu
ssed
wit
h th
e p
atie
nt
All
HC
Ws
who
may
be
req
uire
d t
o u
se r
esp
irat
ory
mas
ks (F
FP2
& F
FP3)
dur
ing
th
e co
urse
of
thei
r w
ork
sho
uld
be
fit t
este
d b
y a
trai
ned
pro
fess
iona
l wit
hin
each
o
rgan
isat
ion
HC
Ws
sho
uld
fit
chec
k th
e m
ask
each
tim
e it
is w
orn
to
che
ck t
he s
eal
HC
Ws
visi
ting
a p
atie
nt in
the
ir o
wn
hom
e sh
oul
d w
ear
a FF
P2
or
FFP
3 m
ask
whi
le
the
pat
ient
is in
fect
ious
(see
cha
pte
r 6
on
Infe
ctio
n P
reve
ntio
n an
d C
ont
rol f
or
dis
cont
inua
tio
n o
f A
irb
orn
e P
reca
utio
ns).
Pat
ient
pri
vacy
mus
t b
e m
aint
aine
d if
m
ask
is w
orn
in t
he h
om
e.
All
mas
ks s
houl
d b
e re
mo
ved
in t
he a
nte
roo
m o
r im
med
iate
ly o
utsi
de
the
sing
le
roo
m if
the
re is
no
ant
e ro
om
Dis
card
mas
k in
to h
ealt
hcar
e ri
sk w
aste
Dec
ont
amin
ate
hand
s im
med
iate
ly a
fter
rem
ovi
ng m
ask
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Use
of
Per
sona
l P
rote
ctiv
e E
qui
pm
ent
(PP
E)
Ap
rons
or
go
wns
Dis
po
sab
le a
pro
ns s
houl
d b
e w
orn
whe
re t
here
is a
ris
k th
at t
he f
ront
of
unifo
rm/c
loth
ing
may
bec
om
e ex
po
sed
to
blo
od
, bo
dy
fluid
s, e
xcre
tio
ns
or
secr
etio
ns
Long
sle
eved
flui
d r
epel
lent
go
wns
may
be
req
uire
d if
the
re is
a r
isk
that
uni
form
/clo
thin
g a
nd s
kin
may
be
exp
ose
d t
o b
loo
d, b
od
y flu
ids,
ex
cret
ions
or
secr
etio
ns
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Rem
ova
l of
PP
ER
emo
ve P
PE
whe
n p
roce
dur
e is
co
mp
lete
. PP
E s
houl
d b
e re
mo
ved
in
the
fo
llow
ing
ord
er a
nd d
isp
ose
d o
f in
to h
ealt
hcar
e ri
sk w
aste
if
cont
amin
ated
wit
h b
loo
d a
nd/o
r b
od
y flu
ids
Glo
ves
•A
pro
n/g
ow
n•
Dec
ont
amin
ate
hand
s •
Eye
wea
r•
Mas
k (h
and
le b
y th
e m
ask
stra
ps
to a
void
to
uchi
ng t
he f
ront
)•
Dec
ont
amin
ate
hand
s•
All
mas
ks s
houl
d b
e d
isca
rded
into
hea
lthc
are
risk
was
te
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Env
iro
nmen
tal
Dec
ont
amin
atio
nR
out
ine
envi
ronm
enta
l cle
anin
g is
req
uire
d t
o m
inim
ise
the
num
ber
of
mic
ro-o
rgan
ism
s in
the
en
viro
nmen
t.
Par
ticu
lar
atte
ntio
n sh
oul
d b
e g
iven
to
fre
que
ntly
to
uche
d s
urfa
ces
and
tho
se m
ost
like
ly
to b
e co
ntam
inat
ed w
ith
blo
od
or
bo
dy
fluid
s e.
g. b
edra
ils, m
attr
ess,
bed
sid
e ta
ble
s,
com
mo
des
, do
ork
nob
s, s
inks
, sur
face
s an
d e
qui
pm
ent
clo
se t
o t
he p
atie
nt
Che
mic
al d
isin
fect
ants
are
no
t re
com
men
ded
fo
r ro
utin
e en
viro
nmen
tal c
lean
ing
Whe
n us
ing
dis
infe
ctan
ts, s
taff
sho
uld
fo
llow
the
man
ufac
ture
r’s in
stru
ctio
ns f
or
dilu
tio
n an
d
cont
act
tim
es
Ref
er t
o N
atio
nal H
osp
ital
Offi
ce C
lean
ing
Man
ual 2
00
6
Pat
ient
car
e en
viro
nmen
t b
e cl
eane
d a
nd
dis
infe
cted
wit
h a
det
erg
ent
and
100
0pp
m
of
avai
lab
le c
hlo
rine
dai
ly b
efo
re u
se o
n an
oth
er p
atie
nt if
co
ntam
inat
ed w
ith
resp
irat
ory
sec
reti
ons
. P
PE
sho
uld
be
wo
rn
for
all c
lean
ing
pro
ced
ures
as
per
pag
e 18
0-18
2.
Ro
om
sho
uld
rem
ain
vaca
nt f
or
one
ho
ur
wit
h w
ind
ow
s o
pen
bef
ore
re-
use
Pat
ient
Car
e E
qui
pm
ent
&D
eco
ntam
inat
ion
of
Med
ical
Dev
ices
Med
ical
dev
ices
des
igna
ted
as
“Sin
gle
Use
Onl
y” m
ust
not
be
rep
roce
ssed
or
reus
ed u
nder
an
y ci
rcum
stan
ces
(MD
A D
B 2
000)
, (M
DD
) 93/
42/E
EC
No
n-cr
itic
al e
qui
pm
ent
No
n-cr
itic
al e
qui
pm
ent
refe
rs t
o e
qui
pm
ent
that
is e
ithe
r no
t in
co
ntac
t w
ith
a p
atie
nt o
r in
co
ntac
t w
ith
heal
thy
skin
. Suc
h eq
uip
men
t sh
oul
d b
e:In
a s
tate
of
go
od
rep
air
in o
rder
to
fac
ilita
te e
ffec
tive
cle
anin
g•
Mus
t b
e th
oro
ughl
y cl
eane
d p
rio
r to
use
on
ano
ther
pat
ient
/res
iden
t. If
so
iled
wit
h •
blo
od
or
bo
dy
fluid
s, d
isin
fect
usi
ng a
chl
ori
ne-r
elea
sing
so
luti
on
of
1000
pp
m, o
r eq
uiva
lent
acc
ord
ing
to
man
ufac
ture
r’s in
stru
ctio
ns, r
inse
and
dry
.
Reu
sab
le in
vasi
ve m
edic
al d
evic
es (
RIM
D)
RIM
D r
efer
s to
eq
uip
men
t th
at is
cla
ssifi
ed a
s se
mi-c
riti
cal o
r cr
itic
al. R
IMD
s ar
e in
co
ntac
t w
ith
ster
ile b
od
y si
tes,
muc
ous
mem
bra
nes
and
bre
aks
in t
he s
kin.
HC
Ws
mus
t en
sure
tha
t R
IMD
s ar
e no
t us
ed f
or
ano
ther
pat
ient
unt
il th
ey h
ave
bee
n cl
eane
d a
nd r
epro
cess
ed
app
rop
riat
ely.
(HSE
Co
de
of
Pra
ctic
e fo
r D
eco
ntam
inat
ion
of
Reu
sab
le In
vasi
ve M
edic
al D
evic
es 2
007)
ww
w.h
se.ie
/eng
/Pub
licat
ions
/Ho
spit
als/
Co
de_
of_
Pra
ctic
e_fo
r_D
eco
ntam
inat
ion_
of_
Reu
sab
le_I
nvas
ive_
Med
ical
_Dev
ices
_.ht
ml
ww
w.h
psc
.ie/h
psc
/A-Z
/Mic
rob
iolo
gyA
ntim
icro
bia
lRes
ista
nce/
CJD
/Gui
dan
ce/
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Man
agem
ent
of
Hea
lth
Car
e R
isk
Was
te
Dis
po
se o
f he
alth
care
ris
k w
aste
in a
cco
rdan
ce w
ith
the
Dep
artm
ent
of
Hea
lth
& C
hild
ren’
s (D
oH
C) G
uid
elin
es f
or
Was
te D
isp
osa
l, w
hich
out
lines
the
cat
ego
risa
tio
n an
d s
egre
gat
ion
of
heal
thca
re w
aste
.
Dis
po
sal o
f sh
arp
s;Sy
ring
es a
nd n
eed
les
sho
uld
be
dis
po
sed
of
as a
sin
gle
uni
t•
Use
d s
harp
s sh
oul
d b
e ca
refu
lly d
isca
rded
into
des
igna
ted
sha
rps
bin
at
the
po
int
of
use
•Sh
arp
s b
in s
houl
d b
e se
cure
ly s
tore
d o
ut o
f re
ach
of
clie
nts,
vis
ito
rs a
nd c
hild
ren
•N
eed
les
sho
uld
no
t b
e re
-cap
ped
, ben
t, b
roke
n o
r d
isas
sem
ble
d•
Shar
ps
sho
uld
no
t b
e p
asse
d f
rom
per
son-
to-p
erso
n b
y ha
nd•
Do
HC
Gui
del
ines
on
Dis
po
sal o
f H
ealt
hcar
e R
isk
Was
te a
re a
vaila
ble
at
ww
w.d
ohc
.ie/p
ublic
atio
ns/s
egre
gat
ion_
pac
kag
ing
.htm
l
Was
te c
ont
amin
ated
wit
h sp
utum
fro
m a
su
spec
ted
or
kno
wn
TB p
atie
nt s
houl
d b
e d
isp
ose
d o
f as
hea
lthc
are
risk
was
te w
ithi
n a
heal
thca
re f
acili
ty
Res
pir
ato
ry m
asks
sho
uld
be
dis
po
sed
of
into
Hea
lthc
are
risk
was
te
Man
agem
ent
of
need
le s
tick
in
juri
es (
NSI
) an
d
blo
od
and
bo
dy
flui
d e
xpo
sure
All
faci
litie
s m
ust
have
a lo
cal g
uid
elin
e o
n th
e m
anag
emen
t o
f ne
edle
sti
ck in
juri
es a
nd b
loo
d
and
bo
dy
fluid
exp
osu
re. T
his
gui
del
ine
sho
uld
incl
ude;
Firs
t ai
d•
Ris
k as
sess
men
t an
d s
cree
ning
of
sour
ce p
atie
nt (i
f kn
ow
n)•
Ris
k as
sess
men
t f
or
chem
op
rop
hyla
xis
•C
oun
selli
ng a
nd f
ollo
w u
p t
esti
ng
•
Furt
her
info
rmat
ion
fro
m
ww
w.d
ohc
.ie/p
ublic
atio
ns/t
rans
mis
sio
n_o
f_b
loo
d_b
orn
e_d
isea
ses_
2006
.htm
l
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-183-
Laun
dry
car
eLa
und
ry s
houl
d b
e ha
ndle
d a
nd t
rans
po
rted
in a
man
ner
that
pre
vent
s tr
ansm
issi
on
of
mic
ro-o
rgan
ism
s to
o
ther
pat
ient
s, H
CW
s o
r th
e en
viro
nmen
t
Staf
f ha
ndlin
g s
oile
d li
nen
sho
uld
wea
r g
love
s an
d a
dis
po
sab
le p
last
ic a
pro
n
Seg
reg
atio
n an
d t
rans
po
rtat
ion
of
used
laun
dry
sho
uld
be
in a
cco
rdan
ce w
ith
the
gui
del
ines
fro
m t
he
Soci
ety
of
Line
n Se
rvic
es a
nd L
aund
ry M
anag
ers
(200
8)
Staf
f sh
oul
d n
ot
man
ually
slu
ice
or
soak
so
iled
or
infe
cted
line
n/cl
oth
ing
Line
n sh
oul
d b
e he
at d
isin
fect
ed d
urin
g t
he w
ash
pro
cess
by
rais
ing
the
tem
per
atur
e to
eit
her
65°C
fo
r no
t le
ss t
han
10 m
inut
es o
r p
refe
rab
ly 7
1°C
fo
r no
t le
ss t
han
3 m
inut
es. D
isin
fect
ion
of
heat
lab
ile m
ater
ials
(a
cco
rdin
g t
o m
anuf
actu
rer
inst
ruct
ions
) can
be
achi
eved
at
low
tem
per
atur
es b
y in
tro
duc
ing
150
pp
m o
f ch
lori
ne in
to t
he p
enul
tim
ate
rins
e.
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Spill
ages
Spill
ages
of
blo
od
, uri
ne, f
aece
s o
r vo
mit
sho
uld
be
dea
lt w
ith
imm
edia
tely
wea
ring
pro
tect
ive
clo
thin
g
For
spill
ages
of
bo
dy
fluid
(e.g
. uri
ne, f
aece
s o
r vo
mit
);So
ak u
p a
s m
uch
of
the
visi
ble
mat
eria
l as
po
ssib
le w
ith
dis
po
sab
le p
aper
to
wel
s•
Dis
po
se o
f th
e so
iled
pap
er t
ow
els
acco
rdin
g t
o n
atio
nal g
uid
elin
es
•C
lean
the
are
a us
ing
war
m w
ater
and
gen
eral
pur
po
se n
eutr
al d
eter
gen
t•
Dis
infe
ct u
sing
a c
hlo
rine
-rel
easi
ng s
olu
tio
n o
f 1,
000p
pm
, rin
se a
nd d
ry
•D
isca
rd g
love
s an
d a
pro
n ac
cord
ing
to
nat
iona
l gui
del
ines
•
Dec
ont
amin
ate
hand
s
•D
o n
ot
app
ly c
hlo
rine
-bas
ed d
isin
fect
ants
dire
ctly
ont
o s
pill
ages
of
urin
e as
it m
ay r
esul
t in
the
•
rele
ase
of
chlo
rine
vap
our
For
blo
od
sp
illag
es;
Dec
ont
amin
ate
all b
loo
d s
pill
s w
ith
a ch
lori
ne b
ased
dis
infe
ctan
t (e
.g. p
ow
der
, gra
nule
s o
r liq
uid
•
cont
aini
ng 1
0,00
0pp
m a
vaila
ble
chl
ori
ne) o
r su
itab
le a
lter
nati
ve, i
n lin
e w
ith
the
man
ufac
ture
r’s
inst
ruct
ions
and
loca
l po
licy
Wip
e up
the
sp
illag
e w
ith
dis
po
sab
le p
aper
to
wel
s an
d d
isca
rd in
to a
yel
low
hea
lthc
are
risk
bag
•
or
rig
id c
ont
aine
r W
ash
the
area
wit
h a
gen
eral
pur
po
se n
eutr
al d
eter
gen
t an
d w
ater
•D
isca
rd g
love
s an
d a
pro
n in
to h
ealt
hcar
e ri
sk b
ag•
Dec
ont
amin
ate
hand
s •
No
ext
ra p
reca
utio
ns r
eco
mm
end
ed
Clin
ical
W
ork
P
ract
ice
STA
ND
AR
D P
RE
CA
UTI
ON
SA
IRB
OR
NE
PR
EC
AU
TIO
NS
Safe
In
ject
ion
Pra
ctic
es
Ad
min
istr
atio
n E
duc
ate
all H
CW
s w
ho a
dm
inis
ter
inje
ctio
ns o
n th
e im
po
rtan
ce o
f sa
fe in
ject
ion
pra
ctic
esA
ll fa
cilit
ies
sho
uld
hav
e a
gui
del
ine
on
the
use
of
mul
ti-d
ose
via
ls.
Pre
par
atio
n o
f In
ject
ions
All
inje
ctio
ns s
houl
d b
e p
rep
ared
in a
cle
an a
rea.
Thi
s ar
ea m
ust
not
be
used
fo
r d
isp
osi
ng o
f us
ed n
eed
les
and
syr
ing
es, h
and
ling
blo
od
sam
ple
s o
r an
y m
ater
ial c
ont
amin
ated
wit
h b
loo
d o
r b
od
y flu
ids
An
asep
tic
tech
niq
ue m
ust
be
used
whe
n d
raw
ing
up
inje
ctio
nsN
eed
les,
syr
ing
es a
nd c
annu
lae
are
ster
ile, s
ing
le u
se it
ems;
the
y m
ust
not
be
reus
ed f
or
ano
ther
pat
ient
no
r to
acc
ess
a m
edic
atio
n o
r so
luti
on
that
mig
ht b
e us
ed f
or
a su
bse
que
nt p
atie
ntU
se s
ing
le d
ose
via
ls w
here
ver
po
ssib
leD
o n
ot
use
sing
le d
ose
via
ls f
or
mul
tip
le p
atie
nts
Do
no
t co
mb
ine
left
ove
rs f
or
late
r us
e
Mul
ti-d
ose
via
lsM
ulti
-do
se v
ials
sho
uld
onl
y b
e us
ed w
hen
abso
lute
ly n
eces
sary
Res
tric
t w
here
ver
po
ssib
le t
he u
se o
f m
ulti
-do
se v
ials
to
a s
ing
le p
atie
ntLa
bel
via
l wit
h p
atie
nt’s
nam
e an
d d
ate
op
ened
Dis
card
if s
teri
lity
is c
om
pro
mis
ed o
r q
uest
iona
ble
Do
no
t le
ave
mul
ti-d
ose
via
ls a
t a
pat
ient
’s b
edsi
de
Use
a s
teri
le s
yrin
ge
and
nee
dle
eve
ry t
ime
a m
edic
atio
n vi
al is
acc
esse
d e
ven
if it
is a
2nd
do
se o
f th
e sa
me
dru
g f
or
the
sam
e p
atie
nt.
Infu
sio
ns a
nd in
trav
eno
us s
ets
Do
no
t us
e b
ags
or
bo
ttle
s o
f in
trav
eno
us fl
uid
s as
a c
om
mo
n so
urce
of
sup
ply
fo
r m
ulti
ple
pat
ient
s
Intr
aven
ous
flui
ds
and
intr
aven
ous
set
s ar
e si
ngle
use
ste
rile
item
s fo
r us
e b
y a
sing
le p
atie
ntC
ons
ider
a s
yrin
ge
or
need
le/c
annu
la c
ont
amin
ated
onc
e it
has
bee
n us
ed t
o e
nter
or
conn
ect
to a
pat
ient
’s
intr
aven
ous
infu
sio
n b
ag o
r ad
min
istr
atio
n se
t.
No
ad
dit
iona
l pre
caut
ions
nec
essa
ry
Pra
ctic
es
for
lum
bar
p
unct
ure
pro
ced
ures
Whe
n in
sert
ing
a c
athe
ter,
inje
ctin
g m
ater
ial/
chem
oth
erap
y in
to t
he s
pin
al c
anal
or
sub
dur
al s
pac
e,
heal
thca
re w
ork
ers
sho
uld
wea
r a
surg
ical
mas
k an
d a
dhe
re t
o a
sep
tic
tech
niq
ue.
No
ad
dit
iona
l pre
caut
ions
nec
essa
ry
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-184-
Appendix 11: Discharge instructions for patients with potentially infectious TB You have been placed on medication to treat TB. You are now being discharged home from hospital. However, your TB may remain infectious (contagious) for some time longer. A number of general instructions and temporary restrictions are therefore being advised until it is certain that you are no longer infectious to others. These restrictions will help reduce any possibility of spread of TB germs to other people. You should follow them carefully until you are advised otherwise by the doctor who is treating your TB.
General instructions:• Take your TB medications as instructed by your doctor• You should always cover your nose and mouth with a tissue when coughing or sneezing• Dispose of used tissues in a bin immediately after use and wash your hands• It is ok to share eating utensils (spoons, forks, cups or glasses) and other household items• Keep your doctor’s or clinic appointment so that you complete your treatment.
Temporary restrictions after hospital discharge• Do not go to work or school and you should avoid going to any public areas (e.g. cinema, pubs or
clubs, using public transport) until the doctor who is treating your TB says it is ok for you to do so.
• If there are others living at home you should- limit the time you spend in common household areas (e.g. kitchen or living room) and keep
your bedroom door closed- If advised by your doctor to wear a surgical mask (as a temporary measure) that covers your
nose and mouth (as explained to you in hospital) when you are around other people, follow the instructions given. This will reduce the number of TB germs that you put into the air when you cough or talk.
• You should not be around babies, young children or, to the best of your knowledge, people who have weakened immune systems such as people with HIV/AIDS. (If there are young children at home, you may still be discharged home if the children have been tested for TB infection and are being followed up by the local public health department).
These temporary restrictions will be removed once your doctor decides that you are no longer infectious. However, your TB treatment will continue until the course is completed.
If you have any questions about your treatment, please call ……………………………….……
Adapted with kind permission from Tuberculosis, Clinical Policies and Protocols. New York City Department of Health and Mental Hygiene (2008). Available from www.nyc.gov/html/doh/downloads/pdf/tb/tb-protocol.pdf.
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-185-
Appendix 12: List of Tuberculosis-related websites and resourcesNational TB WebsitesHealth Protection Surveillance Centrewww.hpsc.ie/hpsc/A-Z/VaccinePreventable/TuberculosisTB/
Irish Thoracic Societywww.irishthoracicsociety.com/
Immunisation Guidelines of Irelandwww.hpsc.ie/hpsc/A-Z/VaccinePreventable/Vaccination/Guidance/
International TB WebsitesCenters for Disease Control and Prevention, USA, Division of TB Elimination www.cdc.gov/tb/
Health Protection Agency, UKwww.hpa.org.uk/webw/HPAweb&Page&HPAwebAutoListName/Page/1191942150134?p=1191942150134
The Public Health Agency of Canadawww.phac-aspc.gc.ca/tbpc-latb/index.html
European Centre for Disease Prevention and Control www.ecdc.europa.eu/Health_topics/Tuberculosis/Tuberculosis.html
EuroTB: Surveillance of TB in Europe www.eurotb.org/
WHO-Geneva Tuberculosis Homepagewww.who.int/tb/en/
WHO-Euro Tuberculosis Sitewww.euro.who.int/tuberculosis
The Global Plan to Stop TB www.stoptb.org/globalplan/
WHO Stop TB Department www.who.int/tb/about/en/index.html
Stop TB Partnershipwww.stoptb.org/
The International Union against TB and Lung Diseasewww.iuatld.org/
NICE: TB information for the Publicwww.nice.org.uk/nicemedia/pdf/CG033publicinfo.pdf
TB Alertwww.tbalert.org/
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-186-
Tuberculosis Guidance
UKNICE Tuberculosis Clinical Guidancewww.nice.org.uk/search/guidancesearchresults.jsp?keywords=TUBERCULOSIS&searchType=guidance
Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000. Joint Tuberculosis Committee of the British Thoracic Society. Thorax 2000. Vol. 55, 11: 887-901www.thorax.bmj.com/cgi/reprint/55/11/887
USACenters for Disease Control and Prevention (CDC) TB Guidelines (listed by category or by date)http://www.cdc.gov/tb/pubs/mmwr/maj_guide.htm
CanadaCanadian Tuberculosis Standards 6th Edition, 2007www.phac-aspc.gc.ca/tbpc-latb/pubs/pdf/tbstand07_e.pdf
New ZealandNew Zealand TB Guidelines, 2003www.moh.govt.nz/moh.nsf/0/4760df3580a6f5b5cc256c86006ed394?OpenDocument
World Health OrganizationTuberculosis and Airflight (WHO) www.who.int/docstore/gtb/publications/aircraft/PDF/98_256.pdf
WHO Guidelines for the programmatic management of resistant TBwww.whqlibdoc.who.int/publications/2006/9241546956_eng.pdf
Treatment Guidelines for National Programmes – WHO Global Tuberculosis Programme, Geneva www.who.int/docstore/gtb/publications/ttgnp/
Guidelines for the prevention of tuberculosis in health care facilities in resource limited settings – WHO Global Tuberculosis Programme, Geneva www.who.int/docstore/gtb/publications/healthcare
What is DOTS? - Guide to the WHO recommended TB control strategy www.who.int/docstore/gtb/publications/whatisdots
Scientific ResourcesMEDLINEplus Tuberculosis www.nlm.nih.gov/medlineplus/tuberculosis.html
Francis J. Curry National Tuberculosis Centerwww.nationaltbcenter.edu/
New Jersey Medical School Global Tuberculosis Institute www.umdnj.edu/globaltb/home.htm
Stanford Center for Tuberculosis Research12www.stanford.edu/group/molepi/index.html
Brown University TB/HIV Research Laboratorywww.brown.edu/Research/TB-HIV_Lab/
The Public Health Research Institute (PHRI) Tuberculosis Centerwww.phri.org/programs/program_tbcenter.asp
Aeras Global TB Vaccine Foundation www.aeras.org/
Guidelines on the Prevention and Control of Tuberculosis in Ireland 2010 HSE/HPSC
-187-
Appendix 13: Respiratory hygiene and cough etiquette
When coughing or sneezing use a tissue or cover your nose and mouth
These 3 steps will help prevent the spread of respiratory infections
Dispose of the tissues afterwards in a waste bin
Decontaminate your hands after discarding tissue using soap and water or alcohol gel